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Abstract
Hibernation is a unique adaptation to conserve energy entering a hypometabolic (low metabolic rate) 
and hypothermic (low body temperature) state called torpor. Torpor is characterized by a drop in 
metabolism to 1-2% of basal metabolic rate and a decrease in body temperature to one to two degrees 
above ambient temperature. Metabolic rate is restored to basal metabolic rate and body temperature 
increases from 2-3°C to 36°C during the regularly timed arousal. The adenosine A1 receptor agonists 
promote the onset of hibernation and torpor in different species, through a yet undefined neuronal 
circuit. In the Arctic ground squirrel, CHA, an adenosine A1 receptor agonist, induces hibernation during 
the winter- hibernation season but not in summer even when the environmental conditions are kept 
constant (ambient temperature of 20C and a light cycle of 4L:20D). Thus, the phenomenon of CHA- 
induced hibernation is entrained to an endogenous circannual rhythm. In this work, I aim to identify the 
changes in neuronal activation that reflect the circannual rhythm regulating the seasonal difference in 
response to CHA. Arctic ground squirrels, housed at constant ambient temperature (2°C) and light cycle 
(4L:20D), were implanted with body temperature transmitters. I collected tissue during Summer, Fall, 
Winter and Torpor conditions for seasonal analysis. For treatment analysis, I collected tissue form 
animals treated with CHA or vehicle in Summer and Winter. Primarily, I used immunohistochemistry to 
identify cell groups affected by season and treatment. I used cFos to identify neuronal activity and other 
immunohistochemical markers to identify neuronal phenotypes, based on specific cytoplasmic proteins. 
An overall seasonal decrease in thermogenesis, measured as reduced neuronal activity in the 
thermoregulatory pathways, and increase in vasoconstriction reflected the higher order processing 
necessary for CHA-induced hibernation. CHA inhibited the histaminergic neurons in the hypothalamus 
suppressing wakefulness and dis-inhibited the nucleus tractus solitarius, further suppressing 
thermogenesis. Preliminary data also suggested a seasonal change in the adenosine metabolic pathway, 
which may have increased adenosine receptor sensitivity during the hibernation season. Our results 
suggest that histaminergic neurons in the hypothalamus and the nucleus tractus solitarius are likely 
targets to manipulate metabolic demand in the clinical setting inducing therapeutic hypothermia or 
increasing metabolic rate.
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Chapter 1: General introduction
1.1 The phenomenon of hibernation
Hibernation is an evolutionary strategy to conserve energy by entering a hypometabolic state, which 
results in a prolonged reduction in metabolism (Ruf and Geiser, 2015). This strategy is not only used in 
cold climates such as the Arctic, but also in the Tropics. As an example, in Madagascar, species like the 
tenrec and lemur hibernate to survive food scarcity, unexpected droughts or changes in microhabitat 
temperature (Blanco et al., 2018; Treat et al., 2018). The hypometabolic state can last from a few hours 
to several weeks, which distinguishes daily torpor from hibernation (Ruf and Geiser, 2015). Here, I will 
describe hibernation in ground squirrels, with a focus on the most northern species: the arctic ground 
squirrel (AGS, Urocitellus parryii renamed from Spermophilus parryii (Helgen et al., 2009)).
Hibernation is regulated by an endogenous circannual rhythm which persists under constant 
environmental conditions (Pengelley et al., 1978). Briefly, in the spring squirrels emerge from 
hibernation. Male AGS emerge a month before females to prepare for the brief mating season and feed 
on cache to restore their reproductive system (Williams et al., 2016). In summer, squirrels steadily 
increase their food intake by becoming hyperphagic (Carey et al., 2003) and their total body mass 
increases 50% in the pre-hibernation season, fall season (Sheriff et al., 2013; MacCannell et al., 2017). 
With the fat storage in place, AGS initiate hibernation that lasts seven to eight months (Williams et al., 
2016) (Figure 1.1).
In the pre-hibernation season, after gaining the majority of the body mass, resting metabolic rate 
and energy expenditure decrease reducing euthermic body temperature (Sheriff et al., 2012, 2013) 
(Figure 1.2A) shifting to a positive energy balance. Squirrels stop eating and enter a hypophagic state 
that may be regulated by leptin, the satiety hormone, produced by the adipose tissue. Infusion of leptin 
during the hyperphagic phase decreases food intake in AGS (Ormseth et al., 1996) and evidence in other 
ground squirrels show high plasma levels of leptin and an increase in leptin receptors within the 
hypothalamus, the brain region controlling energy homeostasis, in hypophagic compared to 
hyperphagic animals (Schwartz et al., 2015). In addition, brown adipose tissue (BAT) undergoes 
substantial changes. BAT is a thermogenic tissue, characterized by a high density of mitochondria and 
blood vessels (Jastroch et al., 2018). Mitochondrial uncoupling protein 1 (UCP1) confers to the BAT the 
ability to produce heat, decreasing the metabolic efficiency producing heat instead of synthetizing ATP 
(Nedergaard et al., 2001). BAT thermogenesis is a mammalian adaption known as non-shivering 
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thermogenesis (NST). BAT is regulated by the sympathetic nervous system (SNS)(Morrison and Madden, 
2014), which is critical during the hibernation season to initiate the regular arousal bouts (Ballinger and 
Andrews, 2018). Thus, BAT mass increases in volume enhancing the squirrel's ability to produce heat 
(i.e. thermogenic capacity)(Abbotts and Wang, 1980; Ballinger et al., 2016; MacCannell et al., 2017). As 
the hibernation season approaches, indicated by a slight (~2°C) decrease in euthermic body 
temperature, in the laboratory body temperature recordings show transient drops from 36°C to about 
200C, called test drops or test bouts (Ballinger et al., 2016)(Figure 1.2A). Interestingly, in the field AGS 
test drops are not observed with the same frequency as in captive AGS, 25% of free-living AGS show test 
drops compared to 66% of captive AGS (Sheriff et al., 2012). In the laboratory, the first torpor bout 
follows the test drops and the hibernation season begins. The hibernation season is composed of 
repeated torpor bouts, interrupted by arousal leading to regular interbout arousals (IBA) also known as 
interbout euthermia (IBE), a subsequent cooling phase precedes the next torpor bout (Figure 1.2B). The 
torpor bout length increases with the hibernation season. In mid-hibernation a torpor bout in AGS can 
last up to 20 consecutive days. Torpor is a hypothermic and hypometabolic state. The body temperature 
drops to a few degrees above ambient temperature and can reach a minimum of -2.90C in free-living 
AGS (Barnes, 1989). Metabolic rate decreases to 1-2% of basal metabolic rate (Buck and Barnes, 2000), 
respiratory rate decreases to 1-2 breath/min (personal observations), heart rate decreases to 3- 5 
beats/minute (personal observations consistent with marmots (Carey et al., 2003)). The arousal or 
rewarming phase lasts on average 5h (Karpovich et al., 2009) and in other species this has been shown 
to be initiated by BAT thermogenesis, followed by shivering once the body temperature increases up to 
around 160C (Cannon and Nedergaard, 2004). During arousal, body temperature is restore to 360C, 
metabolic rate restores to basal metabolic rate, respiratory rate levels off at 90-100 breath/minute and 
heart rate reaches 200-300 beats/min (personal observations consistent with published data in marmots 
(Carey et al., 2003)). These physiological parameters are maintained for about 15h in the IBA, until the 
start of the cooling phase (Karpovich et al., 2009). The onset of torpor is a regulated suppression of 
thermogenesis and metabolism. AGS housed at temperatures lower than -40C, dramatically increase 
their metabolic rate maintaining a constant low body temperature (Buck and Barnes, 2000), highlighting 
the metabolic plasticity of the species.
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1.2 Medical application
Thermoregulation is the ability to maintain body temperature and regulate energy balance (Lowell and 
Spiegelman, 2000). Metabolic reactions hydrolyzing ATP and catalyzed by the mitochondrial respiratory 
chain produce heat, i.e. thermogenesis. As an example, energy expenditure can be directly measured as 
thermogenesis or indirectly as the amount of oxygen consumed (Lowell and Spiegelman, 2000). Hence, 
interventions stimulating thermogenesis would stimulate metabolism, increasing energy expenditure 
and vice versa.
Plasticity in the thermoregulatory system and metabolism is key to hibernation. The understanding 
of the mechanisms used by hibernators to finely modulate their thermoregulatory system across 
seasons will advance thermal biology. With this new knowledge, we can develop clinical strategies to 
manipulate metabolic demand that is fundamental to conditions such as obesity, metabolic syndrome 
and therapeutic hypothermia.
1.2.1 Obesity
Obesity is a growing epidemic. The world health organization (WHO) reports that 39% of adults were 
overweight and 13% were obese in 2016, and current projections agree that the obesity rate will 
increase to 45% of the total population in 2035 (Revels et al., 2017). Obesity is associated with a 
significant decrease in life expectancy due to metabolic disorders such as diabetes, cardiovascular 
diseases and cognitive dysfunction (Lambert et al., 2013; Loh et al., 2017). Lifestyle interventions such as 
increasing physical activity and modifying diet are challenging strategies because they are followed by 
weight regain after weight-loss programs (Weiss et al., 2007). Thus, there is a need for novel approaches 
in developing treatment to minimize comorbidities.
The rediscovery of BAT in humans (Cypess et al., 2009; Zingaretti et al., 2009; Lee et al., 2010), has 
ignited research interest by the possibility to stimulate BAT thermogenesis to increase energy 
expenditure and potentially reverse obesity (Loh et al., 2017). Rodent studies show that cold-exposure 
and pharmacological stimulation of the β3-adrenoreceptors induce BAT thermogenesis (Srivastava and 
Veech, 2019). Similarly, cold-exposure increases BAT activation in healthy humans, but not in obese 
individuals (van Marken Lichtenbelt et al., 2009). BAT activation is controlled by the SNS (Morrison and 
Madden, 2014). Interestingly, studies show that SNS is impaired in obese individuals, who show an 
increase in resting sympathetic tone but a blunted sympathetic response to physiological stimuli 
(Lambert et al., 2013). Therefore, a deeper understanding of the mechanisms connecting the 
sympathetic regulation of BAT thermogenesis and energy balance in obesity is necessary to develop 
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novel therapies. The pre-hibernation fattening is a physiologically induced obesity that offers an ideal 
model to investigate the link between regulation of sympathetic activation of BAT thermogenesis and 
energy balance. As brown and white adipose tissue increase (MacCannell et al., 2017), thermogenesis 
gradually decreases (Sheriff et al., 2012) shifting the animals towards a positive energy balance, 
resembling human obesity, but without the associated comorbidities.
1.2.2 Therapeutic hypothermia
The benefits of induced hypothermia date back to the Egyptians, Greeks and Romans when hypothermia 
was recommended for battle-inflicted trauma and cerebral disturbances (Gunn et al., 2017). We have 
come a long way and currently therapeutic hypothermia or targeted temperature management (TTM ) is 
a standard procedure for cardiac arrest and neonatal hypoxic-ischemic encephalopathy to prevent 
neurological damage (Song and Lyden, 2012; Krokhaleva and Vaseghi, 2018). Two randomized control 
trials show a better rate of good neurological outcome, 49% and 55% respectively, after cardiac arrest in 
patients treated with therapeutic hypothermia compared to the 26% and 39% with good neurological 
outcome in the normothermic group (Bernard et al., 2002; HACA, 2002). The neuroprotective benefits of 
TTM are multifactorial. They include a significant reduction in cerebral metabolism (for every degree of 
temperature reduction, cellular metabolism is reduced by 5%), and reduction of inflammation, oxygen 
free radical production and the accumulation of excitotoxic neurotransmitters (Delhaye et al., 2012; 
Song and Lyden, 2012; Taccone et al., 2014; Gunn et al., 2017).
TTM can be induced through endovascular cooling, infusion of cold fluids using catheters and 
through surface cooling as surface cooling pads (Deye et al., 2015); surface cooling has the advantage 
that it does not require expertise and advanced equipment compared to endovascular cooling, but it 
induces cooling at a slower rate (Song and Lyden, 2012). Nevertheless, both methods encounter the 
same side effects of shivering (Deye et al., 2015). Shivering is suppressed using paralytics, which prevent 
an accurate assessment of the neurological status due to the muscular blockade (Song and Lyden, 2012; 
Karcioglu et al., 2018), highlighting the need to improve the current clinical protocols. This is challenging 
because shivering is a protective mechanism triggered by the thermoregulatory system to defend core 
body temperature in humans and other endothermic species.
Hibernators are heterothermic, they are able to defend their body temperature as endotherms but 
they also show poikilothermy-like characteristic during torpor, as their body temperature reaches the 
surrounding temperature. Hibernation is an endogenous hypometabolic state where the suppression of 
thermogenesis is controlled and regulated (Buck and Barnes, 2000; Richter et al., 2015). The 
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understanding of the thermoregulatory mechanisms promoting the onset of hibernation will provide 
novel approaches to induce a hypometabolic and hypothermic state avoiding the complication of 
shivering.
1.3 Adenosine, a potential mediator of hibernation
1.3.1 Adenosine biosynthesis in the brain 
Within the central nervous system (CNS), astrocytes are the major source of adenosine. Adenosine is a 
neuromodulator and it affects neuronal activity presynaptically, controlling neurotransmitter release, 
postsynaptically, hyper or depolarizing neurons and non-synaptically regulating glial cells (Sachdeva and 
Gupta, 2013).
Adenosine is synthetized from ATP, the cellular "energy currency"(Figure 1.3). ATP is metabolized to
ADP and subsequently to AMP. Cytosolic 5'-nucleotidase (c5'-NT) hydrolyzes AMP to adenosine. 
Adenosine accumulates in the cytosol and the equilibrative nucleoside transporters (ENTs) facilitate 
adenosine diffusion into the extracellular space. Thus, adenosine modulates neuronal activity through 
adenosine receptors (ARs) to restore energy balance (Masino and Boison, 2012). ARs are G-protein 
coupled receptors and they are categorized in four subtypes A1AR, A2aAR, A2bAR and A3AR (Masino and 
Boison, 2012). Activation of A1AR, highly expressed in the CNS, and A3AR inhibits neuronal activity, while 
activation of the A2a AR and A2bAR is stimulatory (Sachdeva and Gupta, 2013). Adenosine deaminase 
(ADA), which converts adenosine to inosine and adenosine kinase (ADK), which phosphorylates 
adenosine to AMP are responsible for decreasing adenosine concentration. ADK is located in astrocytes 
and is the primary regulator of extracellular adenosine. ADK activity lowers intracellular adenosine 
concentration. Therefore, ENT facilitates adenosine diffusion into the astrocytes, thus decreasing 
extracellular concentration, also shown by experimental manipulations of ADK. Pharmacological 
inhibition of ADK and genetic ADK knockout increase extracellular adenosine concentration, in contrast 
overexpression of ADK is associated with a decrease in extracellular adenosine (Boison et al., 2010; Park 
and Gupta, 2013).
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1.3.2 Adenosine and energy metabolism
The increase in extracellular adenosine concentration reflects the increase in breakdown of cellular ATP, 
tying adenosine to cellular energy metabolism. Increases in neuronal activity, increases in energy 
consumption and increases in extracellular adenosine are directly related. Adenosine decreases energy 
demand inhibiting neuronal activity via the A1AR (Porkka-Heiskanen and Kalinchuk, 2011). In addition, 
adenosine is the signaling molecule used by astrocytes in regulating energy homeostasis. The arcuate 
nucleus of the hypothalamus regulates metabolism and energy balance through orexigenic (i.e., 
promoting feeding) and anorexigenic (i.e., decreasing feeding) neurons. Astrocytes release adenosine 
and suppress orexigenic neuronal activity via A1AR, reducing feeding and enhancing satiety (Yang et al., 
2015; Sweeney et al., 2016). Thus, adenosine regulates brain energy metabolism through a general 
suppression in neuronal activity and modulates energy balance via a direct inhibition of orexigenic 
hypothalamic neurons.
1.3.3 Adenosine and sleep
Adenosine regulates sleep and wakefulness. Pharmacological studies in the past 50 years have shown 
that AR agonists increase sleep, while the antagonists disrupt sleep and increase wakefulness (Bjorness 
and Greene, 2009). These findings are also supported by the everyday used of caffeine, a non-selective 
adenosine antagonist, which affects sleep-wake behavior (Bjorness and Greene, 2009). Sleep is under 
homeostatic regulation, i.e., sleep pressure accumulates during the wake period and it dissipates during 
sleep (Porkka-Heiskanen and Kalinchuk, 2011). The homeostatic regulation is at its highest during sleep 
deprivation, which is associated with high adenosine levels in the basal forebrain (Porkka-Heiskanen and 
Kalinchuk, 2011; Donlea et al., 2017). Adenosine levels decrease in the following sleep recovery phase 
(Donlea et al., 2017). Thus, adenosine is recognized as the endogenous neuromodulator regulating the 
sleep homeostatic response.
The preoptic area of the hypothalamus regulates sleep through two brain nuclei: the ventrolateral 
preoptic area (VLPO) and median preoptic nucleus (MnPO)(Saper et al., 2005). The VLPO and the MnPO 
are characterized by sleep-active neurons and they promote sleep via inhibitory projections to the 
arousal systems within the hypothalamus and in the brainstem (Saper et al., 2005). Adenosine activates 
the inhibitory neurons in the MnPO and VLPO via the A2aAR (Scammell et al., 2001; Kumar et al., 2013). 
The role of the A1AR in the VLPO is more controversial. The tonic GABAergic inhibition of the VLPO was 
reduced by adenosine directly applied in brain slices, suggesting a dis-inhibition of the sleep active 
neurons through the A1AR (Chamberlin et al., 2003; Morairty et al., 2004). However, in vivo studies show 
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that direct administration of the A1AR agonists do not promote sleep (Methippara et al., 2005; Zhang et 
al., 2013). However, activation of the A1AR induces sleep through a direct inhibition of the arousal 
centers, including the basal forebrain, the histaminergic neurons in the tuberomammillary nucleus and 
the hypocretin/orexin neurons in the lateral hypothalamus (Chen et al., 2016; Liu and Gao, 2007; Oishi 
et al., 2008; Rai et al., 2010; Yang et al., 2013). Hence, adenosine links together energy metabolism and 
sleep. Interestingly, sleep pressure increases during the hibernation season compared to summer 
(Walker et al., 1980), which is associated with reduced metabolic rate, highlighting similarity with the 
onset of sleep promoted by adenosine and the consequent decrease in metabolism.
1.3.4 Adenosine, hibernation and torpor 
Pharmacological studies have shown that adenosine plays a role in the onset of hibernation and torpor, 
but the mechanisms and the brain regions associated with the phenomenon are still unclear. In the 
Syrian hamster, a hibernating species, intracerebroventricular (ICV) injection of adenosine induces 
hypothermia, which is attenuated when adenosine and 8-cyclopenthyltheophylline (CPT), an adenosine 
A1R antagonist, are delivered together. There results suggest that the A1AR is the main mediator in 
inducing hibernation (Tamura et al., 2005). This finding was confirmed in other studies using 6N 
cyclohexyladenosine (CHA), an A1AR agonist. CHA induces a decrease in body temperature and 
metabolic rate in hamster, AGS and in mice, that enters daily torpor after fasting (Shintani et al., 2005; 
Jinka et al., 2011; Iliff and Swoap, 2012). This was further validated by the lack of torpor onset in AGS 
treated with A3AR agonist (Cl-IB-MECA) and the failure of A2AR antagonists (MSX-2 and DMPX) to 
reverse torpor inducing arousal in AGS and hamsters (Tamura et al., 2005; Jinka et al., 2011). Moreover, 
CPT reversed torpor when delivered during the entrance-cooling phase in both the hamster and AGS 
(Tamura et al., 2005; Jinka et al., 2011). However, CPT was not effective when administered later in the 
torpor bout as shown in the hamster (Tamura et al., 2005), which is consistent with an earlier study in 
hippocampal brain slices showing a decrease in adenosine sensitivity in torpor compared to IBA, 
suggesting a downregulation of the adenosine receptors (Spangenberger et al., 1995). Thus, two 
different mechanisms control the onset of hibernation and the maintenance of torpor, and the A1AR is 
critical in the onset of hibernation.
The hypometabolic state induced by CHA has been effective in rats, a non-hibernating species. CHA 
delivered ICV or within the nucleus tractus solitarius (NTS) in the brainstem produces a marked fall in 
body temperature due to an inhibition of BAT and shivering thermogenesis and other parasympathetic- 
like responses that resemble the onset of hibernation (Tupone et al., 2013). A1AR-induced hibernation­
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like effects in non-hibernating species shows biomedical potential to induce a controlled hypothermia; 
however, the mechanism is still unclear.
A1AR-induced hibernation is a seasonal phenomenon in AGS. CHA promotes the onset of 
hibernation in AGS during the hibernation season, but not in euthermic-summer AGS where the 
response to CHA is transient (Jinka et al., 2011). Further experiments show a relation between a 
seasonal decrease in euthermic body temperature and the effectiveness of CHA-induced hibernation 
(Olson et al., 2013). CHA-induced hibernation in AGS may relate to a seasonal increase in sensitivity of 
A1AR, regulated by a higher order process entrained by the circannual rhythm.
1.4 Research objectives
In the present study, I aim to characterize the neuronal pathways involved in CHA-induced hibernation 
in the AGS and how the endogenous circannual rhythm (i.e. seasons) affects the phenomenon and 
regulates the natural onset of hibernation. The research objectives included:
1- To assess the physiological characteristics that define each seasonal phenotype. I focused on 
changes in the thermoregulatory systems, in particular the hypothalamic-pituitary-thyroid axis, 
which regulates metabolism and thermogenesis. Thyroid hormones also regulate BAT 
thermogenesis synergistically with the SNS. Therefore, I investigated if the sympathetic 
premotor neurons in the raphe pallidus, which activate BAT thermogenesis, changed between 
seasons (Chapter 2).
2- Identify the neuronal pathways activated by CHA. In particular, to identify the seasonal 
differences in neuronal activation that may explain the seasonal difference in response to CHA 
(Chapter 3).
3- Identify whether changes in ADK expression are part of the mechanism underlying the seasonal 
increase in adenosine sensitivity leading to the onset of hibernation. I assessed changes in ADK 
in astrocytes and tanycytes, a type a glial cell involved in seasonal changes and part of the 
hypothalamic system regulating energy balance (Chapter 4).
Completion of these objectives is expected to lead to the understanding of the thermoregulatory 
mechanisms underlying the metabolic plasticity of hibernators. These mechanisms will provide novel 
targets to manipulate metabolic demand in clinical settings, such as obesity and therapeutic 
hypothermia.
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Figure 1.1: Circannual rhythm in the AGS.
The schematic shows AGS during different seasons, images taken by C. Frare.
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Figure 1.2: Seasonal change in Tb in the AGS.
A decrease in euthermic Tb defines the transition from Summer to Fall. Test drops in Tb occur in fall just 
prior to the onset of the hibernation season in winter (A). The hibernation season is characterized by 
Torpor bouts regularly interrupted by interbout arousals (IBA) (B).
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Figure 1.3: ATP-Adenosine formation and catabolism.
Breakdown of ATP increases adenosine concentration within the astrocytes. Adenosine diffuses to the 
extracellular space through the ENTs and modulates neuronal activity via adenosine receptors, here 
highlighted in the neurons, but widely distributed in the CNS. ADK and ADA regulates adenosine 
concentrations converting adenosine into AMP and inosine respectively. Extracellular AMP is converted 
back to ATP. ADA: adenosine deaminase, ADK: adenosine kinase, ARs: adenosine receptors, CNTs: 
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Chapter 2: The raphe pallidus and the hypothalamic-pituitary-thyroid axis gate 
seasonal changes in thermoregulation in the hibernating Arctic Ground Squirrel 
(Urocitellus Parryii).1
1 Published as Frare C, Jenkins ME, Soldin SJ and Drew KL (2018) The Raphe Pallidus and the 
Hypothalamic-Pituitary-Thyroid Axis Gate Seasonal Changes in Thermoregulation in the Hibernating 
Arctic Ground Squirrel (Urocitellus parryii). Front. Physiol. 9:1747. doi: 10.3389/fphys.2018.01747
2.1 Abstract
Thermoregulation is necessary to maintain energy homeostasis. The novel discovery of brown adipose 
tissue (BAT) in humans has increased research interests in better understanding BAT thermogenesis to 
restore energy balance in metabolic disorders. The hibernating Arctic ground squirrel (AGS) offers a 
novel approach to investigate BAT thermogenesis. AGS seasonally increase their BAT mass to increase 
the ability to generate heat during interbout arousals. The mechanisms promoting the seasonal changes 
in BAT thermogenesis are not well understood. BAT thermogenesis is regulated by the raphe pallidus 
(rPA) and by thyroid hormones produced by the hypothalamic-pituitary-thyroid (HPT) axis. Here, we 
investigate if the HPT axis and the rPA undergo seasonal changes to modulate BAT thermogenesis in 
hibernation. We used histological analysis and tandem mass spectrometry to assess activation of the 
HPT axis and immunohistochemistry to measure neuronal activation. We found an increase in HPT axis 
activation in fall and in response to pharmacologically induced torpor when adenosine A1 receptor 
agonist was administered in winter. By contrast, the rPA neuronal activation was lower in winter in 
response to pharmacologically induced torpor. Activation of the rPA was also lower in winter compared 
to the other seasons. Our results suggest that thermogenic capacity develops during fall as the HPT axis 
is activated to reach maximum capacity in winter seen by increased free thyroid hormones in response 
to cooling. However, thermogenesis is inhibited during torpor as sympathetic premotor neuronal 
activation is lower in winter, until arousal when inhibition of thermogenesis is relieved. These findings 
describe seasonal modulation of thermoregulation that conserves energy through attenuated 
sympathetic drive, but retains heat generating capacity through activation of the HPT axis.1
17
2.2 Introduction
Thermoregulation is necessary to maintain energy homeostasis and when disrupted can lead to 
metabolic disorders. The novel discovery of brown adipose tissue (BAT) in humans (Betz and Enerback, 
2015) has increased research interests in better understanding BAT thermogenesis to develop 
therapeutic approaches to increase energy expenditure activating BAT to treat obesity and diabetes 
(Betz and Enerback, 2015). The phenomenon of hibernation is an innovative model to investigate overall 
energy homeostasis and BAT thermogenesis, since this evolutionary adaptation is a model of 
physiological obesity (Cannon and Nedergaard, 2004) without any health consequences seen in humans 
such as type 2 diabetes and heart disease.
Hibernation is a seasonal phenomenon that is preceded by a fall transition phase where body weight 
increases by 40-60% (Sheriff et al., 2013; MacCannell et al., 2017) and body temperature (Tb) decreases 
1-2°C from summer euthermic Tb (Russell et al., 2010; Sheriff et al., 2012). During hibernation, 
metabolic rate is suppressed to 1-2% of basal metabolic rate (BMR) and Tb approaches ambient 
temperature (Barnes, 1989; Buck and Barnes, 2000). The suppression in BMR and Tb characterize the 
torpid state, which is periodically interrupted by interbout arousals initiated by non-shivering 
thermogenesis (NST) via activation of BAT (Cannon and Nedergaard, 2004). While regulation of 
thermogenesis is important to sustain drastic changes in Tb and metabolic rate during the hibernation 
season, the seasonal regulation of thermogenesis is not fully understood. Previous work showed that 
AGS have a different seasonal response to pharmacologically induced torpor (Jinka et al., 2011). 6N- 
cyclohexyladenosine (CHA), an adenosine A1 receptor agonist, induces similar decrease in Tb as seen in 
hibernation during winter, but not in summer underlining an endogenous seasonal modulation in 
thermogenesis independent of environmental factors such as light cycle and ambient temperature (Jinka 
et al., 2011). AGS are robust hibernators where the hibernation phenotype is strongly regulated by 
season. In hibernators, BAT is the main site of NST (Ballinger and Andrews, 2018). BAT thermogenesis is 
regulated synergistically by the sympathetic nervous system (SNS) and thyroid hormones (TH; Ortiga- 
Carvalho et al., 2016). Hypothalamic-pituitary-thyroid (HPT) axis regulates TH production, increasing 
circulating TH to enhance thermogenic response when BAT is activated by the SNS (Silva and Larsen, 
1983). Previous work in hibernation showed changes in circulating TH during torpor (Demeneix and 
Henderson, 1978; Nevretdinova and Shvareva, 1987; Magnus and Henderson, 1988) and thyroid 
morphology (Nunez and Becker, 1970; Krupp et al., 1977) in independent studies in different species. 
Here, we asked if seasonal modification of the HPT axis activation in AGS across season and in response 
to CHA-induced cooling could explain the seasonal response to CHA. As BAT thermogenesis is also
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regulated by sympathetic premotor neurons in the raphe pallidus (rPA; Nakamura et al., 2004), we also 
describe the SNS through the rPA neuronal activity across season and in response to CHA.
2.3 Materials and Methods
All procedures were approved by Institutional Animal Care and Use Committee (IACUC) at the University 
of Alaska Fairbanks and conducted in accordance with the Guide for the Care and Use of Laboratory 
Animals (8th edition). The objective of this study was to define the role of the HPT axis in seasonal 
hibernation and in the seasonal modulation of CHA-induced cooling. We treated animals with CHA or 
vehicle in both summer and winter seasons. Because vehicle did not trigger changes in Tb in either 
winter or summer seasons, we included vehicle-treated animals in our analysis of seasonal changes. We 
used animals treated with vehicle in summer as Summer euthermic (Sum.VEH) and animals treated with 
vehicle in winter as interbout euthermic (ibe), also referred to as Winter euthermic (Win.VEH). For 
seasonal comparisons, we added samples from naÏve animals at two additional time points, Fall (pre­
hibernation) and Torpor.
2.3.1 Animals
Arctic Ground Squirrels (AGS, Urocitellus parryii) were captured in the Brooks Range (68°07'46"N 
149°28'33"W) under permit by Alaska Department of Fish and Game. Beginning August 15th, the year of 
capture, we housed AGS, male and female, individually at constant environmental conditions at an 
ambient temperature (Ta) of 2°C and a photoperiod of 4L:20D until the end of the study to avoid any 
confounding results due to change in light cycle and Ta (Figure 2.1A). We provided approximately 47 g 
Mazuri rodent chow daily and water ad libitum although hibernating AGS do not drink or eat. Juveniles 
(one year old) were preferred for the study, adults were used when larger sample size was required.
2.3.2 Seasonal changes in the HPT-axis
To identify seasonal changes at the level of the HPT axis, we collected tissues at different time points 
defined as Fall, Winter euthermic (Win.VEH), Torpor, and Summer (Sum.VEH) (Figure 2.1B). Torpor was 
monitored daily using the shaving added technique (Jameson, 1964). The animal was defined torpid if 
wood shaving placed on the back remained undisturbed 1-day later. The presence of eight torpor bouts 
defined a winter phenotype that we referred to as a winter season. Summer phenotype (referred to as 
summer season) was characterized by at least 60 consecutive awake days following the end of the 
hibernation season. The fall transition state was characterized by a slight decrease in euthermic Tb.
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Rectal Tb was measured in all animals before intracardial perfusion with a Digital Microprocessor 
Thermometer (model HH21 OMEGA Engineering, INC., Stamford, CT, United States). Table 2.1 reports 
details on each seasonal phenotype. We collected all the animals at the same time of day, 2 h into the 
dark cycle. Fall and torpid AGS were naÏve and torpid AGS were collected between the first and fourth 
day of the torpor bout, consistent with the time of induced-arousal of winter AGS. Win.VEH and 
Sum.VEH were collected following the procedure illustrated in Figure 2.2A and described as follows. 
Brain, thyroid tissue, and blood samples were collected as described below.
2.3.3 Changes in the HPT-axis after CHA-induced cooling
AGS were implanted with iButton, (Maxim integrated, San Jose, CA, United States) abdominal 
temperature data loggers. Anesthesia was induced with 5% isoflurane and maintained at 3% mixed with 
100% medical grade oxygen delivered at a flow rate of 1.5 L/min. During surgery Tb was maintained via a 
water circulating heating pad. Under aseptic conditions, the iButton was inserted intraperitoneally via a 
midline incision through linea alba and sealed with three layers of sutures. Buprenorphine (1.0 mg/kg, 
sc) slow release formulation was administered as analgesic and AGS were allowed at least 1 day of post­
operative recovery in a warm room (17°C, 4L:20D) before being returned to home cage conditions (Ta of 
2°C and 4L:20D). We induced arousal in winter AGS between the first and fourth day of the torpor bout 
and we moved the aroused animals to a warm room (17°C, 4L:20D) to maintain arousal state and to 
delay the occurrence of the following torpor bout. Animals displaying the summer phenotype were also 
moved to a warm room overnight (17°C, 4L:20D), for consistency in the procedure. During the overnight 
period, (approximately 12 h) food was withheld, and water was available ad libitum. In the morning of 
the experiment, AGS were moved to the environmental chamber (2°C, 4L:20D) 1 h before injection to 
acquire baseline data. Vehicle (2.5% hydroxypropyl-β-cyclodextrin) or CHA (0.5mg∕kg, IP) were injected 
and animals were monitored for 3 h. At 3 h after injection, blood was collected via cardiac puncture and 
AGS were perfused intracardially prior to tissue collection. A schematic of the experimental designed is 
illustrated in Figure 2.2A and the related time points for tissue collection are shown in Figure 2.3A.
2.3.4 Drugs
A stock solution of CHA (10 mg/mL, Sigma-Aldrich, Saint Louis, MO, United States) was dissolved in 25% 
(w/v) hydroxypropyl-β-cyclodextrin (Tokyo Chemical Industry CO., Tokyo, Japan) in sterile water. On the 
week of the experiment, stock solution of CHA was diluted to 0.5 mg/mL in sterile normal saline (0.9% 
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NaCl). Diluted CHA was used within 1 month. Solutions for injection were sterilized by 0.2 μm filtration 
(Acrodisc syringe filter; Sigma-Aldrich, Saint Louis, MO, United States).
2.3.5 Brain tissue processing
At 3 h after injection, AGS were anesthetized with 5% isoflurane and maintained at 3% mixed with 100% 
medical grade oxygen delivered at a flow rate of 1.5 L/min. Blood was sampled by cardiac puncture and 
AGS were intracardially perfused first with 0.9% NaCl for 5 min and then with 4% PFA in 0.1 M PB buffer 
pH 7.4 at a flow rate of 79.5 mL/min with a 18 Ga needle through the left ventricle after the descending 
aorta was clamped to obtain a more efficient perfusion of the brain. Brains were removed and post fixed 
in 4% PFA overnight. Brains were blocked in 3 parts to allow better penetration of sucrose into the 
tissue. A gradient of sucrose solutions (5, 10, 15, 20, and 30 % w/v) was made in 0.1M PB buffer pH 7.4 
to cryoprotect the tissue. Brains were maintained in each sucrose solution for up to 3 days and in 30% 
sucrose until brains sank. Brains covered with Tissue-Tek O.C.T. matrix (Electron Microscopy Sciences, 
Hatfield, PA, United States) were rapidly frozen in a bath of n-Hexane 95% cooled with dry ice to a 
temperature of -45°C. Coronal sections (40 μm) were cut with a cryostat (CM1850, Leica Biosystems, 
Buffalo Grove, IL, United States).
2.3.6 Immunohistochemistry
Free floating sections were washed using PBS pH 7.2, blocked with normal goat serum (Vector 
Laboratory, Burlingame, CA, United States) for 2 h at 4°C and labeled with mouse anti-cFos (1:20,000, 
Santa Cruz Biotechnology, Dallas, TX, United States) in PBS-0.2% TritonX-100 for 48 h, followed by 
incubation with biotinylated secondary goat anti-mouse antibody 1:600 (Vector Laboratory, Burlingame, 
CA, United States) in PBS-0.4% TritonX-100. After incubation in avidin-biotin-peroxidase (Vectastain ABC 
kit, Vector Laboratory, Burlingame, CA, United States), sections were treated with 0.05% DAB (3',3- 
diaminobenzidine tetrahydrochloride, Sigma-Aldrich Corp. St. Louis, MO, United States) with 1% 
ammonium nickel sulfate in sodium acetate 0.175M and 0.1% H2O2. For double stain procedures, slices 
were then incubated with the second primary antibody, rabbit anti-TRH (1:10,000, gift from Eva Redei 
Northwestern University) or sheep anti-tryptophan hydroxylase (TPH) (1:2,000, AB1541, Millipore) in 
PBS-0.2% TritonX-100 overnight, followed by incubation with biotinylated secondary goat anti-rabbit or 
goat anti-sheep 1:600 (Vector Laboratory, Burlingame, CA, United States) in PBS-0.4% TritonX-100. After 
incubation with ABC, sections were treated with 0.05% DAB in PBS and 0.1% H2O2. Sections were 
mounted on Superfrost Plus slides (VWR, Radnor, PA, United States) with Cytoseal mounting media
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(Thermo Fisher Scientific, Waltham, MA, United Sates) or Permount (Thermo Fisher Scientific, Waltham, 
MA, United States). Control slices, in which primary antibody was omitted and replaced by PBS, were 
run in every experiment under the same conditions.
2.3.7 Image analysis
Images were analyzed using Metamorph software (version 7.8.8.0, Molecular Devices, San Jose, CA, 
United States) with a Nikon Eclipse TE2000-U inverted microscope equipped with a CCD camera (Cool 
Snap HQ2, Photometrics, Tucson, AZ, United States) for double stain analysis and with Nikon Eclipse 80i 
equipped with a digital camera (Micropublisher 3.3RTV, Qimaging, BC, Canada) for single stain analysis. 
A blind code was assigned to each animal to prevent any bias from the observer. For TRH analysis each 
hemisphere was counted individually in three consecutive slices for each AGS. The mean of six slices, 
three from each hemisphere per AGS, was used for subsequent statistical analysis. The count was done 
manually under a 20X objective using the manual count function in Metamorph to prevent double 
counting. Double stain was defined as brown DAB neurons with a distinct round dark black nucleus. All 
TRH positive neurons and the double stained neurons were counted in the paraventricular hypothalamic 
nucleus (PVN). The PVN was identified by reference to the Paxinos and Watson Rat Atlas Fourth Edition 
(bregma -1.40 to -1.60 mm). The percentage of activated TRH neurons was defined as the ratio between 
double stained neurons and the number of TRH positive neurons. We identified the rPA by Nissl stain 
with reference to the Paxinos and Watson Rat Atlas Fourth Edition (bregma -11.30 to -11.80 mm) and 
TPH staining. We defined a region of interest (ROI) of 0.05 mm2 to include the entire rPA. cFos+ neurons 
were counted manually in the ROI in four consecutive slices under 10X objective in Metamorph.
2.3.8 Thyroid tissue processing and image analysis
After perfusion each thyroid lobe was isolated and stored in 70% ethanol until tissue processing. Paraffin 
sections (4 μm) were stained with hematoxylin and eosin (Carson, 1997). The first slice was collected 
when the tissue was exposed and the next four slices were collected at 50-80 μm intervals. Histological 
analyses were performed in bright field using the Nikon Eclipse 80i upright microscope under 40X 
objective. Stereological analyses were performed using the point-counting method. A grid of points was 
placed on top of the image at final magnification of 400X. A total of 15 randomly selected fields of view 
were analyzed per each section for a total of 4 sections per animal. A total of 60 fields of view per 
animal were used to calculate the thyroid activation index (TAI). First the volume of the colloid and 
follicular epithelium (V,vph ) was calculated based on the following equation V,vph = Pph/Ptot, where Pph is 
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number of points on a particular phase (colloid or epithelium) and Ptot is the total number of points of 
the grid (Weibel et al., 1966), TAI was calculated based on the epithelial (Vve) to colloid (Vvc) volume 
density ratio TAI = Vve/Vvc (Kalisnik, 1972).
2.3.9 TH analysis
Blood was collected via cardiac puncture using a heparinized syringe. Plasma was separated by 
centrifugation at 3,000 ×g for 8 min at 4°C and then store at -80°C until use. TH were measured using 
micro high performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) as previously 
described (Gu et al., 2007; Jonklaas et al., 2009; van Deventer et al., 2011; Masika et al., 2016). 
For total thyroid hormones (TTH) analysis, 150 μL internal standards (IS) L-Thyroxine-[L-Tyr-d5] 
hydrochloride (T4-d5) and 3,3',5-Triiodo-L-thyronine-13C6 (T3-13C6) were added to 200 μL plasma (thawed 
at RT) and mixed using a vortex for 30 s, then centrifuged for 10 min at 13,000 rpm. We added 500 μL 
0.1M ammonium acetate in water to 200 μL supernatant and vortexed for 10 s before HPLC separation 
using a mobile phase A of 2% methanol with 0.01% formic acid and a mobile phase B of 98% methanol 
with 0.01% formic acid. For free thyroid hormones (FTH) analysis, 400 μL plasma was placed in a 30-kDa 
ultrafiltration device (Centrifree YM-30, Millipore) and centrifuged in an Eppendorf temperature- 
controlled centrifuge at 2,700 rpm for 40 min at 37°C. To 150 μL ultrafiltrate was added 250 μL IS. We 
added L-Thyroxine-13C6 (T4-13C6) and 3,3',5-Triiodo-L-thyronine-13C6 (T3-13C6) as IS to each aliquot and 
mixed using a vortex for 30 s, then centrifuged for 10 min at 13,000 rpm. The supernatant, diluted with 
water, was separated via HPLC using mobile phase A of 2% methanol with 0.01% acetic acid and mobile 
phase B of 100% methanol with 0.01% acetic acid.
Each sample, prepared as described, was then injected onto an Agilent SB C-18 (2.1 mm 50 mm, 3.5 m 
ID) chromatographic column (injection volume was 200 μL for TTH analysis and 400 μL for FTH analysis). 
The HPLC system consisted of 3 Shimadzu LC-20AD pumps, a Shimadzu SIL-HTA autosampler, and a 
Shimadzu DGU-20A5 degasser. The procedure involved an online extraction step followed by activation 
of a built-in Valco switching valve and subsequent sample introduction into the mass spectrometer. 
After a 3-min wash with 20% (vol/vol) methanol in 0.01% acetic acid at a flow rate of 1.0 mL/min, the 
switching valve was activated and the analytes of interest were eluted from the column and introduced 
into the mass spectrometer with a water/methanol gradient. We used an API-5000 tandem mass 
spectrometer (Applied Biosystems/MDS Sciex) equipped with TurboIonSpray source (ionspray voltage 
4200V), operated in the negative ionization multiple reaction monitoring (MRM) mode. The MRM 
transitions monitored for T4-d5, T3-13C6, T4, and T3 were 783/135, 658/124, 778/150, and 652/150, 
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respectively in the TTH assay. The MRM transitions monitored for T4, T3, T4-13C6, and T3-13C6were 
776/127, 650/127, 782/127, and 656/ 127, respectively in the FTH assay. Data were acquired and 
processed by Analyst 1.4.1 software package. HPLC-grade methanol was from Fisher Scientific. The 
lower limits of detection were 0.55 ng/dL for Free T4 (FT4), 1.00 pg/mL for Free T3 (FT3), 0.25 μg∕dL for 
T4, and 5.50 ng/dL for T3. Non-detectable values were assumed to be equal to the lower detection limit 
for statistical analysis. Intra assay variability reported as coefficient of variations ranged between 5.3 
and 11.5% for FTH and 3.4-5.2% for TTH. The inter assay variability ranged between 9.4 and 12.6% for 
FTH and 4.8 and 6.2% for TTH.
2.3.10 Statistical analysis
Data are presented as mean ± SEM and a p < 0.05 was considered significant. Data analyses were 
performed using R (version 1.1.423). Groups with both season and treatment as independent variables 
were tested with a two-way ANOVA. To allow for a two-way ANOVA in the cell count analysis, data were 
normalized by transforming to the square root. ANOVA was followed by independent samples t-test. 
One-way ANOVA was used when season was the only independent variable and data were normally 
distributed. Kruskal Wallis and Wilcoxon signed-rank tests were used when data were not normally 
distributed. Groups were randomly matched by sex and age where indicated.
2.4 Results
Body weight and rectal Tb of animals collected in Fall, Winter, Torpor, and Summer were consistent with 
the seasonal phenotype of hibernation (Figure 2.1B and Table 2.1).
2.4.1 Seasonal changes in the HPT-axis
To assess seasonal changes in the HPT axis we defined HPT axis activation based on up-regulation at any 
point of the axis beginning with activation of TRH+ neurons in the PVN, and including TAI (Kalisnik, 1972) 
and circulating total and FTH. We found that TRH neurons were least active during Torpor [F(3,16) = 
11.13, p < 0.001 one-way ANOVA, followed by t-test] compared to the three different euthermic states 
(Figures 2.1C,D). Suppressed activity in TRH neurons is consistent with reduced thermogenesis and 
metabolic rate during torpor. Surprisingly, TAI in Torpor was not lower compared to Summer or Winter 
euthermia. Moreover, TAI was significantly higher in Fall AGS compared to the other three states [H(3) = 
13.48, p < 0.01, Kruskal Wallis test, followed by Wilcoxon's rank-sum test]. In fact, TAI trended toward 
higher activation in Torpor compared to Winter euthermic animals (p = 0.051, Wilcoxon's rank-sum test, 
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Figure 2.1E). Thus, thyroid activity is maintained between Summer, Winter, and Torpor and is 
significantly elevated in the Fall AGS.
Next, we measured the plasma levels of TH. Both total l-Thyroxine (TT4) and total 3,3,,5-Triiodo-L- 
thyronine (TT3) are highest during torpor (Figures 2.1F,G). Plasma concentration of TT4 is significantly 
higher in Torpor compared to Summer euthermic and Fall [F(3,18) = 3.74, p < 0.05 one-way ANOVA, 
followed by t-test]. As with TAI, TT4 in torpor trends toward higher levels compared to Winter euthermic 
(p = 0.07, t-test, Figure 2.1G). Likewise, plasma concentration of TT3 is significantly higher in Torpor 
compared to the three different euthermic states [H(3) = 14.39 p < 0.01 Kruskal Wallis test, followed by 
Wilcoxon's rank-sum test, Figure 2.1F]. Consistent with higher concentration of TTH in torpor, we found 
inverse correlations between TT3, TT4 and Tb (Supplementary Figures S2.3A,B). Neither FT3 nor FT4 
changed significantly across season [H(3) = 1.86 p-value > 0.05 Kruskal Wallis test, FT3; [F(3,18) = 
0.85, p > 0.05 one-way ANOVA, FT4; Figures 2. 1H,I]. [H(3) = 1.86 p-value > 0.05 Kruskal Wallis test, 
FT3; F(3,18) = 0.85, p > 0.05 one-way ANOVA, FT4; Figures 2.1H,I].
We did not find any significant change in plasma levels of reverse triiodothyronine (rT3) the 
pharmacologically inactive hormone between seasons (Supplementary Figure S2.1A), however the ratio 
between rT3 and TT3 was significant lower in torpor compared to Summer and Winter euthermic 
animals, suggesting a downregulation of the HPT axis in torpor (p < 0.05, Supplementary Figure S2.2A).
2.4.2 CHA-induced cooling
Except for the fall transition period, our data support consistent HPT axis activation during euthermia 
across seasons. We next asked if HPT axis activation changes during onset of torpor mimicked by CHA- 
induced cooling. Consistent with previous observations, CHA administered to Winter AGS gradually 
decreased Tb to 26.0 ± 0.9°C after 3 h. By contrast, CHA in Summer AGS produced a rapid, but transient 
decrease in Tb that returned to euthermic values 36.9 ± 1.9°C within 3 h [H(17) = 17.8, p < 0.001, Kruskal 
Wallis test, Figure 2.2B]. Vehicle treatment did not change Tb [H(16) = 8.4, p = 0.9, Kruskal Wallis test, 
Figure 2.2C]. Also consistent with previous observations, resting Tb, reported as mean of Tb measured in 
the 1 h prior injection, was lower in Winter AGS (36.4 ± 0.3°C) compared to Summer AGS (38.6 ± 
0.2°C, p < 0.001, t-test). Such seasonal changes provide evidence of a seasonal decrease in 
thermogenesis as seen by significantly lowering euthermic Tb reported in Table 2.1.
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2.4.3 Changes in the HPT-axis after CHA-induced cooling
At the level of TRH neuronal activation, CHA activated the HPT axis [percent of cFos+ and TRH+ over 
TRH+ after CHA (79 ± 3%) compared to vehicle (69 ± 3%), F(1,17) = 5.562, p = 0.03, two-way ANOVA, 
Figures 2.3B,C] but the interaction with season was not significant. After the two-way ANOVA failed to 
show an interaction with season we minimized inter-animal variation by matching pairs of animals by 
sex and age; sex and age are known to influence TH concentrations (Suzuki et al., 2012). In the analysis 
of TRH neuronal activation as the difference between matched pairs, we found a significant influence of 
season. Matched pairs showed that CHA activated more TRH neurons in Winter than in Summer 
(Figure 2.3D). Greater activation supports an increased thermogenic capacity in winter. Looking at the 
next level of HPT axis activation TAI was stable across CHA and vehicle treatment groups [F(1,15) = 
0.001,p = 0.98, two-way ANOVA]. Although TAI did not change, TTH increased in parallel to TRH 
neuronal activation after CHA in Winter compared to CHA in Summer. Following CHA administration, 
both concentrations of TT4 and TT3 are higher in winter AGS compared to summer (p < 0.05, Wilcoxon's 
rank-sum test, Figures 2.3E,F). Consistent with increased HPT axis activation after CHA in Winter, we 
found greater increases in FT3 after CHA in Winter than after CHA in Summer [F(1,15) = 5.34, p < 0.05 
two-way ANOVA, Figure 2.3G]. FT4, however, was not affected differently by CHA in Summer and 
Winter (p > 0.05 Wilcoxon's rank-sum test, Figure 2.3H). We did not find any significant change in the 
plasma levels of rT3 and in the ratio between rT3 and TT3 between the treatment groups 
(Supplementary Figures S2.1B, S2.2B). The greater HPT axis activation in response to CHA in Winter AGS 
compared to Summer is consistent with greater thermogenic capacity during the winter season.
2.4.4 Seasonal changes in the SNS and in CHA-induced cooling
In hibernating rodents, BAT activation is a significant source of thermogenesis, and BAT mass seasonally 
increases to sustain periodic arousals. Because BAT thermogenesis is regulated by the SNS via activation 
of sympathetic premotor neurons in the rPA, we next asked if changes in the rPA are associated with 
seasonal changes in thermogenesis. rPA activation, measured as the total number of cFos+ cells, 
decreases from Summer to Winter. Density plots visualize the distribution of the number of activated 
cells in the rPA; we chose a density plot, because it defines the distribution shape better than a 
frequency histogram (also shown) when the number of bins is small. Distribution of cFos+ cells in the 
rPA shows a transition between the highest activity in Summer (Figure 2.4A) to the lowest activity in 
Winter (Figure 2.4C) with a broader distribution of rPA neuronal activity during the Fall transition season 
(Figure 2.4B). The adjustment in rPA neuronal activity correlates positively with Tb (r = 0.41, p < 0.05,
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Figure 2.4D). Due to the broader distribution of rPA activation in the fall, the fall group was omitted 
from the subsequent analysis and ANOVA was performed between Torpor, Winter, and Summer groups. 
We found significantly higher activation in Summer compared to Winter and Torpor [F(2,22) = 4.16, p < 
0.05, one-way ANOVA, followed by t-test, Figure 2.4E]. Compared to Vehicle, CHA induced rPA 
activation in Summer, but not in Winter [F(2,35) = 6.6, p < 0.01, two-way ANOVA, followed by t-test, 
Figures 2.4F,G]. Although thermogenic capacity is increased in winter, these results suggest that a 
decrease in sympathetic premotor neuronal activity attenuates thermogenesis during the winter season 
(Figure 2.5).
2.5 Discussion
Here, we describe results that support a model in which thermogenic capacity increases in the 
hibernation season despite a decrease in sympathetic premotor neuronal activity and sympathetic 
response to cooling which is attenuated until interbout arousal. Thermogenesis is regulated within the 
rPA to gate SNS activation of shivering and NST (Tan and Knight, 2018). BAT thermogenesis, the primary 
form of NST in rodents, is regulated by both SNS and TH. Thermogenic capacity increases in winter as we 
find a greater response of HPT axis to CHA-induced cooling in winter compared to summer. HPT axis 
response is evident from higher TRH neuronal activation within the PVN and the increase in circulating 
FT3 and TTH during CHA-induced cooling. Although thermogenic capacity increases, overall sympathetic 
premotor neuronal activity needed to stimulate thermogenesis decreases during the winter season. We 
interpret the data as a decrease in sympathetic activity based on a lower euthermic Tb during winter 
compared to summer and on reduced activation of rPA neurons during winter compared to summer 
euthermia. We also see a decreased sympathetic response to cooling evident from lower rPA neuronal 
activation following CHA in winter compared to summer. Our data suggest that SNS activity changes 
during the fall season indicated by a wider distribution of the number of activated rPA neurons in fall 
compared to summer or winter. Increased TAI further supports modification of the HPT axis during the 
fall transition. Enhancement of HPT axis capacity during the fall transition establishes higher 
thermogenic capacity necessary to support periodic arousals. The higher thermogenic capacity is needed 
to rewarm from an average of 2.9-36°C in about 10 h during periodic arousal (Karpovich et al., 2009) as 
well as a protective mechanism to defend Tb when the thermal gradient between Tb and Ta increases 
(Richter et al., 2015). On the other hand, AGS suppress thermogenesis as seen in the rPA to allow the 
onset of hibernation, overwriting the thermogenic response at the level of the HPT axis in CHA-induced 
cooling. Our model describes how hibernators finely regulate thermogenesis across seasons. A lower 
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thermogenesis in winter allows the onset of hibernation and the parallel increase in thermogenic 
capacity is crucial to enhance thermogenesis when needed.
Other published literature supports our model. Thermogenic capacity measured as maximum NST in 
Richardson's ground squirrel is higher in winter animals (Abbotts and Wang, 1980). Seasonal changes in 
BAT also demonstrate increased thermogenic capacity in winter. BAT mass and BAT UCP1 mRNA 
increases in winter compared to summer hibernators (Kitao and Hashimoto, 2011; Ballinger and 
Andrews, 2018). Consistent with our model describing a period of fall transition in thermogenic capacity, 
a recent study showed that BAT mass increases during fall (Ballinger et al., 2016) and changes in thyroid 
morphology, similar to what we observed, occur in marmots and bats during the pre-hibernation season 
(Nunez and Becker, 1970; Krupp et al., 1977). Early thyroidectomy studies in hibernators underline the 
importance of this gland for hibernation and the role the thyroid plays to enhance thermogenic capacity 
to sustain periodic arousals. Thyroidectomy performed after cold exposure during the fall, does not 
affect hibernation as torpor bouts persist (Henderson et al., 1981), however, when thyroidectomy is 
performed in spring lethal hypothermia occurs (Canguilhem, 1972). Other studies in AGS and 13-lined 
ground squirrels illustrate a gradual decrease in Tb before the onset of hibernation (Barnes, 1989; Russell 
et al., 2010; Sheriff et al., 2012; Olson et al., 2013) consistent with our results. As thermogenic capacity 
increases in fall, basal thermogenesis decreases as seen by the modulation in Tb.
In this study, we minimized the influence of feeding and gastric motility on rPA neuronal activity (Jacobs 
et al., 2002) by withholding food for approximately 12 h before the experiment. The positive association 
between Tb and the number of cFos+ cells within the rPA suggests that rPA neuronal activity is related to 
thermogenesis. Nonetheless, the influence of other autonomic nervous system responses on rPA cannot 
be ruled out and deserves further study.
The increase in TTH during torpor is also seen in 13-lined ground squirrel and hamster using RIA to 
detect TTH (Demeneix and Henderson, 1978; Nevretdinova and Shvareva, 1987; Magnus and 
Henderson, 1988). We also note that our TTH values, determined by LC-MS/MS are consistent with 
values measured by RIA in studies cited above. Increased TTH in torpor is consistent between species, 
however, changes in FTH values are not consistent. Our results are in agreement with previous study in 
Djungarian hamsters where FT4 and FT3 do not change during mid-winter torpor. Djungarian hamsters, 
however, do show an increase in FT3 during late season torpor in preparation for the reproductive 
phase (Seidel et al., 1987). In Richardson's ground squirrel results are contradictory. One study reports 
an increase in FT4 during torpor compared to arousal (Demeneix and Henderson, 1978) while another 
shows the opposite with FTH decreasing in torpor compared to arousal (Magnus and Henderson, 1988).
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Differences in results may be due to species differences and to methods used to separate bound and 
free hormones. We used the ultrafiltration method instead of the classical equilibrium dialysis (ED) to 
separate FTH from bound TH. Ultrafiltration is becoming the preferred alternative method to ED in 
clinical settings (Soldin and Soldin, 2011). Clinical works show a better correlation with thyroid 
stimulating hormones when FTH are measured using MS instead of immunoassay, suggesting higher 
accuracy and precision of LC/MS-MS in quantifying FTH concentration compared to ED-RIA (van 
Deventer et al., 2011).
Our analysis of the HPT axis is limited by a lack of deiodinase levels in BAT. Deiodinase regulates 
intracellular TH levels, in particular type 2 iodothyroinine deiodinase (Dio2) converts T4 to T3. Although 
we did not asses the Dio2 levels in AGS, previous studies in hamster reported seasonal changes in Dio2 
levels in hypothalamus during short photoperiod (Herwig et al., 2009) and in BAT during torpor 
compared to normothermia (Bank et al., 2015). These studies suggest that a low level of T3, as a 
consequence of lower Dio2 expression, promotes torpor. Thus, while we show higher TTH and no 
change in FTH during torpor in AGS, the intercellular level of T3 may be decreased by lower Dio2 
expression that we were unable to measure. Together, lower Dio2 expression and lower sympathetic 
premotor neuronal activity may contribute to decreased thermogenesis during torpor.
We are aware of technical limitations in our study such as the use of vehicle-treated animals for 
assessment of seasonal changes and the small sample size of some of the groups. It is unlikely that 
vehicle treatment confounds our interpretation since vehicle injection had no effect on Tb. Moreover, 
TTH concentration previously reported in AGS (Nevretdinova and Shvareva, 1987) was in the same range 
as values reported in vehicle-treated animals in our study, suggesting a minimal to null effect of handling 
on the parameters measured in the study. The sample size used depended on the availability of wild 
caught animals which is limited by the seasonal nature of hibernation and reproduction. Nonetheless, 
the sample size was sufficient to develop a model that can be further validated with future study. 
The use of cFos immunoreactivity to detect neuronal changes across season may be considered a 
methodological limitation as cFos expression is often used to investigate acute challenges. However, 
cFos is also expressed during spontaneous waking and under basal conditions (Cirelli and Tononi, 
2000; Kovács, 2008), making cFos a reliable marker to investigate physiological states as sleep-wake 
cycle (Cirelli and Tononi, 2000), daily rhythm (Ikeno et al., 2017) hibernation (Bratincsak et al., 2007), 
and seasonal changes (Mishra et al., 2018). Our data does not show any change in cFos activation in the 
rPA between winter euthermic (Win.VEH) and torpor, which is consistent with previous work showing 
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constant cFos mRNA expression within the rPA during the hibernation season in 13-lined ground 
squirrels (Bratincsak et al., 2007).
In conclusion, we report changes in HPT axis activation that is associated with increased 
thermogenic capacity in winter. We also report lower rPA neuronal activity in the winter season and in 
response to CHA-induced cooling. We interpret these findings in the context of a model whereby 
increased thermogenic capacity in winter supports arousal. Meanwhile, attenuated sympathetic 
premotor neuronal activity promotes the onset of torpor.
This work is significant as an increase in thermogenic capacity in winter compared to summer also 
occurs in humans. In healthy subjects, higher thermogenic capacity is associated with higher BAT 
activation after cold exposure during winter season (Cohade et al., 2003; Saito et al., 2009; Ouellet et al., 
2011; Senn et al., 2018) as well as an increase in BAT mass in winter (Ouellet et al., 2011). Furthermore, 
our results show a gradual decrease in thermogenesis from summer to winter during what is called 
physiological obesity in hibernation. The decrease in thermogenesis resembles human obesity. In obese 
individuals, BAT thermogenesis is impaired (Ooijen et al., 2006; Wijers et al., 2010; Orava et al., 
2013; Loh et al., 2017) showing a blunted response to cold exposure compared to lean subjects. Our 
model combines a seasonal increase in thermogenic capacity (independent from photoperiod and Ta) 
with a decrease in thermogenesis and further study may lead to the understanding of endogenous 
thermoregulatory mechanisms to use as therapeutic targets.
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Figure 2.1: Caption on the following page.
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Figure 2.1: HPT-axis is active in summer and winter euthermia, but not in torpor.
All AGS in the study were maintained under the constant environmental conditions (4L:20D and Ta = 
2°C) after capture as shown in (A), AGS maintain seasonal rhythm under the set constant environmental 
conditions. Results from samples collected at times shown in (B), illustrate that TRH activation in the 
PVN is lower in Torpor (D). Photomicrographs of double stained brain sections in (C), TRH neurons 
(brown) and cFos (black) in the PVN are shown in Sum.VEH, as representative of the higher activation 
group, and in torpor; the insert in PVN images show higher magnification area, scale bar 200 μm (lower 
magnification), scale bar 50 μm (higher magnification). Thyroid activity is significantly higher during the 
Fall (E) and concentration of TT3 and TT4 is higher in Torpor (F,G). No changes have been detected in 
FT3 or FT4 (H,I). Symbols in (E-G) represent outliers. Horizontal bars represent differences between 
groups, p < 0.05, t-test in (D,G) and Wilcoxon's rank-sum test in (E,F), n = 4-7.
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Figure 2.2: CHA, adenosine A1 receptor agonist, promotes onset of hibernation in a seasonally dependent 
manner.
Experimental design is illustrated in (A), treatment (CHA or VEH) was administered at time 0 and tissue 
collection was performed 3 h after injection, 2 h into the dark cycle (dark cycle is represented by gray 
area). CHA promotes the onset of hibernation in Winter AGS. Summer AGS respond to CHA briefly and 
restore the initial Tb value (B). Vehicle does not affect Tb (C). Data shown as mean ± SEM, n = 4-7. 
Arrow at 0 h indicates time of injection.
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Figure 2.3: Caption on the following page.
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Figure 2.3: CHA activates HPT axis more in winter than in summer.
Results from samples collected at times shown in (A). Photomicrographs of double stained brain 
sections in (B), TRH neurons (brown) and cFos (black) in the PVN are shown in VEH and CHA animal, the 
insert in PVN images show higher magnification area, scale bar 200 μm (lower magnification), scale bar 
50 μm (higher magnification). TRH neurons are activated after CHA with no effect of season (C). 
Significantly higher activation of TRH neurons after CHA in Winter compared to Summer was evident 
when AGS were matched for age and gender. Data shown are mean ± SEM of differences between CHA 
and vehicle-treated pairs matched for age and gender (D). CHA increases TT3 and TT4 more in Winter 
than in Summer (E,F), FT3 increases after CHA in Winter (G). FT4 does not change after CHA (H). Symbols 
in (F,G) represent outliers. Horizontal bars represent differences between groups, p < 0.05, Wilcoxon's 
rank-sum test in (E,F), t-test in (C,D,G), n = 4-7.
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Figure 2.4: Sympathetic tone decreases in winter.
The density (probability distribution) of active neurons in the rPA is wider in Fall (B) compared to 
Summer (A) and Winter (C). A seasonal decrease in euthermic Tb correlates with a seasonal decrease in 
rPA neuronal activity (D). rPA activation is higher in Summer euthermia compared to Torpor and Winter 
euthermia (E) and significantly increases after CHA in Summer, but not in Winter (F). Photomicrographs 
of double stained brain sections in (G), TPH neurons (brown) used to identify the rPA and cFos (black) 
are shown in the 4 treatment groups (Sum.CHA, Sum.VEH, Win.CHA, and Win.VEH), scale bar 200 μm.
Horizontal bars represent differences between groups, p < 0.05, t-test in (E,F), n = 4-11.
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Figure 2.5: Seasonal modulation of thermoregulation in hibernation.
The HPT axis and SNS change across season to increase thermogenic capacity in winter and gradually 
reduce thermogenesis from summer to winter (A) until arousal, when the higher thermogenic capacity is 
critical to sustain thermogenesis needed to rewarm from torpor (B).
Table 2.1: Characteristics of each seasonal phenotype.
Seasonal phenotype Sample size Torpor Bouts Body weight (g) Rectal Tb (oC)
Fall 7 0 699 ±64b,c 35.4 ±0.3a
Torpor 4 ≥ 8 594 ±35c 2.9 ±0.3c
Ibe (Winter Vehicle) 5 ≥ 8 486 ±28a 36.1 ±0.3a
Summer (Summer Vehicle) 7 0 584 ±33a,c 37.0 ±0.2b
Data shown ±SEM, rectal Tb was measured prior to tissue collection. Different letters indicate 
significantly different values p<0.05, Wilcoxon's rank-sum test.
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SI Figure 2.1: Level of reverse triiodothyronine (rT3) pharmacologically inactive hormone.
rT3 is considered a metabolically inactive thyroid hormone produced by the deiodination of T4 to rT3 
catalyzed by type 3 iodothyronine deiodinase (Dio3), even though type 1 iodothyronine deiodinase 
(Dio1) can perform the conversion. The constant level across seasons (A) and between treatments (B) 
may be explained by a lack of significant alterations in the metabolism of circulating thyroid hormones. 
In eight of 31 AGS (26 %) the rT3 concentration was below the limit of detection. Wilcoxon's rank-sum 
test in A and B, n=4 to 7.
SI Figure 2.2: During torpor HPT axis is downregulated.
The ratio between rT3 and TT3 is lower in torpor compared to winter euthermic and summer euthermic. 
In Fall the ratio is lower than summer euthermic but does not differ from winter euthermic, in 
agreement with Fall being a transition state where thermogenesis is modulated before hibernation 
starts (A). We did not detect any change in the ratio between treatments group (B). Horizontal bars 
represent differences between groups p<0.05, Wilcoxon's rank-sum test in A and B, n=4 to 7.
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SI Figure 2.3: Higher concentration of TT3 and TT4 are associated with low Tb consistent with higher 
circulating levels at minimum Tb during torpor.
We described an inverse correlations between TT3, TT4 and Tb using Pearson's correlation when data 
were normally distributed and Spearman's correlation when data were not normally distributed (for 
TT3, rs= -0.74, p <0.001, SI Fig. 3A, for TT4 rs= -0.72, p <0.001, SI Fig. 3B), n=4 to 7.
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Chapter 3: Seasonal decrease in thermogenesis and increase in vasoconstriction 
explain seasonal response to N6-cyclohexyladenosine -induced hibernation in the 
Arctic Ground Squirrel (Urocitellus parryii).2
2 Published as Frare C, Jenkins ME, McClure KM, Drew KL (2019). Seasonal decrease in thermogenesis 
and increase in vasoconstriction explain seasonal response to N6-cyclohexyladenosine-induced 
hibernation in the Arctic Ground Squirrel (Urocitellus parryii). J Neurochem.
3.1 Abbreviations
MnPO Median preoptic nucleus
A1AR A1 adenosine receptor
A2AR A2 adenosine receptor
ac Anterior commissure
AGS Arctic ground squirrel
AP Area postrema
AVP Arginine vasopressin

















PVN Paraventricular nucleus of the hypothalamus
py Pyramidal tract
ROI Region of interest
rPA Raphe pallidus





Tr Rectal body temperature




TRH Thyrotropin- releasing hormone
VEH Vehicle
VLPO Ventrolateral preoptic nucleus
3.2 Abstract
Hibernation is a seasonal phenomenon characterized by a drop in metabolic rate and body temperature. 
Adenosine A1 receptor agonists promote hibernation in different mammalian species, and the 
understanding of the mechanism inducing hibernation will inform clinical strategies to manipulate 
metabolic demand that are fundamental to conditions such as obesity, metabolic syndrome and 
therapeutic hypothermia. Adenosine A1 receptor agonist-induced hibernation in Arctic ground squirrels 
is regulated by an endogenous circannual (seasonal) rhythm. This study aims to identify the neuronal 
mechanism underlying the seasonal difference in response to the adenosine A1 receptor agonist. Arctic 
ground squirrels were implanted with body temperature transmitters and housed at constant ambient 
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temperature (2oC) and light cycle (4L:20D). We administered CHA (N6-cyclohexyladenosine), an 
adenosine A1 receptor agonist in euthermic-summer phenotype and euthermic-winter phenotype and 
used cFos and phenotypic immunoreactivity to identify cell groups affected by season and treatment. 
We observed lower core and subcutaneous temperature in winter animals and CHA produced a 
hibernation-like response in winter, but not summer. cFos-ir was greater in the median preoptic 
nucleus and the raphe pallidus in summer after CHA. CHA administration also resulted in enhanced cFos- 
ir in the nucleus tractus solitarius and decreased cFos-ir in the tuberomammaliary nucleus in both 
seasons. In winter, cFos-ir was greater in the supraoptic nucleus and lower in the raphe pallidus than in 
summer. The seasonal decrease in the thermogenic response to CHA and the seasonal increase in 
vasoconstriction, assessed by subcutaneous temperature, reflect the endogenous seasonal modulation 
of the thermoregulatory systems necessary for CHA-induced hibernation (Figure 3.1).
3.3 Introduction
Hibernation is a seasonal strategy to conserve energy and is characterized by a state of torpor, lasting up 
to 20 days in mid-winter in ground squirrels, interrupted by spontaneous regularly timed arousal called 
interbout arousal. In torpor, the body temperature (Tb) can reach a minimum of -2.9ºC in the Arctic 
ground squirrel (AGS) (Barnes, 1989) and metabolism is suppressed to 1-2% of the basal metabolic rate 
(Buck and Barnes, 2000).
The ability to induce an endogenous hypometabolic state, like hibernation, will improve current 
therapeutic hypothermia protocols. Therapeutic hypothermia is a clinical approach proven to have 
neuroprotective benefits during ischemic trauma and to improve survival after cardiac arrest (Arrich et 
al., 2016; Song and Lyden, 2012), but artificial cooling shows side effects such as generation of 
thermogenesis through shivering (Song and Lyden, 2012). Obesity is a worldwide growing epidemic and 
is associated with increased morbidity and mortality (Mitchell et al., 2011; Lambert et al., 2013). Poor 
understanding of how metabolic rate and thermogenesis are regulated limits development of 
interventions aimed at manipulating metabolic rate for therapeutic benefit (Lambert et al., 2013; 
Schoeller, 2001).
The adenosine A1 receptor (A1AR) is a key target for inducing hibernation, torpor and hypothermia in 
non-hibernating species (Tamura et al., 2005; Jinka et al., 2011; Iliff and Swoap, 2012; Tupone et al., 
2013). Previous work has shown that in AGS, which are obligate (seasonal) hibernators, N6- 
cyclohexyladenosine (CHA), an A1AR agonist, induces a decrease in Tb and metabolic rate similar to the 
endogenous onset of torpor only in winter (the hibernation season) (Jinka et al., 2011). The same AGS 
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treated in summer show a brief and slight response to CHA, which does not lead to hibernation even if 
the environmental conditions are kept constant (Jinka et al., 2011). The response to CHA is mediated by 
the central nervous system, but the mechanism underlying the seasonal difference in response is still 
unclear.
A seasonal decrease in euthermic Tb followed by a decrease in thermogenesis precedes the onset 
the hibernation season (Sheriff et al., 2012; Frare et al., 2018), which coincides with a circannual 
increase in sleep in euthermic ground squirrels (Walker et al., 1980) and an increase in vasoconstriction 
(Karoon et al., 1998; Swoap and Gutilla, 2009). Vasoconstriction, sleep and the decrease in 
thermogenesis are seasonal strategies employed to achieve energy conservation during hibernation. 
However, we do not know if the seasonal phenotypes are expressed independent of environmental 
conditions or their role in the seasonal response to CHA. Recently, we found that the winter decrease in 
neuronal activity of the sympathetic premotor neurons in the raphe pallidus (rPA), decreasing 
thermogenesis, is associated with the different seasonal response to CHA (Frare et al., 2018). Here, we 
investigate if the other energy saving strategies, sleep and vasoconstriction, and the brain regions 
regulating these physiological functions may also explain the seasonal response to CHA. In particular, we 
hypothesized that brain nuclei in thermoregulatory pathways upstream of the rPA may show similar 
changes in neuronal activity associated with the seasonal response to CHA and that CHA inhibits brain 
regions controlling arousal, as adenosine is known to promote sleep through the A1AR (Bjorness and 
Greene, 2009).
3.4 Materials and Methods
All procedures were approved by the Institutional Animal Care and Use Committee (IACUC) at the 
University of Alaska Fairbanks (assurance number D16-00482) and were conducted in accordance with 
the Guide for the Care and Use of Laboratory Animals (8th edition). The objective of this study was to 
identify neuronal activity after CHA administration underlying the seasonal difference in the 
physiological response to the drug. The study was not pre-registered.
3.4.1 Animals
Arctic ground squirrels (AGS, Urocitellus parryii) were captured in the Brooks Range (68°07'46"N 
149°28'33"W) under permit by Alaska Department of Fish and Game. AGS are available to investigators 
upon request. Beginning August 15th of the year of capture, AGS were housed at constant environmental 
conditions at an ambient temperature (Ta) of 2°C and a photoperiod of 4L:20D until the end of the 
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experiment (Figure 3.2a). AGS, male and female, were housed individually in stainless steel ¼" wire 
mesh cages (dimensions 12”X19”X12”) and provided with approximately 47 g Mazuri rodent chow and 
water ad libitum, even though AGS do not eat or drink during the hibernation season. Juveniles (one 
year old) were preferred for the study to minimize age as a biological variable, but when juveniles were 
limited at time of capture, adults were used to increase the sample size (Table 3.1).
We excluded 11 of 52 animals who met any or all of these exclusion criteria. We excluded five 
animals tested during the winter season for failure to hibernate. We excluded an additional six animals 
during the winter season because they did not display the characteristic response to CHA. Three of these 
six animals had displayed irregular hibernation bouts, characterized by frequent two-day long torpor 
bouts interrupted by unusually long interbout arousals lasting two or more days. In two of these six AGS, 
we administered CHA after only 7 bouts of hibernation. For subsequent tests, we administered CHA 
after at least 8 bouts of hibernation, since responsiveness to CHA increases as the hibernation season 
increases (Jinka et al., 2011). One animal tested during the summer season was excluded because it 
responded like a winter phenotype. This animal had displayed three spontaneous test drops prior to 
testing, which indicated an advanced circannual rhythm approaching the winter phenotype. Of the 52 
animals we used a final number of 41 for the study.
Two groups of AGS were used for the study. Group 1 was implanted with IPTT -300 transponders 
(Bio Medic Data Systems) subcutaneously between the scapulae and subcutaneous temperature (Tsc) 
was recorded every 30 min throughout the experiment. Group 2 was surgically implanted with an 
iButton (Maxim integrated, San Jose, CA) abdominal data logger and Tb was recorded every 15 min. In 
group 2, we implanted the iButtons in all AGS in August. We programmed the data logger to record Tb 
from mid-November to mid-March in Winter AGS, and to record data from mid-May to mid-July in 
Summer AGS. Additionally, as standard laboratory procedure, we measured rectal Tb (Tr) just prior to 
intracardial perfusion with a digital microprocessor thermometer (model HH21 OMEGA Engineering, 
INC., Stamford, CT).
3.4.2 Surgery
AGS were implanted with iButton using sterile technique. Anesthesia was induced with 5% isoflurane 
and maintained at 3% mixed with 100% medical grade oxygen delivered at a flow rate of 1.5 L/min. 
During surgery, Tb was maintained via a water circulating heating pad. The iButton was inserted 
intraperitoneally via a midline incision through the linea alba, and the abdomen was sutured closed in 
three layers. We administered buprenorphine (1.0 mg/kg, subcutaneously) slow release formulation for 
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analgesia, and AGS were allowed at least one day of postoperative recovery in a warm room (17°C, 
4L:20D) before being returned to home cage conditions (2°C, 4L:20D). Surgery occurred at least one 
month before the onset of hibernation.
3.4.3 Oxygen consumption
O2 consumption was monitored as described previously (Tøien, 2013). Briefly, we used a Plexiglas 
cylinder as a metabolic chamber (diameter 28 cm, height 23 cm). The air drawn from the chamber was 
filtered and passed through a mass flow controller at 3 L/min (Model 840, 0-5 L/min, Sierra 
Instruments). An air subsample was passed through a multiplexing valve system and dried by a Nafion 
drier (model PD-50T-24-PP, Perma Pure) before passing through the O2 and CO2 analyzers (Model FC-1B 
and CA-2A, Sable Systems International). The software LabGraph (Tøien, 2013) was used for automated 
data acquisition and analysis. We tested the accuracy and precision of the system before and during the 
study period by burning a measured amount (grams) of 100% ethanol in a small lamp (a glass vial with a 
wick). Measured O2 consumption was within 3% of O2 consumption calculated from the stoichiometric 
loss of ethanol from the lamp.
3.4.4 Experimental procedure
We arbitrarily assigned AGS to each experimental group before the surgical procedure. Based on the list 
of animals provided by the animal facility, we assigned every other AGS to a season (Summer or Winter); 
for each season, we assigned each treatment to every other AGS, starting with CHA. We attempted to 
balance the number of female and male AGS within each experimental group, although the availability 
of the sexes depended on the availability at the time of capture.
As previously described (Frare et al., 2018), winter phenotype (referred to as Winter AGS) was 
defined by at least eight torpor bouts. Torpor was monitored by the shavings added technique 
(Jameson, 1964); when the wood shaving placed on the animal's back remained undisturbed the 
following day, the animal was considered torpid. Summer phenotype (referred to as Summer AGS) was 
characterized by at least 60 consecutive awake days following the end of the hibernation season. 
Physiological characteristics of summer and winter phenotypes are described in Table 3.1. All AGS were 
housed in an environmental chamber (2°C, 4L:20D).
In Winter AGS, arousal was induced within the fourth day of the torpor bout by handling the AGS 
the night before the day of the experiment. After handling, the AGS was placed overnight in a warm 
room (17°C, 4L:20D) to delay onset of the following torpor bout. To be consistent with Winter AGS,
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Summer AGS were also moved to a warm room (17°C, 4L:20D) the night before the experiment. We 
withheld food during the overnight period (approximately 12 hours) and throughout the experiment, 
but water was available ad libitum. All animals used in the experiment were food deprived in the same 
manner. If hunger activated cFos, the same cFos expression would be measured in both VEH-treated 
and in the CHA-treated groups. Therefore, the VEH group is not only a control for the drug effect, but 
also for food deprivation.
On the day of the experiment, the AGS were moved back into the environmental chamber (2°C, 
4L:20D) one hour before the drug injection. Group 1 AGS, implanted with IPTT, were moved back into 
their home cage and Tsc recorded every 30 min. Group 2 AGS were placed in the metabolic chamber and 
O2 consumption was acquired for one hour as baseline. We handled and restrained the animals for two 
minutes to perform the intraperitoneal (IP) injection; as USDA Pain and Distress classifies this procedure 
a category C, there was no requirement for any medication to reduce pain. Vehicle (2.5% hydroxypropyl- 
β-cyclodextrin, 0.5mg/kg, IP) or CHA (0.5mg/kg, IP) was administered by a researcher who was aware of 
the treatment. AGS were returned to the cage and monitored for the following three hours. We 
alternated VEH and CHA treatment every other test. At the time of injection, the metabolic chamber 
was opened to handle AGS in group 2. At three hours after injection, AGS were perfused intracardially 
prior to tissue collection (Figure 3.2a).
We choose three hours after injection based on the time required to express the cFos protein. We 
are interested in the seasonal difference in response to CHA, which is evident at one hour after 
injection. cFos protein is an immediate early gene induced by a stimulus. The highest level of cFos 
protein expression occurs two hours after the applied stimulus (Chaudhuri, 1997; Cirelli and Tononi, 
2000). To detect the neuronal activity associated with the seasonal difference in response to CHA (one 
hour after injection), we collected the brains at the time when cFos expression was presumed to be at 
the highest (three hours after injection). cFos can also be expressed in astrocytes associated with 
differentiation and proliferation (Hisanaga et al., 1990) or in reactive astrocytes associated with 
neuroinflammation and pathological conditions (Groves et al., 2018). We do not expect CHA to promote 
proliferation or differentiation of astrocytes or to induce neuroinflammation; therefore, we interpret 
cFos+ cells as cFos+ neurons, but we cannot rule out involvement of astrocytes.
3.4.5 Drugs
A stock solution of CHA (10 mg/mL, Sigma Aldrich, Saint Louis, MO) was dissolved in 25% (w/v) 
hydroxypropyl-β-cyclodextrin (Tokyo Chemical Industry CO., Tokyo, Japan) in sterile water. On the week 
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of the experiment, the stock solution of CHA was diluted to 0.5mg/mL in sterile normal saline (0.9% 
NaCl). Diluted CHA was used within one month. Solutions for injection were sterilized by 0.2 μm 
filtration (Acrodisc syringe filter; Sigma-Aldrich, Saint Louis).
3.4.6 Brain tissue processing
Three hours post injection, AGS were anesthetized via chamber induction with 5% isoflurane and 
maintained via facemask at 3% mixed with 100% medical grade oxygen delivered at a flow rate of 1.5 
L/min. AGS were intracardially perfused, first with 0.9% NaCl for 5 minutes, and then with 4% PFA in 
0.1M PB buffer pH 7.4 at a flow rate of 79.5mL/min with an 18Ga needle, through the left ventricle, 
after the descending aorta was clamped, to obtain a more efficient perfusion of the brain. Brains were 
removed and post fixed in 4% PFA overnight.
Group 1 brains were cryoprotected in 30% w/v sucrose solution made in milliQ water, until brains 
sank. Brains were blocked in two parts rostral and caudal to the cerebellum and rapidly frozen in a bath 
of n-Hexane 95% cooled with dry ice to a temperature of -45°C. Frozen blocks were covered with 
Shandon™ M-1 Embedding Matrix (Thermo Fisher Scientific, Waltham, MA) and placed in - 20°C freezer 
until frozen. This procedure caused some freezer artifacts in the tissue that disrupted appearance of the 
plasma membrane and cytoplasm; therefore, we used these brains for nuclear cFos-ir. We next 
optimized the procedure as follows for double staining immunohistochemistry. Group 2 brains were 
blocked in three parts to allow for better penetration of sucrose into the tissue. A gradient of sucrose 
solutions (5,10,15, 20 and 30% w/v) was made in 0.1M PB buffer pH 7.4 to cryoprotect the tissue. Brains 
were maintained in each sucrose solution for up to 3 days and in 30% sucrose until brains sank. Brains 
covered with Tissue-Tek O.C.T. Matrix (Electron Microscopy Sciences, Hatfield, PA) were rapidly frozen 
in a bath of n-Hexane 95% cooled with dry ice to a temperature of -45°C. Coronal sections (40μm) from 
all brains were cut with a cryostat (CM1850, Leica Biosystems, Buffalo Grove, IL).
3.4.7 Immunohistochemistry
Free floating sections were washed using PBS pH 7.2, blocked with normal goat serum (NGS) (Vector 
Laboratory, Burlingame, CA) for 2 hours at 4°C and labeled with monoclonal mouse anti-cFos (1:20,000, 
Santa Cruz Biotechnology, Dallas, TX, CAT# sc271243, RRID:AB_10610067) in PBS-0.2% TritonX-100 for 
48 hours, followed by incubation with biotinylated secondary goat anti-mouse antibody (1:600, Vector 
Laboratory, Burlingame, CA, CAT# BA9200, RRID: AB_2336171) in PBS-0.4% TritonX-100. After 
incubation in avidin-biotin-peroxidase (Vectastain ABC kit, Vector Laboratory, Burlingame, CA,CAT#
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PK6100, RRID:AB_2336819), sections were treated with 0.05% DAB (3',3-diaminobenzidine 
tetrahydrochloride, Sigma-Aldrich Corp. St. Louis, MO) with 1% ammonium nickel sulfate in sodium 
acetate 0.175M and 0.1% H2O2. Sections were mounted on Superfrost Plus slides (VWR, Radnor, PA) 
with Cytoseal mounting media (Thermo Fisher Scientific, Waltham, MA) or Permount (Thermo Fisher 
Scientific, Waltham, MA). Control slices, in which primary antibody was omitted and replaced by PBS, 
were run in every experiment under the same conditions.
3.4.8 Double-labeled immunohistochemistry
Free floating sections were washed using PBS pH 7.2, blocked with NGS for 2 hours at 4°C and labeled 
with monoclonal mouse anti-cFos as the first, primary antibody in PBS-0.2% TritonX-100 for 48 hours, 
followed by incubation with biotinylated secondary goat anti-mouse antibody in PBS-0.4% TritonX-100. 
After incubation with ABC, sections were treated with 0.05% DAB with 1% ammonium nickel sulfate in 
sodium acetate 0.175M and 0.1% H2O2. The sections were then washed before incubation with the 
second, primary antibody prepared in PBS-0.2% TritonX-100 to double-label the cFos+ cells. Table 3.2 
shows the list of all the primary antibodies used. Slices were then incubated with biotinylated secondary 
goat anti-rabbit (1:600, Vector Laboratory, Burlingame, CA, CAT# BA1000, RRID: AB_2313606) or rabbit 
anti-sheep (1:600, Vector Laboratory, Burlingame, CA, CAT# BA 6000, RRID: AB_2336217) in PBS-0.4% 
TritonX-100. After incubation with ABC, sections were treated with 0.05% DAB in PBS and 0.1% H2O2. 
Sections were mounted on Superfrost Plus slides with Cytoseal mounting media or Permount. Control 
slices, in which primary antibody was omitted and replaced by PBS, were run in every experiment under 
the same conditions.
Before the NGS blocking step, we performed an antigen retrieval step (adapting one of the protocols 
provided by the website www.ihcworld.com) with the polyclonal rabbit anti-histamine antibody (1:1000, 
ImmunoStar, Hudson, WI, CAT#22939, RRID: AB_572245). Slices were incubated in hot 10mM Sodium 
Citrate with 0.05% Tween 20 at pH 6.0 (pre heated up to 80oC) for 30 min. Slices were then washed for 
15 min in PBS and blocked with NGS as described above.
3.4.9 Antibody characterization
We used brain tissue collected from animals that were not part of the study to optimize and assess 
antibody specificity. We performed immunohistochemistry in brain slices at different distances from 
bregma. For each antibody, we assessed specificity from presence of immunoreactivity in the region 
where antigen is known to be expressed, and absence of immunoreactivity in other regions. Specificity 
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of immunoreactivity was also assessed on the basis of neuronal morphology, evident in the stained 
sections. We found that the number of immunoreactive neurons gradually increased as the sections 
approached the brain region known to express the antigen within defined cell group. The pattern of 
phenotypic-ir in the AGS brain regions was similar to the neuroanatomical pattern described previously 
in rat.
We used pro-TRH antibody to label TRH neurons in the paraventricular nucleus of the hypothalamus 
(PVN) (bregma -1.8). In brain sections of the hypothalamus, the TRH-ir gradually increased at the level of 
the PVN; few TRH+ neurons were detected in box2 (SI Figure 3.1a) compared to a larger number of TRH+ 
neurons in the PVN (box1 SI Figure 3.1b). The pro-TRH-ir is identical to immunorectivity in rat brain at 
bregma -1.8 using the same rabbit anti-pro TRH donated by Eva Redei (Al-Noori et al., 2008; Fekete et 
al., 2000). In addition, TRH-ir was detected only in the PVN region, as seen by the lack of TRH-ir in box1 
(SI Figure 3.1a) and box2 (SI Figure 3.1b). We used a similar approach to characterize the other 
antibodies. AVP-ir was absent in the frontal region of the hypothalamus (box1, SI Figure 3.1c) and in the 
cortex (box3, SI Figure 3.1d). A dense AVP-ir was detected in the PVN (box1, SI Figure 3.1d), and 
throughout the supraoptic nucleus (SON) (box3, SI Figure 3.1c and box2, SI Figure 3.1d) as expected. 
Using a different AVP antibody (guinea pig anti-AVP) together with AVP mRNA expression, AVP-ir was 
previously shown in the PVN of AGS, but not in the suprachiasmatic nucleus (SCN), which is in contrast 
to other species (Williams et al., 2017). We detected the same pattern of AVP-ir in the PVN and the lack 
of AVP+ cells in the SCN in AGS (box2, SI Figure 3.1c) consistent with Williams et al. Moreover, the rabbit 
anti-AVP antibody used in our study (RRID: AB_90782, AB_11212336, AB_90772) shows an identical 
AVP-ir pattern in the PVN in rats (Das et al., 2007; Parker et al., 2017). Orexin A+ neurons are detected in 
the perifornical nucleus of the hypothalamus (PeF), on top of the fornix (box2, SI Figure 3.1e). Orexin 
fibers are also visible in the ventral part of the hypothalamus (box3, SI Figure 3.1e), but we did not 
detect any immunoreactivity in the area above the mammillary tract (box1, SI Figure 3.1e). The same 
orexin-ir pattern is detected in rats using the same rabbit anti-orexin A (RRID: AB_91545)(Zhao et al., 
2012), which specificity has been previously shown in preadsorption experiments in rats (Nambu et al., 
1999). The histamine-ir was visible in PFA perfused tissue after antibody penetration was enhanced with 
the antigen retrieval step. Histamine+ neurons were detected in the ventral location of the brain slice, 
identified as the tuberomammillary nucleus (TMN) (box3, SI Figure 3.1f), but not in other areas of the 
same coronal section (box1, box2, SI Figure 3.1f). The histamine-ir pattern in AGS is identical to the 
pattern seen in rats stained with the same rabbit anti-histamine (RRID: AB_572245) after 4% 1-ethyl-3- 
[3-dimethylaminopropyl] carbodiimide perfusion (Ellender et al., 2011; Noseda et al., 2014), and to the 
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histaminergic neurons at bregma -3.80 identified by adenosine deaminase-ir (Parks et al., 2016). TH-ir 
was detected in the catecholaminergic neurons in the locus coeruleus (LC) (box1,SI Figure 3.2a) and 
nucleus tractus solitarius (NTS) (box1, SI Figure 3.2b). Ventral immunoreactivity was associated with the 
A5 noradrenaline cells (box3, SI Figure 3.2a). We did not detect other clusters of TH+ neurons in the 
same coronal section (box2, SI Figure 3.2a and box2, SI Figure 3.2b). The neuroanatomical distribution of 
TH+ neurons in AGS is the same as the distribution reported in rats using the same antibody (RRID: 
AB_390204) in both the NTS (García-Perez et al., 2012) and LC, where specificity was confirmed by TH 
downregulation experiments (Khanday et al., 2016). TPH-ir was detected in the rPA (box3, SI Figure 3.2c) 
and in the midline corresponding to the raphe magnus. We did not detect TPH-ir in other areas of the 
section (box1-2, SI Figure 3.2c). The anatomical distribution of TPH+ neurons in AGS is identical to TPH+ 
neurons distribution in rats using the same sheep-anti TPH (RRID: AB_90754) (Oliveira et al., 2018) or 
using a different antibody (Hale et al., 2011).
3.4.10 Cell counting procedures
We assigned a blind code to each animal to prevent any bias from the observer. Images were analyzed 
using Metamorph software (version 7.8.8.0, Molecular Devices, San Jose, CA) with a Nikon Eclipse 
TE2000-U inverted microscope equipped with a CCD camera (Cool Snap HQ2, Photometrics, Tucson, AZ) 
or with Nikon Eclipse 80i equipped with a digital camera (Micropublisher 3.3RTV, Qimaging, BC, Canada). 
When tissue sections were symmetrical in each brain hemisphere (i.e. PVN, SON, SCN, NTS, LC, TMN), 
each hemisphere was counted individually in at least two consecutive slices for each AGS. The mean of 
at least four slices, two from each hemisphere per AGS, was used for subsequent statistical analysis. The 
mean of at least three slices was used in non-symmetrical sections such as the median preoptic nucleus 
(MnPO) and rPA. The count was done manually under a 20X objective using the manual count function 
in Metamorph to prevent double counting. Double stain was defined as brown DAB neurons with a 
distinct round dark black nucleus. In double stained analysis, the percentage of activated neurons was 
defined as the ratio between double stained neurons and the number of neurons positive for the 
phenotypic marker used. As an example, percent activation of AVP neurons was calculated as the ratio 
between AVP+cFos+ neurons and total AVP+ neurons.
The region of interest (ROI) included each brain region identified by Nissl stain (0.1% w/v Cresyl 
Violet) or positive phenotypic-ir (SI Figure 3.1-2) and anatomical landmarks (i.e. the anterior 
commissure, the optic chiasm, the mammillary tract, the fornix), by reference to the Paxinos and 
Watson Rat Atlas Fourth Edition (Paxinos and Watson, 1998) (Figure 3.3). We counted all cFos-ir cells 
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within the ROI borders in the MnPO, SON, VLPO, SCN, PVN and dorsal medial hypothalamus (DMH). We 
counted all cFos-ir cells and double labeled neurons within the ROI borders in the PeF/lateral 
hypothalamus (LH), TMN, LC, rPA, NTS.
MnPO: The ROI was identified by the presence of the anterior commissure and the fornix, 
corresponding to bregma -0.30 in the rat atlas (all the references to bregma refer to the rat brain). The 
bottom border of the ROI (1000μm by 350μm) was placed on top of the third ventricle.
The cFos-ir in the SON and VLPO were counted in the same coronal section corresponding to 
bregma -0.80. SON: The shorter edge of the ROI (400μm by 650μm) was placed on the edge of the optic 
chiasm and the bottom aligned with the ventral edge of the slice. VLPO: The ROI (200μm by 650μm) was 
placed along the top border of the SON ROI.
SCN: The ROI was identified in the brain section corresponding to bregma -0.92 in the rat atlas. The 
size of the ROI was defined by the area that included the entire SCN identified in nissl stained sections 
from three animals not included in the study. The bottom border of the ROI (400μm by 225μm) was 
placed on the dorsal edge of the optic chiasm. The medial border was aligned with the third ventricle.
PVN: We defined the ROI by proximity to regionally specific anatomic landmarks; these included the 
shape of the optic chiasm and the presence of the fornix and the mammillary tract, corresponding to 
bregma -1.88. The ROI box (650μm by 400μm) was placed next to the ventricle and the shorter edge 
aligned with the top of the ventricle.
We counted cells in the DMH and PeF/LH in the same coronal section corresponding to bregma - 
3.14. LH/PeF: We identified the ROI by orexin-ir and anatomical landmarks including the ventricle 
shape, the median eminence and the location of the mammillary tract. The ROI box (650μm by 540μm) 
was placed with the longer edge just on top of the fornix, and the middle of the box was aligned with 
the middle of the fornix.
DMH: The ROI box (689μm by 519μm) was placed with the longer edge next to the third ventricle 
wall and the bottom of the box aligned with the ventral extent of the fornix.
TMN: The ROI was identified by histamine-ir and by landmarks including the caudal extent of the 
third ventricle, the mammillary tract shape and the presence of the medial lemniscus. This 
corresponded to the plane defined by bregma -3.80 in the rat atlas. The longest edge of the box (688μm 
by 374μm) was placed on the ventral edge of the brain slice and the box was aligned with the middle of 
the fornix.
LC: The ROI was identified by the distinct shape of the fourth ventricle at bregma -10.04 and by TH- 
ir. The shorter edge of the box (1035μm by 517μm) was aligned with the top of the fourth ventricle.
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rPA: The ROI was identified by TPH-ir and the “protrusion” of the pyramidal tract and the dorsal 
cochlear nucleus at bregma -11.60. The box (311μm by 173μm) was placed with the middle part aligned 
with the medial longitudinal fasciculus and the bottom part of the box (the smaller edge) on the ventral 
edge of the slice between the pyramidal tracts.
NTS: We identified the ROI by the area postrema and the central canal at bregma -13.68 and TH-ir. 
The shorter edge of the box (302μm by 647μm) was aligned with the middle of the central canal and the 
bottom part of the box was placed on top of the central canal.
The AVP and TRH neurons were identified by immunoreactivity. We counted all the TRH-ir neurons 
and all the cFos-TRH-ir neurons in the slice in the PVN at bregma -1.88, and all the AVP-ir neurons and all 
the cFos-AVP-ir neurons in the slice in the PVN at bregma -1.40.
3.4.11 Statistical analysis
A statistical a priori power analysis (G*Power software version 3.1.9.4 ), using the statistical test ANOVA: 
Fixed effects, special, main effects and interactions in the F tests family, was performed for sample size 
estimation based on published data on cFos count in the MnPO during sleep and wakefulness (Gong et 
al., 2000). With the effect size=3.1, alpha=0.05, power=0.8, numerator df=1 and number of groups=4, 
the estimated sample size is approximately n=6 to detect a significant interaction between season and 
treatment (Faul et al., 2007). All outliers were included in the data analyses performed using R (version 
1.1.423). Data are presented as mean ± SEM and a p <0.05 was considered significant. We tested the 
normality assumptions on the data using Shapiro test, when the assumption was not met, the data were 
normalized by transforming to the square root. Before combing data from group 1 and group 2, we ran a 
three way ANOVA to test for effects of season, treatment and group. Groups 1 and 2 were combined 
when no significant interactions with group were noted and we excluded group 1 from the analysis 
when interactions with group were statistically significant. Next, we used two way ANOVA to test for 
effects of season and treatment. When the interaction between the independent variables was 
significant and one mean tended to be different from the three other means, we used the Dunnett test. 
When the two way ANOVA showed only a significant (p<0.05) main effect of season or treatment and 
did not show any significant interaction, we reported data collapsed across variables that were not 
statistically different from one another, and we performed a single post-hoc t test. We report results 
grouped by effect of season, effect of treatment and effect of an interaction between season and 
treatment. If data, after transformation, failed the assumption of normality, we used the nonparametric 
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Kruskal Wallis test for multiple comparisons and the Wilcoxon signed-rank test for comparison between 
groups.
3.5 Results
CHA induced-hibernation promotes a delayed and persistent decrease in metabolic rate and Tb in Winter 
AGS, but not in Summer AGS under constant environmental conditions (Figure 3.2). Our results show the 
time course of this response for three hours, at which time we collected the brain tissues for 
immunohistochemical analysis.
3.5.1 Effect of handling on torpor bout in Winter AGS
As shown in Figure 3.2a, we handled the torpid AGS the night before the experiment to induce arousal 
in Winter AGS. We then moved the Winter AGS to a warm room (17oC, 4L:20D) to delay the natural 
onset of the next torpor bout. In 94.4% of AGS the torpor bout was successfully delayed, but the 
procedure was not effective in one AGS, assigned to the Winter VEH group. Four hours prior to drug 
administration, we found the AGS in a curled position, re-entering torpor. We handled the AGS a second 
time to restore the arousal state. At the time of injection, the Tb reached the euthermic temperature of 
35.1oC. This animal contributed to the large variation in the Tb data between time -1 and time 0 in the 
Winter VEH group (Figure 3.2c).
3.5.2 Seasonal changes in euthermic Tb
Hibernation is a seasonal phenomenon characterized by physiological changes between summer and 
winter, which led us to ask if the euthermic Tb changes between seasons under constant environmental 
conditions. We found a significantly lower core Tb and Tsc in Winter AGS compared to Summer AGS 
(t(17)=6.57, p<0.001 t test in Tb; t(16)=5.90 , p<0.001 t test in Tsc; Table 3.1). VEH-treated AGS also 
showed a significantly lower Tr in Winter AGS compared to Summer AGS, measured just prior to 
perfusion (t(19)=4.08, p<0.001 t test in Tr; Table 3.1). We also observed in VEH-treated AGS a 
significantly lower core Tb in winter compared to summer when core Tb was monitored over the VEH 
treatment period, beginning one hour before VEH administration to the time of tissue collection for a 
total of 4 hours (F(1,156)=4.45, p<0.05 Season by time, two way ANOVA, Figure 3.2c-2e).
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3.5.3 Effect of treatments on Tb and metabolic rate
CHA significantly decreases metabolic rate, measured as the rate of O2 consumption, and Tb from time 
of injection (time zero) to the time of tissue collection. In Winter AGS, the effect of CHA on metabolic 
rate and Tb leads to the onset of hibernation (H(192)=479.3, p <0.001, for O2 consumption; 
H(12)=50.567, p <0.001 for Tb; Kruskal Wallis test; Figure 3.2b). Summer AGS show a transient decrease 
in metabolic rate and Tb; metabolic rate and Tb return to the initial values within one hour from CHA 
administration (H(182)=396.78, p <0.001, Kruskal Wallis test for O2 consumption; F(11,36)=13.16, p< 
0.001 one way ANOVA for Tb; Figure 3.2d). Interestingly, in Winter AGS metabolic rate decreases 
immediately at time zero, while the decrease in Tb is delayed by one hour (Figure 3.2b). By contrast, 
both the metabolic rate and Tb decrease at the same time in Summer AGS (Figure 3.2d). In the control 
groups, Winter and Summer AGS treated with VEH, metabolic rate and Tb showed no change after 
injection (Winter AGS: H(181)=84.77, p=1, Kruskal Wallis test for O2 consumption; F(11,48)=0.468, p=0.9 
one way ANOVA for Tb; Figure 3.2c. Summer AGS: H(182)=148.4, p =1.0, Kruskal Wallis test for O2 
consumption , F(11,60)=0.877, p=0.6 one way ANOVA for Tb; Figure 3.2e). We found that the seasonally 
dependent effect of CHA was the same whether we monitored core Tb or Tsc (SI Figure 3.3a-b).
3.5.4 Effect of season on sleep-wake and thermoregulatory pathways
Summer and Winter AGS are characterized by seasonal changes in physiology. First, we asked if 
neuronal activity within sleep-wake and thermoregulatory pathways changes with season. We identified 
seasonal differences in neuronal activity in the SON, the SCN and in the rPA. Table 3.3 shows a 
significant increase in cFos activation in the SON (t(16)=-2.1676 p<0.05 two sample t test) and a 
significant decrease in the SCN (t(9.49)=4.01, p<0.01 two sample t test) in Winter compared to Summer 
AGS, also shown by photomicrographs (SI Figure 3.4a-b). In the rPA, two way ANOVA analysis showed a 
significant interaction, so data were not collapsed and we performed a post hoc t test between the two 
VEH groups to assess the effect of season. We found significantly higher cFos activation in the Summer 
VEH compared to the Winter VEH (t(18.9)=2.35, p<0.05 two sample t test, Table 3.2 and SI Figure 3.4c). 
These results suggest that a seasonal modulation of neuronal activity in the SCN, the SON and the rPA is 
associated with the AGS seasonal phenotype.
3.5.5 Effect of CHA on sleep-wake pathways
We next asked how CHA affects the sleep-wake pathways (Schwartz and Roth, 2008; Saper and Fuller, 
2017) illustrated in Figure 3.4a. We identified the ventrolateral preoptic nucleus (VLPO) a known sleep­
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active region, based on anatomical landmarks within the hypothalamus; this region did not show any 
change in cFos expression after CHA (SI Table 3.1). Unfortunately, we were not able to confirm the 
identity of the region because the antibodies used as phenotypic markers were not effective in AGS 
brain (SI Table 3.2). Next, we looked at the brain nuclei within the arousal pathways. cFos-ir cells were 
counted in the TMN, but we excluded group 1 AGS from the analysis because of a significant interaction 
with group (F(1,31)=8.06, p<0.05, interaction treatment by group three way ANOVA). The TMN (Figure 
3.4b) shows a decrease in cFos expression after CHA compared to VEH (t(19)=-3.5184 p<0.01 two 
sample t test, Figure 3.4d). When we double stained the TMN for cFos+ and histamine (HIST)+ neurons 
(Figure 3.4c), the percent activation of HIST+ neurons was significantly lower in the CHA-treated 
compared to the VEH-treated group (t(19)=-3.6208 p<0.01two sample t test, Figure 3.4e). Group 1 and 2 
data were combined in the LH (F(1,31)=0.066, p=0.8, interaction season by treatment by group three 
way ANOVA). Although we saw a tendency towards lower cFos expression in the LH in Winter AGS 
compared to Summer AGS (t(37)=1.9168 p=0.06 two sample t test, Table 3.3), after double staining the 
LH for cFos+ and orexin+ neurons, we did not find any change in percent activation of orexin+ neurons 
(SI Table 3.1). Moreover, we did not find any difference in activation of TH+ neurons in the LC (SI Table 
3.1).The TMN is the main nucleus in the sleep-wake pathways significantly inhibited by CHA, 
independent of season.
3.5.6 Effect of CHA on thermoregulatory pathways
As CHA lowers Tb and metabolic rate, we asked if brain regions regulating thermogenesis are affected by 
CHA. First, we looked at the PVN, as a main regulator of energy homeostasis. We did not find any 
significant difference in the number of cFos+ neurons in the PVN between CHA and VEH-treated AGS 
(Table3. 4). However, we found a significant increase in percent activation in AVP+ neurons 
(t(18)=4.0517, p<0.001 two sample t test, Table 3.4, SI Figure 3.5a) as well as in percent activation of 
TRH+ neurons in CHA-treated AGS compared to VEH (t(19)=2.2838, p<0.05 two sample t test, Table 3.4, 
SI Figure 3.5b). We found higher numbers of TRH+ neurons in Winter AGS compared to Summer (131±11 
Summer, 83±7 Winter, t(19)=-3.8 p<0.01, n=10-11 animals per group); and no difference in AVP+ 
neurons (103±4 Summer, 114±8 Winter, p>0.05, n=10 animals per group). Although an increase in TRH+ 
neurons suggests plasticity and increased thermogenic capacity consistent with prior findings (Frare et 
al., 2018), we cannot conclude that TRH+ neurons proliferate in the PVN without counting neurons 
within the full extent of the nucleus and this was beyond the scope of this study.
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Next, we looked at the brain regions known to regulate thermogenesis reported in Figure 3.5a. The 
DMH, showed an increased neuronal activity in the CHA-treated group compared to VEH (t(18)=3.5153 
p<0.01 two sample t test, Figure 3.5d-e). We also found changes in cFos activation in the NTS, a nucleus 
located in the brainstem. cFos-ir cells were counted in the NTS, but we excluded group 1 AGS from the 
analysis because of a significant interaction with group (F(1,31)=8.12, p<0.05, interaction season by 
group three way ANOVA). The NTS showed an increase in neuronal activation in CHA-treated AGS 
compared to VEH-treated AGS (t(10.92)=3.27 p<0.01 two sample t test, Table 3.5). We double stained 
the NTS for cFos+ and TH+ neurons. We expressed the number of double-labeled neurons as a 
percentage of total TH+ neurons. Using this approach, we found an increase in percent activation of TH+ 
neurons within the NTS in the CHA-treated AGS compared to VEH-treated AGS (t(18)=2.1763, p<0.05, 
Table 3.5 and SI Figure 3.5c). We saw no difference between absolute numbers of neurons double 
stained for cFos and TH (F(1,16)=1.57, p=0.23, interaction season by treatment, two way ANOVA).
3.5.7 Interaction of CHA and season on sleep-wake and thermoregulatory pathways
Finally, because the metabolic and thermoregulatory response to CHA is different with seasons, we 
asked in which brain regions CHA induces a different neuronal activation between summer and winter. 
The MnPO and rPA show seasonal differences in cFos expression in response to CHA. Neuronal 
activation is significantly higher in the MnPO in the Summer CHA group compared to Summer VEH, 
Winter CHA and Winter VEH (F(1,16)=4.862 p<0.05 interaction season by treatment two way ANOVA, 
followed by Dunnett test; Figure 3.5b-c). cFos+ cells counted in group1 and 2 in the rPA were combined 
(F(1,31)=0.2, p=0.6, interaction season by treatment by group three way ANOVA). The rPA shows a 
higher number of cFos+ cells in the Summer CHA compared to Summer VEH, Winter CHA and Winter 
VEH (F(1,35)=6.605 p<0.05 interaction season by treatment two way ANOVA, followed by Dunnett test; 
Figure 3.5f-g). We did not observe any changes in the percent activation of TPH+ neurons in the rPA (SI 
Table 3.1). The changes in neuronal activation in the MnPO and the rPA explain the seasonal difference 
in response to CHA.
3.6 Discussion
3.6.1 Seasonal modulation of thermoregulatory response to CHA underlies onset of hibernation
Consistent with our previous findings (Frare et al., 2018; Jinka et al., 2011), we report the different 
seasonal response to CHA in Winter and Summer AGS, maintained under constant environmental 
conditions (2ºC, 4L:20D). Here we show that the MnPO and the rPA, two brain nuclei that are part of the 
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thermoregulatory pathways (Morrison and Madden, 2014), are associated with the seasonal response to 
CHA. We define for the first time the MnPO as another seasonal component of CHA-induced 
hibernation, together with the previously described premotor neurons in the rPA (Frare et al., 2018), 
which regulate both shivering and non-shivering thermogenesis (Tan and Knight, 2018). The direct 
inhibition of the rostral ventromedial medulla including the rPA by the GABAA agonist muscimol induces 
a torpor-like state in rats (Cerri et al., 2013), therefore, it is likely that the suppressed activation of the 
rPA should promote the onset of hibernation. However, the direct inhibition of the rPA in rats produced 
massive cutaneous vasodilation that worked in concert with suppressed thermogenesis to lower Tb 
(Cerri et al., 2013). By contrast, vasoconstriction predominates during hibernation shown by Tsc 
measurements. The seasonal increase in neuronal activation of the MnPO and the rPA after CHA in 
Summer reflects activation of the thermogenic pathway. Previous evidence suggests that when Tb 
decreases, the GABAergic neurons in the MnPO disinhibit the DMH allowing activation of the premotor 
neurons in the rPA which in turn activates sympathetic innervation of brown adipose tissue (BAT) and 
increases thermogenesis (Nakamura et al., 2004; Morrison and Madden, 2014). However, this response 
is blunted after CHA in Winter so Tb decreases. Where CHA acts to blunt the thermogenic response 
remains unknown.
The MnPO is part of the preoptic area (POA) of the hypothalamus that integrates thermogenic 
stimuli and other physiological states (McKinley et al., 2015). We focused our interpretation on the role 
of the MnPO in the thermoregulatory and sleep pathways as the most likely physiological functions 
affected by CHA (Bjorness and Greene, 2009; Tupone et al., 2013), but acknowledge that the function of 
the MnPO is diverse (McKinley et al., 2015) and we cannot rule out activation of the MnPO related to 
other functions without further study. The GABAergic neurons in the MnPO not only regulate 
thermoregulatory function, as described above, but also promote sleep through direct inhibition of the 
arousal centers and dis-inhibition of the VLPO (Uschakov et al., 2007). The MnPO, a sleep active region, 
is most likely a major component in the cross-talk between thermoregulation and sleep (Gong et al., 
2004; Dentico et al., 2009; Harding et al., 2018). Currently published data suggest that different 
GABAergic populations within the MnPO may control the two physiological processes (Dentico et al., 
2009; Harding et al., 2018). Unfortunately, we were not able to perform a comprehensive 
characterization of the cFos+ neurons in the MnPO using phenotypic markers for GABA neurons, due to 
limited cross-species reactivity of commercially available antibodies. Inability to label GABAergic 
neurons within the POA, also limited our analysis in this region with dispersed cell groups that Nissl stain 
cannot define. However, the distinctly higher cFos expression in the MnPO in our data and the well 
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described activation of the MnPO and the rPA associated with thermogenesis (Nakamura et al., 2004; 
Nakamura and Morrison, 2008) are consistent with our interpretation that the thermogenic response 
after CHA in Summer AGS is suppressed after CHA in Winter. Thus, our data suggest the MnPO and rPA 
as the likely regulators of the seasonal response to CHA.
Nonetheless, as sleep increases in euthermic (not hibernating) squirrels during the hibernation 
season compared to summer (Walker et al., 1981), we cannot exclude possible seasonal changes in 
subpopulations of GABAergic neurons in the MnPO promoting sleep and also regulating the seasonal 
response to CHA. Although we found no evidence of a change in seasonal sensitivity to CHA in sleep 
active neurons in the VLPO, CHA inhibited the arousal promoting neurons in the TMN (discussed below) 
regardless of seasonal phenotypes.
3.6.2 Thermolytic and somnogenic effects of CHA promote the onset of hibernation
Brain nuclei within the thermoregulatory pathways are activated in response to CHA. The thermolytic 
effect of CHA is evident from the decrease in metabolic rate followed by a decrease in Tb after drug 
administration. Our data suggest that the NTS is the brain region mediating the thermolytic effect of 
CHA. The role of the NTS in suppression of thermogenesis has been previously suggested via indirect 
projections to the rPA (Cao et al., 2010), but the mechanism is still poorly understood. However, the NTS 
is characterized by a large number of A1AR (Pickel et al., 2006), making this area a likely site of action of 
CHA. Our result in AGS are consistent with previous findings also showing a higher cFos activation in the 
NTS in CHA-induced hypometabolic state in rats (Tupone et al., 2013), and supported by the direct effect 
of CHA administration in the NTS in suppressing Tb (Tupone et al., 2013), thus metabolism. Within the 
NTS, we saw no difference between absolute numbers of neurons double stained for cFos+ and TH+, 
consistent with prior work in rat (Tupone et al., 2013). However, we expressed the number of double-
labeled neurons as a percentage of total TH+ neurons, and we found a significant effect of CHA on the 
activation of TH+ neurons in the NTS. An alternative interpretation as to why we saw TH+ neurons 
activated is that our observations may reflect hypotension caused by systemic administration of CHA. 
Hypotension activates the barosensitive TH+ neurons in the NTS (Daubert et al., 2012; Li and Dampney, 
1994) to adjust arterial pressure through the baroreceptor reflex control system. The neuronal activity 
of TH+ neurons in the NTS increases after CHA administration as a negative feedback mechanism to the 
direct peripheral effect of CHA on decreasing heart rate with subsequent decrease in blood pressure 
(Tupone et al., 2013; Vicent et al., 2017; Laughlin et al., 2018).
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Interestingly, AGS maintain their cold-defense response despite CHA-induced inhibition of 
thermogenesis. TRH neurons and AVP neurons within the PVN, known to stimulate thermogenesis 
(Angulo et al., 1991; Jasnic et al., 2015; Mchler et al., 2010), are activated after CHA in Summer and 
Winter but these cold defense responses are attenuated at the level of the MnPO and rPA in Winter to 
allow the onset of hibernation, but not in Summer. The ability of AGS to maintain a cold-defense 
mechanism is especially important during the hibernation season when the stimulation of 
thermogenesis is necessary to rewarm from torpor during interbout arousals, and in extreme ambient 
cold when torpid AGS increase their metabolic rate (Buck and Barnes, 2000; Richter et al., 2015). The 
thermogenic brain nuclei (AVP and TRH) activated in response to CHA-induced cooling are most likely 
the nuclei activated during rewarming from torpor. It has been shown that both AVP injection in the 
lateral septum (Hermes et al., 1993) and intracerebroventricular injection of TRH (Tamura et al., 2005) 
interrupt torpor and induce arousal. In addition, TRH receptor quantification in ground squirrel shows 
seasonal variations (Stanton et al., 1992). TRH receptor density decreases in torpor compared to the 
euthermia in the PVN and in the medial preoptic area of the POA, both thermoregulatory regions 
(Stanton et al., 1992). As TRH is linked to metabolic state, we can speculate that a metabolic clue may 
trigger thermogenesis, however the signaling mechanisms initiating rewarming are still unknown (Drew 
et al., 2017).
DMH is the intermediary nucleus between the MnPO and the rPA (Zhang et al., 2011; Morrison and 
Madden, 2014) so it is unclear why we did not observe any winter seasonal blunting of activation of 
DMH neurons as seen in the rPA and the MnPO. In Summer, the increase in cFos expression in the DMH 
after CHA may be associated with the activation of thermogenesis through the MnPO-rPA pathway. In 
Winter, activation of cold-defense mechanisms may also activate neurons within the DMH which are 
blunted downstream at the level of the sympathetic premotor neurons in the rPA.
Adenosine is a well-known endogenous sleep promoting neurotransmitter (Bjorness and Greene, 
2009) and the role of the A1AR in hibernation and torpor has been shown in AGS, hamsters and mice 
(Drew et al., 2017). We identify the TMN, within the sleep-wake pathway as the major nuclei mediating 
the somnogenic effect of CHA. We discussed above a possible effect of CHA in the disinhibition of the 
sleep active neurons (i.e. the MnPO and VLPO) that suppress arousal, but CHA may also inhibit the TMN 
directly. A previous study supports a direct effect of A1AR agonist on the histaminergic neurons to 
promote sleep in rats (Oishi et al., 2008).
The significant effect of CHA on HIST+ neurons could be explained by the larger extent of the 
histaminergic system in the ground squirrel compared to rat (Sallmen et al., 1999). The extensive 
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histaminergic system in ground squirrel could place the histamine signaling as the major wakefulness 
nucleus within the arousal pathways in hibernators. Moreover, the histamine signaling has been 
proposed as the mechanism triggering arousal from torpor as the histaminergic fibers increased during 
the hibernation season (Sallmen et al., 1999; Panula et al., 2000). Therefore a direct inhibition through 
A1AR and the increase in autoregulatory receptor (H3R) in hypothalamic regions seen in torpor (Sallmen 
et al., 2003a; Herwig et al., 2007) may act together to suppress wakefulness and to promote torpor. 
However, the role of histaminergic signaling in hibernation is controversial. One study showed increased 
torpor bout length by intrahippocampal histamine administration (Sallmen et al., 2003b), which is 
surprising, but the possibility that histamine lengthened torpor through H3R, has not been excluded. 
CHA suppresses thermogenesis and promotes sleep, but a seasonal clock controls both the onset of 
natural and CHA-induced hibernation.
3.6.3 Seasonal decrease in thermogenesis is required for the onset of hibernation
Here we show that a seasonal decrease in thermogenesis involves attenuated activation of 
thermogenesis as well as a seasonal increase in vasoconstriction, both of which occur without changes 
in environmental conditions and contribute to energy conservation. Tsc is an indirect, but valid measure 
of vasoconstriction. The seminal core-shell model of thermoregulation defines Tsc and skin temperature 
as the component of the outer shell (Webb, 1992) whereby a decrease in Tsc and skin temperature is 
secondary to a decrease in vasoconstriction (Barcroft and Edholm, 1946). The lack of thermogenic 
response, likely attenuated at the level of the MnPO and the rPA after CHA administration in Winter, 
reflects a seasonal decrease in sensitivity of thermoregulatory pathways as described in our previous 
model of seasonal modulation of thermogenesis (Frare et al., 2018).
Increased vasoconstriction described here and by others during fasting-induced torpor in mice and 
hibernation in ground squirrels and hamsters (Lyman and O'Brien, 1961; Lyman and O'Brien, 1963; 
Karoon et al., 1998; Swoap and Gutilla, 2009) decreases conductive heat loss in Winter AGS after CHA 
treatment. CHA induces an immediate drop in O2 consumption, followed by a delayed decrease in Tb in 
Winter AGS. The delayed decrease in Tb is due to the seasonal increase in vasoconstriction.
In hibernation, the seasonal modulation of thermogenesis occurs despite of external stimuli, 
challenging the classic view of warm- and cold-activated pathways where a stimulus activates a suite of 
coordinated responses that together promote an increase or decrease in Tb. Here we show for the first 
time that vasoconstriction in hibernation is seasonally modulated to conserve energy regardless of 
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environmental cues. Challenging the current compartmentalization of neuronal pathways, hibernation 
shows that neuronal circuits can be individually used to conserve heat and energy.
We identify the SON, characterized by vasopressinergic neurons, as the brain area most likely to 
mediate the increase in vasoconstriction as AVP is known to be a strong vasoconstrictor (Ohbuchi et al., 
2015). We were not able to quantify activated AVP+ neurons in the SON because the high density of 
AVP+ neurons prevented the accurate count of the individual neurons and densitometry was not 
feasible in double stained slices. Even though we had these technical issues, we speculate that the cFos+ 
neurons are vasopressinergic neurons as the majority of cells in the SON are AVP+ (Zhao and Ai, 2011; 
Otero-García et al., 2016) and the oxytocin neurons in the SON mediate behaviors and functions 
(Althammer and Grinevich, 2018), which do not occur during the hibernation season.
CHA-induced hibernation highlights the similarity between hibernation and sleep, in particular the 
relation between sleep and thermoregulation. The physiological onset of sleep follows the circadian 
decrease in core Tb (Szymusiak, 2018; Te Lindert and Van Someren, 2018) just as the seasonal onset of 
hibernation is facilitated by a seasonal decrease in core Tb. While in sleep, the decrease in Tb is obtained 
through vasodilation, in hibernation it is not. In hibernation, the decrease in Tb is reached through the 
seasonal increase in vasoconstriction and decrease in thermogenesis, which are intended to conserve 
energy. Thus, the idea that hibernation is an extension of sleep (Walker et al., 1981) is in part supported 
by our data as the seasonal decrease in thermogenesis is needed for adenosine mediated hibernation.
3.6.4 Seasonal differences in neuronal activation within the SCN unrelated to CHA
Modulation in thermoregulatory pathways is necessary for the onset of hibernation; however, the 
mechanism underling the circannual clock is still unknown. The SCN controls the circadian rhythm and 
plays a role in the timing of daily torpor (Ruby, 2003), however its function in hibernation is still 
debated. During the hibernation season, the SCN is arrested as cFos expression is significantly reduced in 
Winter compared to Summer AGS. Our results are consistent with previous work in AGS that found the 
periodicity of the SCN to be absent during hibernation (Ikeno et al., 2017). Moreover, we found similar 
levels of cFos measured here under a 4L:20D cycle as levels of cFos measured by others under constant 
darkness (Ikeno et al., 2017). A study in 13-lined ground squirrels also excludes the role of the SCN in 
regulating hibernation as the level of cFos mRNA is constant throughout the torpor bout (Bratincsak et 
al., 2007). By contrast to reports of cFos protein expression in AGS, cFos mRNA levels are higher in 
hibernating 13-lined ground squirrels compared to the euthermic control group (Bratincsak et al., 2007). 
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Notably, the control group was not well characterized with regard to season and may have included 
both summer and winter phenotypes, and mRNA and protein expression may differ.
Even if we suggest that activity of the SCN is attenuated during the hibernation season, some 
baseline neuronal activity is still present, consistent with a reduced but persistent SCN metabolic activity 
in hibernating golden-mantled ground squirrels (Kilduff et al., 1989). Moreover, cFos protein expression 
in AGS and cFos mRNA in golden-mantled ground squirrels are both higher during arousal at 200C Tb 
compared to torpor and interbout arousal (Bitting et al., 1994; Ikeno et al., 2017). It is tempting to 
speculate that the SCN activity during rewarming is required to produce melatonin, also known to be a 
potent neuroprotectant. A surge in melatonin production is detected in early arousal in Siberian 
hamsters (Larkin et al., 2003) and melatonin signaling pathway is critical for neuroprotection during 
arousal at 200C Tb 13-lined ground squirrels (Schwartz et al., 2015).
In conclusion, the seasonal decrease in Tb achieved through a decrease in thermogenesis and an 
increase in vasoconstriction contributes to CHA-induced hibernation in the winter season. A circannual 
rhythm modulates thermogenesis and vasoconstriction independent of environmental temperature and 
day length. The MnPO and the rPA stand out as key sites of circannual modulation of thermogenesis and 
the SON stands out as a site of circannual modulation of vasoconstriction. Understanding 
thermoregulatory mechanisms in hibernation will expand our fundamental understanding of Tb and 
metabolic regulation and will develop novel strategies to regulate metabolic demand.
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Figure 3.1: Graphical abstract
Adenosine promotes hibernation and torpor through the A1 receptor. However, an endogenous 
seasonal rhythm regulates the response to adenosine A1 receptor agonist-induced hibernation in arctic 
ground squirrels. We hypothesized that thermoregulation is seasonally modulated. Using 
immunohistochemical analyses in brain tissue of arctic ground squirrels, we identify the median preoptic 
area (MnPO) and raphe pallidus (rPA) as the main brain nuclei regulating the seasonal difference in 
response to CHA, an adenosine A1 receptor agonist. The seasonal increase in vasoconstriction, measured 
by subcutaneous body temperature and associated with higher cFos expression in the supraoptic 
nucleus (SON) explains the delayed fall in Tb observed in winter ground squirrels after CHA.
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Figure 3.2: CHA promotes the onset of hibernation in a seasonally dependent manner.
(a) After capture, AGS were kept in constant environmental conditions (2°C, 4L:20D) year-round. The 
night before the experiment, both Summer and Winter AGS were handled and moved into a warm room 
(17°C, 4L:20D). An hour before injection we moved the AGS back to the environmental chamber (2°C, 
4L:20D). Collected one hour of baseline measurements, then administered CHA or VEH at time 0, and we 
collected the tissue after three hours. (b) Winter AGS treated with CHA, decreased O2 consumption 
followed by Tb leading to the onset of hibernation. (d) Summer AGS treated with CHA showed a 
transient and gradual decrease in O2 consumption and Tb. (c and e) VEH produced no change in Tb or O2 
consumption in either Winter AGS or Summer AGS. Dotted line represents Tb, solid line represents O2 
consumption. Data are shown as mean ±SEM. SEM are represented as shaded area, number of animals 
per group n= 4 to 7. Arrow at 0h indicates injection time.
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Figure 3.3: Caption on the following page.
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Figure 3.3: Regions of interests investigated in this study.
The coronal plane and bregma are based on the Paxinos and Watson Rat Brain Atlas. For bilateral ROI, 
labels are positioned on the side opposite the box defining the ROI. See methods section for a detailed 
description of each ROI. MnPO: median preoptic nucleus, VLPO: ventrolateral preoptic nucleus, SON: 
supraoptic nucleus , SCN: suprachiasmatic nucleus, PVN: paraventricular nucleus of the hypothalamus, 
LH: lateral hypothalamus, PeF: perifornical nucleus, DMH: dorsal medial hypothalamus, TMN: 
tuberomammillary nucleus, LC: locus coeruleus, rPA: raphe pallidus, NTS: nucleus tractus solitarius, fx: 
fornix, ac: anterior commissure, ox: optic chiasm, sm: stria medullaris of the thalamus, opt: optic tract, 
mt: mammillary tract, ml: medial lemniscus, 7n: facial nerve, py: pyramidal tract, DC: dorsal cochlear 
nucleus, AP: area postrema.
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Figure 3.4: CHA reduces neuronal activity in the histaminergic neurons of the TMN.
The classical sleep-arousal pathways are illustrated in (a), green arrows represent excitatory 
connections, red arrows represent inhibitory connections, in addition the circadian regulation of sleep is 
illustrated by the black line from the SCN to the LH. (b) Representative photomicrograph of the TMN at 
low magnification (for better resolution, the image was constructed from images taken under 2X 
magnification). (c) Photomicrographs of double stained brain sections, histamine (HIST) neurons (brown) 
and cFos (black) in the TMN. The inserts in the TMN image show an area at higher magnification. (d) The 
TMN shows a decrease in cFos expression, in the CHA group compared to VEH group. (e) CHA
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significantly inhibits histaminergic neurons compared to VEH, measured as the percent activation of 
HIST+cFos+/HIST+ in the TMN. Data are shown as mean ±SEM, solid line represents p<0.05, t test. 
Number of animals n=10 to 11 per each treatment group. Cell count represents the mean of three slices 
per animal (d, e); symbols represent outliers (d). MnPO: median preoptic nucleus, VLPO: ventrolateral 
preoptic nucleus, LH: lateral hypothalamus, LC: locus coeruleus, TMN: tuberomammillary nucleus, DR: 
dorsal raphe nucleus, SCN: suprachiasmatic nucleus, DMH: dorsomedial hypothalamus, SPZ: 
subparaventricular zone, 5-HT: serotonin, DA: dopamine, OX: orexin, HIST: histamine.
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Figure 3.5: Caption on the following page.
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Figure 3.5: Regions in the thermoregulatory pathway show differential activation in CHA groups 
compared to VEH.
(a) Schematic of the pathway known to regulate brown adipose tissue (BAT) thermogenesis showing the 
brain regions analyzed. (b) Representative images showing cFos expression in the MnPO (for better 
resolution the image was constructed from five images taken under 10X magnification). (c) The MnPO 
shows higher cFos expression after CHA in summer compared with Summer VEH, Winter CHA and 
Winter VEH. (d) Photomicrographs of cFos stained brain sections in the DMH. (e) DMH shows increased 
cFos expression in the CHA-treated group compared to the VEH-treated group independent of season.
(f) Photomicrographs of cFos stained brain sections in the rPA. (g) The rPA shows higher cFos expression 
in Summer CHA compared with Summer VEH, Winter CHA and Winter VEH. Data shown as mean ± SEM, 
number of animals per groups n=5 to 11. Cell count represents the mean of three slices per animal. 
Symbols represent outliers (c, g). Solid line indicates p<0.05, Dunnett test (c, g), t test (e). MnPO: median 
preoptic nucleus, DMH: dorsomedial hypothalamus, rPA: raphe pallidus nucleus, 3V: third ventricle, ac: 
anterior commissure, ox: optic chiasm.
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Number of torpor bouts 0 >8
Body Weight (g) all AGS 573 ±2 n=22 489 ±3* n=18
Body Weight (g) Adult Female 628 ±3 n=6 n/a n/a
Body Weight (g) Adult Male 594 n=1 665 n=1
Body Weight (g) Juvenile Female 547 ±4 n=8 421 ±2 n=8
Body Weight (g) Juvenile Male 553 ±4 n=7 515 ±4 n=9
Euthermic respiratory rate (breath/min) 139 ±8 n=22 91 ±8* n=18
Euthermic Core Tb (Tb, °C) a,b 38.6 ±0.2 n=10 36.4 ±0.3* n=9
Euthermic Subcutaneous Tb (Tsc , °C)a 37.4 ±0.3 n=10 33.7 ±0.6* n=8
Euthermic Rectal Tb (Tr ,°C) 37.0 ±0.2 n=11 35.7 ±0.3* n=10
Data are shown as mean ±SEM, number of animals per each phenotype (n), *p<0.05 t test. In the 
Juvenile AGS, we found a significant lower body weight in the Winter AGS compared to the Summer AGS 
(F(1,27)=5.5, p<0.05, main effect of season, two way ANOVA with sex and season as variables) and no 
sexual differences. aData represent the mean of the average Tb in the hour before the injection. bWe 
excluded the animal re-entering torpor from the mean and statistical analysis.
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Table 3.2: List of primary antibodies used to identify cFos and phenotypic markers, Research Resource 
Identifier (RRID).
Primary antibody Dilution Incubation CAT# Company RRID
Mouse anti-cFos 1:20,000 48 hours, 4°C SC271243 Santa Cruz
Biotech, TX
AB_10610067
Monoclonal; Immunogen: amino acids 120-155 within an 














Polyclonal; Immunogen: recombinant rabbit tryptophan hydroxylase.
Rabbit anti-orexin A 1:5,000 48 hours, 4°C AB3704 Millipore, MA AB_91545
Polyclonal; Immunogen: synthetic peptide corresponding to the C-terminal 
portion of the bovine Orexin-A peptide.





Polyclonal; Immunogen: Synthetic histamine coupled to succinylated 



















Polyclonal; Immunogen: Arginine vasopressin conjugated to thyroglobulin.
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Table 3.3: Seasonal changes in cFos expression.
Number of cFos+ neurons
ROI Summer Winter Percent change
Lateral hypothalamus (LH) 88± 6 n=21 72± 7 # n=18 18%
(ROI= 0.4 mm2)
Supraoptic nucleus (SON) 199± 14 n=10 244± 15* n=8 23%
(ROI= 0.3 mm2)
Suprachiasmatic nucleus (SCN) 196± 39 n=10 36± 7* n=9 82%
(ROI= 0.09 mm2)
Raphe pallidus (rPA) (ROI= 0.05 mm2) 28± 3 n=11 19± 3* n=10 32%
The mean number of cFos+ neurons in three to four brain slices per each animal was used to calculate 
the mean ±SEM. n indicates the number of animals, *p<0.05, # p=0.06, t test. Percent change indicates 
the magnitude of the changes observed from Summer to Winter. The rPA data are not collapsed as the 
two way ANOVA showed a significant interactions between season and treatment; thus the rPA Summer 
and Winter data in the table includes only the Summer VEH and the Winter VEH groups.
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Table 3.4: Treatment induced changes in neuronal activation, measured as cFos activation, in the 
paraventricular nucleus of the hypothalamus (PVN).
CHA VEH
Number of cFos+ neurons (ROI=in 0.3 mm2) 445± 56 n=11 386 ± 54 n=9
Percent activation of TRH+ neurons (%) 79.4 ± 2.8 n=9 69.4± 3.1* n=12
Percent activation of AVP+ neurons (%) 73.5 ± 3.1 n=10 54.2 ±3.6* n=10
Data are shown as mean ±SEM, number of animals per each treatment group (n). Cell count represents 
the mean of three to two brain slices per animal, *p<0.05 t test. The percentage of activated neurons 
was defined as the ratio between double stained neurons and the number of neurons positive for the 
phenotypic marker used.
Table 3.5: Treatment induced changes in neuronal activation, measured as cFos activation, in the nucleus 
tractus solitarius (NTS).
CHA VEH
Number of cFos+ neurons (ROI=in 0.2 mm2) 70 ± 8 n=17 42 ± 3* n=20
Percent activation of TH+ neurons (%) 58.3 ± 4.7 n=9 45.9 ± 3.4* n=11
Data are shown as mean ±SEM, number of animals per treatment group (n), Cell count represents the 
mean of three slices per animal,*p<0.05 t test. The percent activation of TH+ neurons was calculated as 
the ratio between TH+cFos+ neurons and total TH+ neurons.
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SI Figure 3.1: Caption on the following page.
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SI Figure 3.1: Characterization of the antibodies used in the hypothalamus.
Antibodies have been characterized in brain tissue from AGS, which were not part of the study. Antibody 
immunoreactivity is present in the brain regions expected to show positive immunoreactivity. An initial 
thyrotropin-releasing hormones (TRH)-ir is visible in the frontal hypothalamic region (a-2) and the 
number of TRH+ neurons increase moving towards to mid part of the hypothalamus (b-1); TRH-ir is 
specific for the area of interest as the lack of immunoreactivity is visible in other hypothalamic regions 
(a-1, b-2) and in the cortex (b-3). Arginine vasopressin (AVP)-ir is expected in the SON, SCN and in the 
PVN. AVP-ir is visible in the SON (c-3), but not in the SCN (c-2) and the frontal hypothalamic area (c-1), 
AVP-ir increases in the hypothalamus moving towards to mid part of the forebrain (d-1), AVP+ neurons 
are still present in the SON (d-2), but not in the cortex (d-3). Orexin-ir is present in the area above the 
fornix as expected (e-2), and orexin fibers not neurons are visible in the ventral area of the 
hypothalamus (e-3). Orexin-ir is absent in other hypothalamic areas (e-1). Histamine-ir is present in the 
region identified as the TMN (f-3). Histamine+ neurons are not detected in the other hypothalamic area 
(f-2, f-1)). For better resolution, each image was constructed from images taken under 2X magnification. 
SON: supraoptic nucleus, SCN: suprachiasmatic nucleus, PVN: paraventricular nucleus of the 
hypothalamus, TMN: tuberomammillary nucleus, 3v: third ventricle, fx: fornix, ac: anterior commissure, 
ox: optic chiasm, opt: optic tract, mt: mammillary tract, ml: medial lemniscus.
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SI Figure 3.2: Characterization of the antibodies used in the brainstem.
Antibodies have been characterized in brain tissue from AGS, which were not part of the study. Antibody 
immunoreactivity is present in the brain regions expected to show positive immunoreactivity. Thyrosine 
hydroxylase (TH)-ir is visible in the LC (a-1), the noradrenaline cells A5 (a-3) and in the NTS (b-1) as 
expected, TH+ neurons are not detected in mid region of the slice (a-2, b-2). Thryptophan hydroxylase 
(TPH)-ir is detected in the raphe region as the rPA (c-3), but not in the mid region of the slice (c-1, c-2). 
For better resolution, each image was constructed from images taken under 2X magnification. LC: locus 
coeruleus, rPA: raphe pallidus, NTS: nucleus tractus solitarius, 4v: fourth ventricle, py: pyramidal tract, 
cc: central canal, AP: area postrema.
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SI Figure 3.3: CHA induces a decrease in subcutaneous Tb (Tsc ) that resembles the effect of CHA on core 
Tb.
In Winter AGS, CHA decreases Tsc leading to the onset of hibernation. On the contrary, in Summer AGS 
CHA has a transient effect on Tsc (a). Vehicle does not show changes in Tsc in both Winter and Summer 
animals. A greater vasoconstriction characterized the winter season, indicated by the lower Tsc in 
euthermic Winter AGS compared to euthermic Summer AGS, both phenotypes housed at 2ºC and 
4L:20D(b). Breaks in the lines represent missing data points in Tsc. Data are shown as mean ±SEM, 
represented as shaded area. Where shaded area is missing only one data point is plotted. Number of 
animals per group n=3 to 6. Arrow at 0h indicates the time of injection.
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SI Figure 3.4: Representative images showing the seasonal changes in cFos expression. 
Photomicrographs show cFos expression in the SON (a). The inserts show an area of higher 
magnification (a). Photomicrographs show cFos expression in the SCN (b). The inserts show an area at 
higher magnification (b). Photomicrographs show cFos expression in the rPA (c). SON: supraoptic 
nucleus , SCN: suprachiasmatic nucleus, rPA: raphe pallidus, 3v: third ventricle.
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SI Figure 3.5: Representative images showing changes in neuronal activation in the CHA and VEH groups.
Vasopressinergic (AVP) neurons (brown) and cFos (black) are stained in the paraventricular nucleus of 
the hypothalamus (a). The inserts show an area of higher magnification scale bar 50μm (a). Thyrotropin­
releasing hormone (TRH) (brown) and cFos (black) are stained in the paraventricular nucleus of the 
hypothalamus (b). The inserts show an area of higher magnification area, scale bar 50μm (b). Tyrosine 
hydroxylase neurons (TH) (brown) and cFos (black) are stained in the nucleus tractus solitarius (c). 3v: 
third ventricle, cc: central canal.
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SI Table 3.1: Brain regions in the AGS that do not show any differences between groups.
Summer CHA Summer VEH Winter CHA Winter VEH
Number of cFos+ neurons in the 
ventrolateral preoptic nucleus 
(VLPO) (ROI= 0.3mm2)
45 ± 6 n=6 38 ± 3 n=4 42 ± 7 n=4 40 ± 9 n=4
Percent activation of orexin+ 25± 5 n=5 26 ± 4 n=6 43 ± 11 n=5 31 ± 8 n=5
neurons in the LH (%)
Percent activation of TPH+ 24.3± 7.0 n=3 18.9 ±3.1 n=7 12.8 ±3.9 n=5 17.7±4.5 n=5
neurons in the rPA (%)
Percent activation of TH+ neurons 19.0± 4.0 n=5 16.4 ±4.6 n=7 24.6 ±10.8 n=4 20.6 ±5.1 n=5
in the LC (%)
Data are shown as mean ±SEM, animal number per group (n), represents the mean of three slices per 
animal. The percentage of activated neurons was defined as the ratio between double stained neurons 
and the number of neurons positive for the phenotypic marker used.
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SI Table 3.2: List of primary antibody not showing immunoreactivity in AGS brain tissue.













Ab5909 Millipore, Temecula, CA AB__2108517












Ab5062P Millipore, Temecula, CA AB_2301998
Rabbit anti-GAD67, 
polyclonal
Ab97739 Abcam, Cambridge, MA AB_.10681171
Mouse anti-GAD67, MAB5406 B Millipore, Temecula, CA AB_2278725
monoclonal
Mouse anti-GAD67, monoclonal MAB5406 Millipore, Temecula, CA AB_2278725
(-ir in Cortex only)
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Chapter 4: Seasonal changes in adenosine kinase in tanycytes underlie the possible 
mechanism of adenosine-induced hibernation in the Arctic Ground Squirrel 
(Urocitellus parryii).
4.1 Abstract
Hibernation is a seasonal strategy to conserve energy, characterized by modified thermoregulation, an 
increase in sleep pressure and drastic metabolic changes. The mechanisms controlling hibernation are 
still undefined, but adenosine plays a significant role through the activation of the adenosine A1 receptor 
(A1AR). In Arctic ground squirrels, hibernation, induced by activating A1AR, occurs during the hibernating 
season, but not in summer. This suggests that a higher order process entrained to an endogenous 
circannual rhythm controls adenosine-induced hibernation. Seasonal changes in brain tissue levels of 
adenosine may contribute to seasonal sensitivity to A1AR agonist. Adenosine kinase, located in 
astrocytes, is a primary regulator of extracellular adenosine concentration. Astrocytes and tanycytes are 
brain metabolic sensors, and tanycytes regulate seasonal changes in phenotypes, but it remains 
unknown if either cell type contributes to seasonal expression of hibernation. This study aims to 
characterize changes in adenosine kinase expression and tanycyte morphology during the seasonal 
modulation of adenosine signaling, as potential contributors to the higher order process regulating 
hibernation. We collected brain tissue from Arctic ground squirrels in different seasons. We performed 
immunohistochemical analysis to identify changes in tanycytes morphology and in adenosine kinase 
expression within the hypothalamus and the area postrema, two regions characterzed by tanycytes and 
involved in energy homeostasis. We found seasonal changes in tanycyte morphology in the 
hypothalamus. Next, we observed for the first time the presence of adenosine kinse in tanycyte cell 
bodies, and we found a seasonal change in adenosine kinase levels in tanycytes, but not in astrocytes. 
We suggest that tanycytes may regulate adenosine signaling through the presence of ADK.
95
4.2 Introduction
Hibernation is a seasonal strategy of energy conservation (Carey et al., 2003). In obligate hibernators like 
the Arctic ground squirrel (AGS), a circannual rhythm regulates the onset of the hibernation season 
(Pengelley et al., 1978). A fall transition phase, characterized by a seasonal modulation in thermogenesis 
leading to a decrease in euthermic body temperature (Tb), precedes the onset of hibernation (Sheriff et 
al., 2012; Frare et al., 2018, 2019). The mechanisms that control hibernation are poorly understood. 
However, the activation of central nervous system (CNS) adenosine A1 receptors (A1AR) promotes the 
onset of hibernation and torpor in different species (Drew et al., 2017), suggesting a possible common 
mechanism that is conserved between species. A1AR agonist-induced hibernation in AGS is controlled by 
processes affecting A1AR signaling that are entrained to an endogenous circannual rhythm (Jinka et al., 
2011; Frare et al., 2019). The nature of these processes are unknow, but are expected to include 
modulation of extracellular concentrations of adenosine in the CNS or the efficacy of A1AR agonist 
signaling.
Adenosine kinase (ADK) is the primary enzyme regulating extracellular levels of adenosine in the 
CNS. In adult brain ADK is expressed in astrocytes and not neurons (Boison, 2013), but expression in 
tanycytes has not been defined. The role of adenosine in sleep is well established and ADK may 
modulate sleep drive by affecting extracellular levels of adenosine highlighting the connection between 
sleep and energy metabolism (Bjorness et al., 2016). In addition, adenosine release from astrocytes 
inhibits orexigenic hypothalamic neurons via A1AR, and consequently feeding (Yang et al., 2015). 
Although the hibernation season is characterized by an increase in sleep pressure compared to summer 
(Walker et al., 1980) and a suppression in metabolism and feeding (Carey et al., 2003), it is unknown if 
ADK expression changes seasonally.
Tanycytes, ependymal glial cells with a distinct morphology, line the floor of the third ventricle (3V) 
and function as a barrier regulating the transport of substances from the vasculature to the brain 
parenchyma (Rodríguez et al., 2005; Ebling and Lewis, 2018). Tanycytes are characterized by long 
processes originating from the cell body and extending to the median eminence and to the nearby 
parenchyma (Rodríguez et al., 2005). The plasticity of the tanycytes' endfeet regulates the release of 
hormones in the fenestrated blood vessels of the median eminence in seasonal reproductive species 
(Prevot et al., 2010), and a seasonal “plasticity in gene expression” also regulates seasonal changes in 
body weight and energy homeostasis (Bolborea and Dale, 2013; Herwig et al., 2013; Ebling, 2014). 
Tanycytes are also metabolic sensors and deliver metabolic information from the periphery directly to 
the hypothalamic neurons regulating energy homeostasis (Frayling et al., 2011; Balland et al., 2014).
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Tanycyte-like cells are present in the floor of the fourth ventricle (4V) and in the area postrema (AP) 
functioning as a barrier between the periphery and the CNS (Felten et al., 1981; Langlet et al., 2013a), 
but not enough work has been done to fully assess the function of tanycytes of the 4V. Although 
tanycytes share features with astrocytes, it is unknown if tanycytes express ADK or if tanycyte or 
astrocyte plasticity and ADK expression is associated with seasonal expression of hibernation.
Here we test the hypothesis that seasonal changes in tanycytes morphology and ADK levels are 
phenotypic markers of the hibernation season.
4.3 Materials and Methods
All procedures were approved by the Institutional Animal Care and Use Committee (IACUC) at the 
University of Alaska Fairbanks and conducted in accordance with the Guide for the Care and Use of 
Laboratory Animals (8th edition). The objective of this study was to identify seasonal changes in tanycyte 
morphology and ADK expression.
4.3.1 Animals
Arctic Ground Squirrels (AGS, Urocitellus Parryii) were captured in the Brooks Range (68°07'46"N 
149°28'33"W) under permit by Alaska Department of Fish and Game. After capture, AGS were housed in 
an environmental chamber at constant conditions at an ambient temperature (Ta) of 2ºC and a 
photoperiod of 4L:20D until the end of all experiments. The hibernation cycle persists under constant 
environmental conditions that are needed to investigate the endogenous circannual rhythm without 
confounding variables such as Ta and photoperiod. We housed AGS individually and fed the animals 
approximately 47 g Mazuri rodent chow, daily, and provided water ad libitum. Food and water were 
provided even though AGS do not eat or drink during the hibernation season. We included both juvenile 
and adult animals of both sexes in the study as the age and sex of the animals depended on the 
availability at the time of capture. We collected euthermic animals in Summer, defined as two months 
after the last day of hibernation, and Fall. Fall AGS were identified by the lower euthermic Tb that 
precedes the beginning of the hibernation season (Sheriff et al., 2012). During the hibernation season 
we monitored torpor by the shavings added technique (Jameson, 1964); when the wood shavings placed 
on the animal's back remained undisturbed the following day, the animal was considered to be 
hibernating (i.e., torpid). We collected AGS during deep torpor (Torpor AGS) and we induced arousal 
within the third day of the torpor bout. Tissue from the induced-aroused AGS were then collected 
during the interbout arousal (IBA) phase, here referred to as Winter AGS. All AGS collected during the 
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hibernation season had at least eight torpor bouts. We measured rectal Tb in all AGS just prior to 
intracardial perfusion with a Digital Microprocessor Thermometer (model HH21 OMEGA Engineering, 
INC., Stamford, CT). Physiological characteristics of each seasonal phenotype are described in Table 4.1.
4.3.2 Brain tissue processing
AGS were anesthetized via chamber induction with 5% isoflurane and maintained via facemask at 3% 
mixed with 100% medical grade oxygen delivered at a flow rate of 1.5 L/min. AGS were intracardially 
perfused first with 0.9% NaCl for 5 min and then with 4% PFA in 0.1M PB buffer pH 7.4 at a flow rate of 
79.5mL/min with a 18Ga needle through the left ventricle after the descending aorta was clamped to 
obtain a more efficient perfusion of the brain. Brains were removed and post fixed in 4%PFA overnight. 
Brains were blocked in three parts to allow better penetration of sucrose into the tissue. A gradient of 
sucrose solutions (5,10,15, 20 and 30 % w/v) was made in 0.1M phosphate buffer (PB) pH 7.4 to 
cryoprotect the tissue. Brains were maintained in each sucrose solution for up to 3 days and in 30% 
sucrose until brains sank. Brains covered with Tissue-Tek O.C.T. matrix (Electron Microscopy Sciences, 
Hatfield, PA) were rapidly frozen in a bath of n-Hexane 95% cooled with dry ice to a temperature of 
-45ºC. Coronal sections (40μm) were cut with a cryostat (CM1850, Leica Biosystems, Buffalo Grove, IL). 
Slices were then stored until used at -20ºC in cryo-protective (antifreeze) solution made in 0.1 M PB pH
7.4 with 60%w/v sucrose, 2%w/v polyvinylpyrrolidone (PVP-40, Sigma, St. Louis, MO) and 60%v/v 
ethylene glycol (VWR, Radnor, PA).
4.3.3 Immunohistochemistry
We used five animals per group from the brain tissue bank. Upon tissue availability, we used two tissue 
slices per animal at Bregma -2.80 to -3.14 based on the Paxinos and Watson Rat Atlas Fourth Edition. 
Free floating sections were washed using PBS pH 7.2, treated with 0.5% Triton X-100 for 20 min at RT, 
then blocked with 10% normal goat serum (NGS) (Vector Laboratory, Burlingame, CA) in PBS for 30min 
at room temperature (RT). After a second wash in PBS, the sections were incubated in a humidified 
chamber for 48hours at 20C with a cocktail of antibodies including mouse anti-vimentin (1:1000, 
Millipore, MA) and rabbit anti-adenosine kinase (ADK, 1:4000, Bethyl Laboratories, TX ) diluted in PBS 
with 1% NGS and 0.1% TritonX-100. Slices were washed in PBS and incubated with a mixture of goat 
anti-mouse Alexa 488 (1:500, Invitrogen, NY) and goat anti-rabbit Alexa 456 (1:750, Invitrogen, NY) in 
PBS containing 1% NGS in a dark room for 2hours at RT. Brain slices were mounted on Superfrost Plus 
slides (VWR, Radnor, PA) with Vectashield mounting media (Vector Laboratories, CA).
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4.3.4 Image analysis
Images were collected with Slidebook 6 software using the Olympus IX81 inverted confocal microscope 
(objective LUCPlanFLN 40X, NA 0.60), equipped with a CCD camera (Hamamtsu ORCA-ER,6.45 μm x6.45 
μm pixel size, Japan). To minimize exposure time, first we captured images for ADK analysis (exposure 
time 3000ms, Gain150); next we collected images as a Z-stack over 10 μm with a step of 0.5 μm 
(exposure time 400ms, Gain255) for tanycyte analysis. Images were analyzed using ImageJ software 
(version 1.52a, National Institute of Health, USA).
We stained two consecutive brain slices per animal. In the hypothalamus, we analyzed six to eight 
fields of view per each brain slice, for a total of 12 to 16 fields of view per animal. In the AP we analyzed 
five to six fields of view, for a total of 10 to 12 fields of view per animal.
To measure the length of the tanycyte processes, we overlapped a grid on top of the image. The grid 
number zero was assigned to the grid containing the cell body, and then we traced the processes 
emanating from the cell body. We counted the number of grid lines crossed by each process. We set the 
number of processes crossing the first line of the grid (grid1) as 100% of the processes present in the 
field of view. We then calculated the percent of processes crossing the other lines of the grid as follow: 
% processes in gridn= (number of processes in gridn*100%)/ (number of processes in grid1).
To measure the width of the tanycyte processes, we traced a vertical line parallel to the 3V, across the 
tanycytes' processes. We used the function “plot profile” in ImageJ, which displays the intensity peak for 
each process along the traced line. Then, we set the threshold to 500 grey value and we manually 
measured the process's width at the base of each peak. We averaged 12 to 16 plots for each AGS. We 
displayed the data as the percentage of tanycytes with processes' width smaller than 5 μm and greater 
than 5 μm.
We measured ADK intensity in the layer of the 3V, tracing the region of interest (ROI) around the 
tanycyte cell bodies. For the remainder of the hypothalamus we traced the ROI excluding the ventricle 
layer ROI. In the AP and 4V, we applied the same technique. Since the ROI were different within fields of 
view, we used the image J measure of the mean grey value that allows comparison of different size ROI. 
The mean grey value measures the average of grey value within the ROI (the sum of all the grey value of 
all the ROI pixels divided by the total number of pixels in the ROI).
4.3.5 Statistical analysis
Data are presented as mean ± SEM and a p ≤0.05 was considered significant. Data analyses were 
performed using R (version 1.1.423). First, we tested the data for the assumption of normality using
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Shapiro test and the assumption of homogeneity of variance using the Bartlett test. If these assumptions 
were met, we compared the groups using a one way ANOVA followed by Tukey's honestly significant 
difference (HSD) test. When the data did not meet the assumption of homogeneity of variance, even 
after being transformed to the square root, we performed a Welch's ANOVA test followed by multiple 
comparison t tests with the Bonferroni's correction. We performed a linear regression analysis using the 
relative intensity of ADK as a predictor of Tb. Our preliminary data was used to perform a priori linear 
regression power analysis using G*Power software (version 3.1.9.4) to calculate the optimal sample size 
to detect a significant difference in the regression model, which details are reported under the result 
section “4.4.2 Tanycytes express ADK”.
4.4 Results
4.4.1 Seasonal changes alter tanycytes process width, but not length in the 3V.
Qualitative observations, showed a difference in tanycyte morphology between the Summer and the 
Winter groups. The Winter group was characterized by tanycytes with consistently thinner processes 
compared to the Summer group, which had wider processes (Figure 4.1A). The two morphologies were 
not as distinct in the Torpor and Fall groups, which included both thin and wide processes (SI Figure 4.1­
4.2). We followed this qualitative assessment with a measure of the processes' width in the 3V. We 
found that Winter AGS showed a significantly higher number of thin tanycytes compared to Summer, 
reported as percentage of tanycytes with processes' width less than 5 μm (F(3,7.08)=12.386, p<0.01 
Welch's ANOVA, followed by t tests with Bonferroni's correction, Figure 4.1B). This quantitative analysis 
supports our qualitative observation of thinner tanycyte processes in Winter AGS. Data show a 
significant decrease in the number of tanycytes wider than 5 μm in Winter compared to the other 
seasons (F(3,16)=9.055. p< 0.001 one way ANOVA, followed by Tukey HSD test, SI Figure 4.3). We next 
asked if tanycyte process length changes across seasons. We did not find any difference in process 
length between seasons in the tanycytes of the 3V (Figure 4.1C). We next examined the morphology of 
tanycyte-like cells around the central canal compared to the tanycytes lining the 3V: the cell body is 
cubical with short processes converging towards the ventral part of the brain (Figure 4.1D). The lack of 
long processes in 4V tanycyte-like cells prevented us from quantifying process width and length like we 
did for 3V.
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4.4.2 Tanycytes express ADK
ADK is the primary regulator of extracellular adenosine concentration in the brain prompting us to ask if 
ADK is present in tanycytes. We identify ADK within the cell bodies of the tanycytes lining the 3V (Figure 
4.2). We next measured ADK intensity in the tanycytes. ADK intensity showed a high variation in the 
torpor group (Figure 4.3A), and for this reason, we excluded the torpor group from the following 
statistical analysis. ADK intensity in the tanycyte cell bodies changed between seasons 
(F(2,6.52)=12.287, p<0.01 Welch's ANOVA); ADK intensity significantly decreased in the Winter group 
compared to the Summer (p< 0.01 t test with Bonferroni's correction, Figure 4.3B). A multiple linear 
regression was calculated to predict Tb based on ADK levels (Figure 4.3C). A regression equation was 
found with a tendency towards significance (F(1,8)=4.25, p=0.07), with an R2 of 0.35. As ADK tended 
towards significance as a predictor of Tb, we performed an a priori power analysis to estimate the 
sample size needed based on the data we collected. We used the statistical test ‘Linear bivariate 
regression: One group, size of slope' in the t tests family with two tails. We performed the analysis using 
the experimental standard deviation for ADK intensity=75.60 and Tb=0.78, and the correlation 
coefficient ρ=0.59 to calculate the Slope H1. With H1=0.006087, alpha=0.05 and power=0.8 the 
estimated sample size of 17 animals is needed to detect a significant regression analysis between ADK 
and Tb.
We next asked if ADK levels in the hypothalamic astrocytes show a similar tendency. We observed 
similar variation in ADK levels in the torpor group as seen in tanycytes (Figure 4.3E). We then excluded 
the torpor group for the statistical analysis, but we did not detect any significant difference between 
groups in ADK intensity in the ventral hypothalamic astrocytes (F(2,12)=1.456, p=0.27 one way ANOVA, 
Figure 4.3F).
4.4.3 ADK expression in the tanycyte-like cells in the AP and 4V
Next, we looked at the tanycyte-like cells in the AP and the ADK intensity in astrocytes and tanycyte-like 
cells. We observed ADK immunoreactivity in the AP and in the cell bodies of tanycyte-like cells lining the 
4V (Figure 4.4A). We did not find a significant difference in ADK intensity between the groups in the 
tanycyte-like cells (F(3,16)=1.3, p=0.30 one way ANOVA, Figure 4.4B). Similar to the hypothalamic data, 
we observed a high variation in ADK levels in the AP of the torpor group and we excluded the torpor 
group from the following statistical analysis. We did not find a significant difference in ADK levels 
between groups in the AP (F(3,16)=1.53 p=0.24 one way ANOVA, Figure 4.4C).
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4.5 Discussion
In this study, for the first time we identify the presence of ADK in the cell bodies of tanycytes lining the 
3V and tanycyte-like cells lining the 4V. Adenosine kinase (AdK; EC 2.7.1.20) is an enzyme that 
phosphorylates adenosine to AMP. ADK determines the availability of adenosine and thereby controls 
adenosine receptor activation (Etherington et al., 2009).The presence of ADK in tanycytes has not been 
characterized before this study, although the use of ATP, as a signaling molecule, by tanycytes was 
previously described. ATP is released from tanycytes in the parenchyma by metabolic clues, such as 
glucose and amino acids and it activates the nearby neurons (Frayling et al., 2011; Lazutkaite et al., 
2017). The presence of purinergic receptors in the cell membrane and the expression of the enzyme 
hydrolyzing ATP, suggest that tanycytes also metabolize ATP (Braun et al., 2003; Dale, 2011; Prevot et 
al., 2018). Through this work, we show that tanycytes could be an additional cell type for ATP-adenosine 
metabolism. As tanycytes and astrocytes already share some functions such as being glucose responsive 
and releasing ATP (García-Cáceres et al., 2019), it is not surprising that tanycytes may contribute in 
regulating extracellular adenosine levels.
ADK is the main regulator of extracellular adenosine, a neuromodulator known to play a role in sleep 
and in energy metabolism (Boison et al., 2010). Interestingly, the role of ADK is emerging as a 
component in the somnogenic properties of adenosine. Overexpression of astrocytic ADK suppresses 
sleep (Palchykova et al., 2010; Diógenes et al., 2014), while the ablation of ADK increases homeostatic 
sleep drive highlighting the connection between sleep and energy metabolism (Bjorness et al., 2016).
In addition, adenosine promotes the onset of hibernation through stimulation of A1AR, but in a 
seasonally dependent manner (Jinka et al., 2011; Frare et al., 2018). A1AR-induced hibernation is 
effective after the seasonal modulation of thermogenesis occurs, indicated by an increase in 
vasoconstriction and a decrease in euthermic Tb (Frare et al., 2019). We previously reported a seasonal 
adjustment in the neuronal pathways during the fall season, in particular a progressive decrease in 
neuronal activity of the premotor neurons in the raphe pallidus leading to a decrease in euthermic Tb 
(Frare et al., 2018). Here, we observed a similar phenomenon. In the Fall group, tanycyte morphology 
shares characteristics of both the Summer and Winter morphologies suggesting a transition from thick 
processes in summer to thinner processes in Winter. Furthermore, the ADK levels in the Fall group are 
not different from Summer or Winter groups, suggesting a progressive seasonal modulation of 
extracellular adenosine during the fall transition. The lower levels of ADK in Winter compared to 
Summer is expected to increase extracellular adenosine in winter. Intracellular ADK activity decreases 
intracellular adenosine and thus clears adenosine from the extracellular space via equilabrative 
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nucleoside transporters (Boison, 2013). Overexpression of ADK in the brain leads to a decrease in 
extracellular ADK and to sleep disruption (Palchykova et al., 2010; Diógenes et al., 2014). If the ADK 
levels change between seasons in the AGS, adenosine metabolism and the rate of adenosine clearance 
would change accordingly. During arousal metabolic activity increases significantly (Karpovich et al., 
2009) and adenosine, as a byproduct of ATP, increases in plasma in 13-lined ground squirrel (Epperson 
et al., 2011). Similarly, adenosine may increase in the extracellular space as neuronal activity is restored 
during arousal from torpor (Ohe et al., 2007) or directly through the plasma via adenosine transporters 
in the blood brain barrier (Isakovic et al., 2004). Lower ADK levels in Winter compared to Summer, 
would reduce the rate of adenosine clearance and adenosine persisting in the extracellular milieu would 
promote the onset of hibernation through A1AR.
Interestingly, we do not observe a similar change in ADK levels in the AP. The AP is a 
circumventricular organ that conveys the peripheral information through the dense population of 
fenestrated capillaries to the CNS (Price et al., 2008). In particular the AP regulates autonomic pathways 
controlling food intake, fluid homeostasis and the cardiovascular system (Price et al., 2008). In 
hibernation, the cardiovascular system undergoes significant changes between torpor and IBA; heart 
rate can drop from 300 to 10 beats/min during entrance into torpor and it is reversed during arousal 
(Milsom et al., 1999). The AP regulating cardiovascular output, may need to maintain its integrity 
throughout the seasons avoiding additional changes in adenosine metabolism, that could augment the 
sensitivity of AP neurons to adenosine (Chen and He, 1999).
We did not expect to observe such a large variation in ADK expression during torpor. However, 
torpor is characterized by a significant decrease in Tb and the neuronal network changes dramatically 
with a 50-60% loss in synapses and retraction of neuronal cell bodies and dendrites, which are restored 
during IBA (Ohe et al., 2006, 2007). A high variability may derive from the small sample size or by the 
state of torpor per se that may affect ADK expression, through an unknown mechanism.
In AGS, the tanycyte-like cells in the AP and the central canal showed a different morphology from 
the tanycytes in the 3V. The central canal was characterized by a honeycomb structure with polygonal 
and cuboidal shape, with processes that did not extend as far as the one in the 3V. Interestingly the 
processes merged towards the midline and the ventral part of the brain. These morphological 
assessments are similar to previous work describing the tanycytes of the 4V floor in rabbit, showing 
similar polygonal shape and the tendency of the processes to cluster in the midline (Felten et al., 1981). 
We also observed some differences between the tanycyte-like cells in the AP and in the central canal. 
We could not identify any distinct process within the AP, and even if there was a honeycomb structure 
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similar to the central canal, the shape of the cell bodies was round; a shape that resembled the shape of 
tanycyte cell bodies in the 3V. The lack of processes within the AP in the AGS is consistent with previous 
work showing the processes emanating from the edge of the AP, not within the AP (Guillebaud et al., 
2017). Another study describes the processes within the AP to elongate in several directions (Langlet et 
al., 2013a), if the processes of the tanycyte-like cells “tangle” in a complex 3D structure, a coronal cut 
would truncate the processes limiting visualization to short segments. Tanycyte-like cells in the 4V are 
suggested to be a barrier within the CSF and the periphery (Langlet et al., 2013a), however this group of 
ependymal cells requires further anatomical and functional characterization.
A well know feature of tanycytes is their ability to change morphology depending on the 
physiological state of the animals such as reproductive state (Prevot et al., 2010; Pouchain Ribeiro Neto 
et al., 2017) and diet (Langlet et al., 2013b; Ramalho et al., 2018). Hibernation is characterized by 
seasonal changes in the reproduction system (Barnes et al., 1986; Darrow et al., 1988; Barnes and York, 
1990) and by drastic changes in metabolism (Andrews et al., 2009). We were able to asses changes in 
the processes' width between the Summer and the Winter groups, which is consistent with previous 
data showing a decrease in vimentin gene expression in winter compared to summer in hamsters 
(Herwig et al., 2013; Petri et al., 2014). Even if we did not find difference in process length, we cannot 
exclude a change in the tanycytes' endfeet as seen in rats during the reproductive cycle (Prevot et al., 
2010). Further work is required to identify if endfeet morphology undergoes similar changes between 
seasons, and during hibernation (Torpor and IBA) via higher resolution microscopy. Tanycytes also play a 
role in seasonal changes in phenotype modulating availability of thyroid hormones in hamster (Herwig 
et al., 2013). Here we propose that tanycytes serve as seasonal modulators of adenosine signaling 
through changes in ADK expression.
In conclusion, tanycytes likely play a role in adenosine signaling through expression of ADK. An 
expected increase in extracellular adenosine during the hibernation season may explain part of the 
seasonal phenotype and the seasonal response to A1AR agonist-induced hibernation.
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Figure 4.1: Caption on the following page.
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Figure 4.1: Tanycytes process' width does change between seasons, but not tanycytes length.
Qualitative observations showed a difference in morphology between Summer and Winter tanycytes as 
visible by the photomicrographs of tanycytes stained with vimentin (green) taken from an AGS in the 
Summer and Winter seasons (A). Consistent with our observations, we measured a significant higher 
number of tanycytes with a width smaller than 5 μm in Winter AGS compared to Summer; percent of 
processes represent the ration between the thinner processes over the total number of processes 
measured, solid line rapresent p<0.05, t test with Bonferroni's correction, and symbols rapresent 
outliers (B). The process length did not change between seasons; percent of processes refers to the 
percent of processes that reach the grid line indicated on the x-axis (C). The central canal is 
characterized by tanycyte-like cells with very short processes and a cubical cell body (for better 
resolution the image was constructed from two images taken under 40X magnification) (C). Scale bar 25 
μm. Sample size n=5 animals per season, values in the y-axis are the average of 12 to 16 fields of view 
analyzed in two consecutive brain slices per each animal. 3V: third ventricle, 4V: fourth ventricle, cc: 
central canal.
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Figure 4.2: ADK is present in the cell body of the tanycytes.
Photomicrographs show ADK (red) present in the cell body of the tanycytes (green) in endothelium of 
the 3V (white arrow) in all four groups. ADK in astrocytes is visible in the ventral hypothalamus. Scale 
bar 25μm. 3V: third ventricle.
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Figure 4.3: Caption on the following page.
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Figure 4.3: ADK levels are lower in Winter compared to Summer in the tanycytes cell bodies.
Relative intensity of ADK was measured within the cell bodies of tanycytes in the 3V, Torpor shows a 
high variability compared to the other groups (A), similar variability in Torpor was present in the relative 
intensity of ADK in the astrocytes in the ventral hypothalamus (D). Relative intensity of ADK is higher in 
Summer compared to Winter in the cell bodies of the tanycytes in the 3V; solid line represente p<0.01, t 
test with bonferroni's correction (B). Relative intensity does not change in the astrocytes in the ventral 
hypothalamus (E). A linear regression analysis show a tendency for ADK levels to predict Tb (p=0.07)(C). 
Sample size n=5 animals per season, values in the y-axis are the average of 12 to 16 fields of view 
analyzed in two consecutive brain slices per each animal; symbols represents outliers (A-D).
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Figure 4.4: Tanycyte-like cells and ADK are present in the AP.
Vimentin (green) stained tanycyte-like cells in the AP and in the area contacting the 4V. ADK (red) is 
visible within the tanycyte cell bodies lining the 4V and in the astrocytes present in the AP, 
representative photomicrographs taken from a Fall and a Winter AGS (A). Relative intensity of ADK did 
not change between seasons within the cell body of tanycyte-like cells in the 4V (B), and in the 
astrocytes within the AP (C). Scale bar 25 μm. 4V: fourth ventricle, cc: central canal, AP: area postrema. 
Sample size n=5 animals per season, values in the y-axis are the average of 10 to 12 fields of view 
analyzed in two consecutive brain slices per each animal, symbol represents outliers (C).
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Table 4.1: Physiological characteristics of the animals.
Weight (g) Tb (ºC) Torpor Bout
Summer 564± 18 37.22± 0.2a,c 0
Fall 645± 78 35.46± 0.3b,d 0
Winter (IBA) 486± 28 36.06± 0.3c,d ≤8
Torpor 546± 55 2.62± 0.4e ≤8
Data are presented as mean ± SEM. Values with different letters are statistically different from each 
other (p<0.05, Tukey HSD test). Sample size n=5 animal per season.
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SI Figure 4.1: Tanycytes morphology in the Torpor group.
Qualitative observations show that tanycytes stained with vimentin (green) presented morphology 
inclusive of thin and wide processes within the Torpor group. The majority of tanycytes are thin in AGS 
14-48, while 14-51 shows wider tanycytes. A combination of both wide and thin processes is visible in 
AGS 14-49.
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SI Figure 4.2: Tanycytes morphology in the Fall group.
Qualitative observations show that tanycytes stained with vimentin (green) presented morphology 
inclusive of thin and wide processes within the Fall group. As an example AGS 15-37 is characterized by 
thin processes, while AGS 14-73 shows wider processes.
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SI Figure 4.3: Tanycytes width decreased in Winter IBA.
Winter euthermic AGS showed a significant lower number of tanycytes wider of 5 μm compared to the 
other seasons. Solid line indicates p<0.05, Tuckey HSD test, symbols rapresent outliers. Sample size n=5 
animals per season, values in the y-axis are the average of 12 to 16 fields of view analyzed in two 
consecutive brain slices per each animal.
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Chapter 5: General conclusions
In the present work, I used CHA, the adenosine A1 receptor agonist, to promote hibernation in Arctic 
ground squirrels (AGS) housed under constant ambient temperature (2ºC) and light cycle (4L:20D). AGS 
maintained their circannual rhythm as previously shown (Pengelley et al., 1978) and the seasonal 
manipulation allowed for the investigation of the endogenous circannual rhythm, without confounding 
factors such as photoperiod and temperature. AGS showing at least eight torpor bouts were referred to 
as Winter AGS (i.e. Winter phenotype), and AGS that did not show any torpor for at least two months, 
since their last day of hibernation, were defined as Summer AGS (i.e. Summer phenotype). I confirmed 
the seasonal difference in CHA-induced hibernation. CHA triggered the onset of hibernation in Winter 
AGS shown by a decrease in metabolic rate and body temperature (Tb). On the contrary, CHA provoked a 
slight and transient decrease in metabolic rate and Tb in Summer AGS. These findings highlight that the 
seasonal difference in response to CHA is regulated by an endogenous circannual rhythm, which is 
independent from photoperiod and ambient temperature.
The seasonal changes in AGS phenotypes mirror the endogenous circannual rhythm. The pre­
hibernation season, i.e. fall, is critical to prepare hibernating mammals, for instance by increasing brown 
adipose tissue (BAT) mass and adjusting feeding behavior (Schwartz et al., 2015; Ballinger et al., 2016; 
MacCannell et al., 2017). Thus, Fall is when the transition from Summer to Winter phenotype occurs. A 
gradual decrease in euthermic Tb during the Fall season has been previously reported in AGS and 13- 
lined squirrels (Russell et al., 2010; Sheriff et al., 2012). However, I found that the decrease in Tb 
correlated with a decrease in sympathetic activity in the raphe pallidus (rPA). The gradual decrease in 
the sympathetic tone in Fall led to lower thermogenesis in Winter compared to Summer (Chapter 2). 
However, the thermogenic capacity, the ability to produce heat and rewarm, increased as seen by the 
higher response of the hypothalamic-pituitary-thyroid axis to CHA-induced cooling in Winter AGS 
compare to Summer AGS (Chapter 2), also shown in Richardson's ground squirrels (Abbotts and Wang, 
1980). Thermogenic capacity is fundamental to the hibernation season as the Tb is restored from 2-30C 
to 360C in 5 hours during arousal (Karpovich et al., 2009), but also to defend Tb when the ambient 
temperature drops below -40C (Buck and Barnes, 2000). The seasonal modulation of the 
thermoregulatory system is also supported by the observed increase in vasoconstriction in Winter AGS 
compared to Summer AGS (Chapter 3). After I assessed the seasonal changes in thermoregulation 
associated with seasonal phenotypes, I identified the neuronal pathways of CHA-induced hibernation. A 
dis-inhibition of the nucleus tractus solitarius (NTS) and an inhibition of the tuberomammillary nucleus 
(TMN) occurred in both Summer AGS and Winter AGS in response to CHA. The same effect of CHA in 
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both Summer and Winter phenotypes underlined a higher order process entrained to the endogenous 
circannual rhythm that regulated CHA-induced hibernation.
The seasonal difference in response to CHA resided in the thermoregulatory system, highlighting a 
connection between thermoregulation and the higher order process. I primarily investigated the rPA 
and median preoptic area (MnPO), two brain nuclei associated with the BAT thermogenesis (Morrison 
and Madden, 2014). The thermogenic response was suppressed in winter CHA-induced hibernation as 
shown by the significant decreased in neuronal activity in the rPA and MnPO in Winter AGS compared to 
Summer AGS. These results reflected the seasonal physiological response to CHA seen by the drop in 
metabolic rate and Tb in Winter AGS. A seasonal decrease in thermogenesis was a prerequisite for CHA- 
induced hibernation (Chapter 3).
Preliminary data also showed a possible circannual modulation of adenosine signaling within the 
tanycytes. I described the tanycytes as an alternative location of adenosine signaling in the brain, as 
shown by the presence of adenosine kinase (ADK). The preliminary results showed a decreased of ADK 
in Winter compared to Summer, leading to a likely seasonal increase in extracellular adenosine (Chapter 
4). The high level of extracellular adenosine would explain the seasonal increase in sleep pressure seen 
in euthermic ground squirrels (Walker et al., 1980). In sleep-awake studies, an increase in adenosine, 
reflecting ATP breakdown, indicates activity-dependent neuronal energy use and is associated with 
increase sleep (Bjorness and Greene, 2009; Holst and Landolt, 2015). Similarly, ATP breakdown may 
occur in arousal from torpor as metabolic rate increases and neuronal activity is restored (Ohe et al., 
2006; Karpovich et al., 2009), likely increasing adenosine levels. In addition, the decrease in ADK activity 
in Winter may have reduced the clearance rate of adenosine from the extracellular space. Thus, 
adenosine may trigger the onset of hibernation via A1AR dis-inhibiting the NTS, further suppressing 
thermogenesis and inhibiting the TMN, promoting sleep.
In conclusion, a circannual decrease in euthermic Tb achieved by attenuating sympathetic tone and 
increasing vasoconstriction, and a circannual increase in thermogenic capacity are mechanisms 
underlying the higher order process that regulates the onset of the hibernation season.
These findings are a significant contribution to the field of thermo-biology. It is well established that 
cold exposure activates BAT thermogenesis to generate heat and that vasoconstriction, another cold­
defense strategy, prevents heat loss in rats and mice (Tan and Knight, 2018), but I showed that 
hibernation challenges these mechanisms. Hibernators employ vasoconstriction to conserve energy 
reducing heat loss, but vasoconstriction is not associated with an increased in BAT thermogenesis. On 
the contrary, I showed that the sympathetic tone is attenuated. Thus, in hibernation the 
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thermoregulatory mechanisms, present in homeothermic species, are individually used to maintain the 
seasonal energy homeostasis required.
In addition, seasonal suppression in thermogenesis is required for adenosine-induced hibernation 
reaffirming the similarity between hibernation and sleep. The onset of sleep is characterized by a 
decrease in core Tb, which is obtained by increasing heat loss through vasodilation (Szymusiak, 2018) 
and it is regulated by adenosine, an endogenous neuromodulator (Bjorness and Greene, 2009). Here, I 
confirmed that adenosine via the A1AR extends sleep into the onset of hibernation, that is preceded by a 
seasonal decrease in core Tb. This illustrates another parallel with sleep as a decrease in core Tb 
precedes sleep onset. This is consistent with previous work in AGS maintained at 12L:12L and ambient 
temperature of 18ºC, showing that CHA is more effective in decreasing Tb when administered at the 
seasonal minimal Tb (Olson et al., 2013). However, the decrease in Tb is facilitated by vasodilation in 
sleep, while in hibernation vasoconstriction occurs. Interestingly, even if sleep is associated with 
vasodilation, thus heat loss, sleep-related behaviors prevent heat loss by creating microclimates using 
bedding and curled positions (Van Someren, 2006; Okamoto-Mizuno and Mizuno, 2012). In addition, a 
mild increase in skin temperature, without an effect on core Tb, increases sleep and suppresses 
nocturnal wakefulness (Van Someren, 2006; Okamoto-Mizuno and Mizuno, 2012). Therefore, sleep may 
minimize heat loss through behavioral adaptations while autonomic adaptations prevail in hibernation. 
The understanding of hibernation and its thermoregulatory system may help us understand the complex 
relation between sleep and thermoregulation.
Further studies are needed to confirm these finding using a direct manipulation of the brain regions 
here identified through optogenetic or chemogenetic techniques (Park and Carmel, 2016). To validate 
the role of the autonomic nervous system in the cooling phase, I would expect that a stimulation of the 
rPA or the MnPO in Winter AGS after CHA would prevent the onset of hibernation. I would also assess 
changes in adenosine receptor sensitivity. First, I would test if a higher dose of CHA may overwrite the 
thermogenic response seen in Summer AGS with a dose response study; next, I would manipulate the 
adenosine signaling pathway. A chronic inhibition of ADK, mimicking the ADK levels seen in Winter 
phenotype, would affect sensitivity to adenosine, thus CHA-induced hibernation. Finally, to fully reverse 
a Summer phenotype into a Winter phenotype the chronic inhibition of ADK would be combined to the 
optogenetic suppression of the rPA. The attenuated sympathetic drive and the increase in adenosine 
accumulation would provide the AGS with the optimal conditions for CHA-induced hibernation.
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Appendix A 2: AGS Husbandry Protocol
Standard Operating Procedures
Drew Lab
IACUC#: Date Approved: Last Revised:
Arctic Ground Squirrel Husbandry (non-breeders)TITLE:
PURPOSE: Daily care for non-breeding Arctic Ground
Squirrels
Person(s) Responsible for Daily Care and Welfare: Drew lab personnel
• Required permits:
• Seasons
o Summer months = May 15 - August 15 (or AGS which do not show torpor bout for at least 30
consecutive days)
o Winter months = August 15 - May 15 (or AGS which show signs of torpor bouts)
• Animal Room 39 B (recovery room)
o Lighting:
? Intensity (Range): 10-20 
ft. candles ?
Photoperiod:
Summer: May 15th Fast switch to16L:8D, 7am to 11pm
Winter: beginning August 1, 16L:8D transitioning to D:D by reducing lighting 30 
minutes a day (split am and pm) when animals first brought into the facility. 
Following years fast switch on August 15th to 4L:20D
o Temperature:
Warm Room 39 B 16-18°C
• Animal Room 39 C1 and C2 (cold chambers)
o Lighting:




■ Summer: May 15th Fast switch to16L:8D, 7am to 11pm
■ Winter: beginning August 1, 16L:8D transitioning to D:D by reducing lighting 30 
minutes a day (split am and pm) when animals first brought into the facility. 
Following years fast switch on August 15th to 4L:20D
o Temperature
• Chamber 39 C2 2°C year-round
• Chamber 39 C1 16-18°C Summer, 2°C Winter
• Housing
o Primary containment:
■ Non-hibernators When animals are not hibernating, stainless steel ¼" wire 
mesh hanging cages, dimensions 12”X19”X12”. Cages hang over trays of ammonia 
absorbing corn cob litter.
■ Hibernators Hibernating animals will be housed in polycarbonate cages 
(8.5”x17”x8.5”) with stainless steel top or micro insulation top
o Bedding:
■ Non-hibernators All cages with wire mesh floors require cotton batting equal 
to two times the animal's body size.
■ Hibernators Cotton batting equal to two times the animals body size on a bed 
of shavings, 1”deep
o Density:
■ One animal per cage
o Enrichment:
■ Non-hibernators
• 8” length of 4” PVC tube










■ Non-hibernators One 8 or 16 ounce bottle with stainless steel sipper tube, ad 
lib
■ Hibernators One water gel pack, ad lib, replace if less than 2 ounces or soiled
• Animal Marking or Identification:
O Type of Mark or Identification: Cage cards
O Age and sex: Marked upon arrival at animal facility.
O Person(s) Responsible for Applying Identification, age and sex: ARC staff
• Veterinary Care:
O Person(s) Responsible for Veterinary Care: ARC Veterinary Staff
• Euthanasia & Disposal
o Disposition of Non-Usable or Surplus Animals: euthanasia or hold until moved to an IACUC 
approved protocol
o Euthanasia Method to be used for emergencies or routine culling:
• Routine procedure is overdose of isoflurane using isoflurane vaporizer in a 
suitable induction chamber.
• Alternative methods may only be used on order by Attending 
Veterinarian or designee.
• Daily care of non-hibernators
o Fill out Animal Room Activity sheet
o Scrape feces from inside of cage. Decontaminate
tool with GS Neutral solution between cages.
■ dilution instructions; ½ ounce GS Neutral per gallon 
of water
o Ad lib feeding till August 15th
o Fill the water bottle if ½ full or below
o Remove any soiled bedding & replace with new, making sure 
cotton batting is at least 2x the size of the animal.
o Twice a week, replace trays under wire mesh hanging cages 
and line trays with fresh cobs. Provide clean wire cages only if 
excessively dirty.
o Record the animals status (Awake = A, Hibernating Shavings 
Added = HSA, or Hibernating = H) on the room hibernation sheet 
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o Record maximum & minimum temperature from 
thermometer in room.
o Check all animals for any abnormalities; behavioral, illness or 
injuries.
■ Note any abnormalities on disposition records and 
notify ARC staff
■ Any deaths should be reported to ARC staff - refer to 
SOP ARC-5454
o Clean up cart or countertop
■ Fill feed and water containers if getting low - making 
sure lids are on the feed and water containers once done
o Sweep the floor and mop if necessary
Transition into hibernation
o 24 hours after the first day of torpor, AGS are moved into the 
plastic tub for the hibernation season.
o When AGS is moved into the plastic tub, food will not be 
moved, a gel pack for water will be provided.
Daily care of hibernators
o Fill out Animal Room Activity sheet
o Record the animals status (Awake = A, Hibernating Shavings 
Added = HSA, or Hibernating = H) on the room hibernation sheet
o If animal is hibernating and bin/cage appears clean, cage 
will not be disturbed. Animal must be aroused/awake when moved 
to a new bin/cage.
o Spot remove feces from corner of cage.
o Remove any soiled bedding & replace with new,
making sure cotton batting is at least 2x the size of the animal.
o Record maximum & minimum temperature from 
thermometer in room.
o Check all animals for any abnormalities; behavioral, illness or 
injuries.
■ Note any abnormalities on disposition records and 
notify ARC staff
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■ Any deaths should be reported to ARC staff - refer to 
SOP ARC-XXXX
o When arousal is longer than 3 days, AGS is moved to a 
separate location in chamber and food is returned to the animal. If 
AGS is awake for other 7 days it will be moved out of the experimental 
chamber.
o Clean up cart or countertop
■ Fill feed and water containers if getting low - making 
sure lids are on the feed and water containers once done
o Sweep the floor and mop if necessary
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Appendix A 3: Protocol for Experiment and Animal Handling
Winter AGS EXPERIMENT DESIGN:
“Mid-season” AGS needs to be at least in the 8th torpor bout of the season. 
AGS needs to be within day 1 to day 4 of the torpor bout
1. At the second hour of the light cycle starts experiment (if the light cycle is from 12pm to 4pm, 
the experiment will start at 2pm).
2. Collect respiratory rate (count the number of breath per min). Move the shaving from the AGS 
and move a little the cotton to expose the AGS so you can well see the belly. When you are 
ready start the timer (noise doesn't bother the AGS) and count the movements of the belly. Do 
it at least couple of times (usually the first try helps you to find the point in the belly where to 
look at).
3. In the meantime leave the thermometer on so you can monitor the Chamber temperature.
4. Take the AGS with the nest outside of the cage (usually on the top of the racket). Record core 
body temperature with rectal thermometer (use large amount of lubricant, they are really dry 
and slowly insert the thermometer).
5. Put the AGS back in the cage with the nest.
6. Move the cage outside to weight the AGS
7. Take the AGS without nest and put in the balance right outside of the Chamber
8. Bring the AGS (with the cage) to the warm room (Ta=20°C) light cycle 4:20 L:D room B12 (the 
light cycle has to match the one in the cold chamber)
9. With a little shaver, shave the AGS above the shoulder
10. Test the IPTT with the wound, it must read!!
11. Implant IPTT transponders subcutaneous: Take the shaved skin within your finger, make a little 
tent
Inject the IPPT
Feel the transponder pushed out 
Slowly roll your finger around it 
Put some surgical glue on the hole of the injection 
(vectabond) with 25g needle and 1mL syringe.
12. Handle the animal to make sure it is going to wake up
13. Check the transponder getting few reads.
14. Fast OV in the warm room MARK “do not feed”
15. The morning after check that the animal is awake
16. In the two hours before the animal is moved back in the cold room, record the Tb (every half an 
hour if you can)
17. Move the animal back in the cold room exactly at the same time you took it off the day before 
(two hour in the light cycle)
18. Leave the animal there for 1 hour to acquire baseline
19. At the 3rd hour in the light cycle do the injection with CHA (0.5 mg/kg IP) or Vehicle using 25G 1 
½ inches (blue needle). The injection is i.p., two people one handles the AGS and the other give 
the injection in the belly (make sure the needle goes under the large amount of fat they have)
20. When you handle the animal read the Tb and start the timer because every 30 min the Tb needs 
to be recorded
21. After 3 hours move the AGS in the jar and start the perfusion.
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DAY 1 DAY 2
Steps 1 to 14 Steps 15 to 21
Perfusion protocol Day 1 Perfusion protocol Day 2
Summer AGS EXPERIMENT DESIGN:
“Off season” AGS needs to be awake for at least one month (no showing torpor consecutively for a 
month).
If the IPTT has not been implanted while the animal was torpid, it's necessary to anesthetize the AGS 
with isoflurane.
1. Put the animal in the jar
2. Weight the animal and record the weight in your note book
3. Turn on the anesthetic and oxygen tank
4. When the animal is down, take it off of the jar and keep it down with the mask (isoflurane at 3).
5. With a little shaver, shave the AGS above the shoulder
6. Test the IPTT with the wound, it must read!!
7. Implant IPTT transponders subcutaneous: Take the shaved skin within your finger, make a little 
tent
8. Inject the IPPT
9. Feel the transponder pushed out
10. Slowly roll your finger around it
11. Put some surgical glue on the hole of the injection (vectabond) with 25g needle and 1mL 
syringe.
12. Put the animal back to its cage in the cold chamber.
13. Wait one week before the experiment.
Day before the experiment
1. At the second hour of the light cycle starts experiment (if the light cycle is from 12pm to 
4pm, the experiment will start at 2pm).
2. Collect respiratory rate (count the number of breath per min) with the timer.
3. Collect body temperature reading the IPTT
4. Have the thermometer to monitor the Chamber temperature.
5. Put the AGS in the jar
6. Record weight on the balance outside the Chamber
7. Bring the AGS (with the cage) to the warm room (Ta=20°C) light cycle 4:20 L:D room B12 
(the light cycle has to match the one in the cold chamber)
8. Fast OV in the warm room MARK “do not feed”
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Day of the experiment
1. In the two hours before the animal is moved back in the cold room, record the Tb (every half 
an hour if you can)
2. Move the animal back in the cold room exactly at the same time you took it off the day 
before (two hour in the light cycle)
3. Leave the animal there for 1 hour to acquire baseline
4. At the 3rd hour in the light cycle do the injection with CHA (0.5 mg/kg IP) or Vehicle using 
25G 1 ½ inches (blue needle). The injection is i.p., two people one handles the AGS and the 
other give the injection in the belly (make sure the needle goes under the large amount of 
fat they have)
5. When you handle the animal read the Tb and start the timer because every 30 min the Tb 
needs to be recorded
6. After 3 hours move the AGS in the jar and start the perfusion.
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Appendix A 4: Perfusion Protocol
PERFUSION PROTOCOL (updated Carla Frare 2016)
JOVE video - Whole Animal Perfusion Fixation for Rodents - http://library.uaf.edu/dbnews-jove
1. Prepare 4%PFA and stored in a 4C (in a sealed container is good for one month- usually stored in 
a 4 L empty methanol bottle)
2. Day before prep:
• Make 0.9% saline solution, stored in 4C until perfusion (possible to make it the day of 
perfusion, but it needs to be cold at time of perfusion).
• Print data sheets
• Label tube for brains and spinal cords with Date, Animal #, Tissue (Brain or Spinal Column), 
Treatment (eg. CHA), and 4% PFA. Fill with ~20 ml PFA (or fill it the day of perfusion)
• Check O2 tank and isoflurane levels
• Weigh scavenger
• Weigh animals
• Check for all material needed (mask for rat/needles with sleeves (usually the needle is inserted
in a plastic tube 1 cm shorter than the needle, so the needle does not go too further into the 
heart) /syringes/timer/light/PFA funnel)
3. Day of prep:
4. Saline and PFA are used cold, moved them form the fridge into an ice bucket
5. Turn on pump (setting 1 for rat, 2 for squirrel) and run saline through line to work out all air and 
prime the pump, get ready instruments (little scissors to cut right atrium, curved hemostat to 
clamp the aorta, big scissor to cut abdomen, big hemostat to grab bib cage and expose to heart)
6. Get the animal and anesthetize it with isoflurane starting at 5
7. Move animal to perfusion tray in hood, put the mask and maintain anesthesia level at 3 for 
squirrels and 2 for rats. Check for surgical plane of anesthesia with toe pinch method.
8. Open abdomen and thorax, exposing heart: cut across abdomen just beneath rib cage, cut 
diaphragm, lift away sternum with the long hemostat and cut away connective tissue
9. Move the heart and clamp descending aorta behind it with hemostat.
10. Make small incision in left ventricle and insert 18 gauge olive-tipped or blunted perfusion needle 
through left ventricle into ascending aorta (Usually the needle is inserted in the apex proximity 
and does not necessary reach the aorta). Tip should be visible through wall of aorta, shouldn't 
reach aortic arch, and should be at correct angle to facilitate max flow rate. If you can, clamp 
the heart and aorta with 2 hemostats to keep needle in place (sometimes it is not feasible and 
you have to hold the needle in place by yourself). Clip right atrium to release fluids.
11. Start the pump: perfuse with 0.9% saline ~5 minutes, pump setting 1 (34 ml/min) or 2 
(62mL/min) until fluid from right atrium runs clear (~300 ml total, depends on animal size). 
Note end time of saline wash.
12. Turn pump off. Move uptake tubing to 4% PFA (to avoid air bubbles, squeeze tube or clamp it 
so that drop of saline protrudes from end). Restart pump, making sure it is on correct setting 
(sometimes moving the tube may touch the setting knob).
13. Perfuse with 4% PFA for ~10-15 min or until end of ‘formalin dance' (~500 ml, 1L for squirrel). 
Note time of fixation (time that fixation tremors are seen)
14. At completion of perfusion, rinse tubing with clean water and replace needle/sleeve.
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15. Remove head with blade or guillotine. Carefully expose and remove brain, making sure to cut 
optic chiasm without damage. Place brain in 4%PFA for 24 hours at 4C. Best to do it in the fume 
hood.
16. Remove whole spinal column, mark rostral end with marker for reference, and place in 4% PFA. 
Best to do it in the fume hood.
17. Clean up perfusion area and tools.
18. Return unused solutions to refrigeration and other support tools to proper storage.
19. Empty the tray with used solutions mixed to blood into the blue waste container with the 
proper PFA funnel (in the flammable cabinet), Do not Spil! when containers are full, tell Vet 
Services and they will dispose it.
20. Place carcass in refrigerator (pit tag disposed of with body- no need to remove) if it's after 8pm, 
otherwise bring carcass upstairs in the incinerator fridge, tag the bag with the yellow 
“pathological waste” and fill the log (with weight, the animal and your name). If you leave the 
carcass in room 20, make sure to bring it upstairs the morning after, or we get in troubles!!!!
21. Fill out disposition form in animal Suite, include IACUC protocol #
SOLUTIONS:
0.9% Saline total volume 1 L (make it fresh the day of experiment and keep it at 4°C):
9 g NaCl dissolved in1L milliQ water, make up in 1L designated flask (in the fume hood)
4% PFA make up 2 L (good for one month at 4°C):
Sodium phosphate dibasic Na2HPO4 SIGMA S9763 FM 141.96
Sodium phosphate monobasic NaH2PO4 - H2O SIGMA S9638 FM 138.0 
Paraformaldehyde prilled, 95% 1 Kg cat#441244 SIGMA
1. Dissolve 21.87 g Dibasic Na2HPO4 (sodium phosphate) in ~1050 ml milliQ water. Make up in 
designated 2L flask in hood and put heat setting on 2-3 to help dissolve
2. Dissolve 6.35 g Monobasic NaH2PO4-H2O (sodium dihydrogen phosphate) in ~270 ml milliQ 
water in 500 ml flask
3. When dibasic dissolved, add 80g PFA prills (rinse PFA tray with milliQ):
a. Weigh out PFA in hood (move scale to hood)
b. Use designated weigh tray
c. Put designated thermometer in PFA while it dissolves, do not let heat rise above 60 
deg C
4. When everything is dissolved, add monobasic to dibasic container (~ 2-3 hr)
5. Filter and measure volume as it filters
6. Finally bring to volume (2000 ml) with milliQ water
7. Do not rinse out flasks: cover with paraffin and store in hood
8. Dispose of all PFA waste in designated containers
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w/V = g/100 ml 
w/V = g/100 ml 
w/V = g/100 ml 
w/V = g/100 ml 
w/V = g/100 ml
5g in 100mL PB
10g in 100mL PB
15g in 100mL PB
20g in 100mL PB
30g in 100mL PB
0.1M Phosphate Buffer (PB): 3.2g NaH2PO4∙H2O, 10.9g Na2HPO4 reach final volume of 1L, adjust pH to
7.4,
Antifreeze: 500 ml 0.1 M phosphate buffer pH 7.4, 300g sucrose, 10g polyvinylpyrrolidone (PVP-40), 
300ml ethylene glycol. Let it dissolved overnight and adjust to final volume 1L with PB. Store at -20oC. 
Before use it, test it overnight at -20oC: it should be liquid.
24 hours after perfusion
Move brain to sucrose at 4oC. Follow sucrose gradient from 5%, 10%, 15% to 20% let the brain for two 
days in each gradient. Last move it in 30% sucrose and leave it until it sank or until you are ready to 
freeze it and cut it (it's better to leave it in sucrose than in -80oC, usually I leave it in 30% sucrose for 10 
days).
Before moving the brain in 10% sucrose, it is necessary to block it for optimal penetration 
(cryoprotection):
I cut the brain in 3 parts, at the cerebellum level and the rostral part. In theory the volume of sucrose 
solution should be at least 4 times the volume of your sample. (I used 50mL falcon tube). (DO NOT 
STORE IN ANTIFREEZE if you want to use cryostat!)
Flash Freezing procedure:
• Foil boat/ or plastic container




• Thermometer - Omega thermocouple
• Dry ice
• Styrofoam box with lid
1. Prepare little boat with aluminum foil (I use a little glass vial and shaped around with foil) or if 
you have something like “dixie cup”, label it with animal ID.
2. Get the Hexane solution cold, fill the dewar with hexane and start adding pieces of dry ice, until 
you reach temperature -45o to -50o C (control it with the thermocouple). If a little dewar is not 
available I have used a styrofoam coffee cup.
3. Get the brain out of 30% sucrose, “rinse” it in OCT using a dixie cup (flip the brain around gentle 
to get rid of sucrose and have a first layer of OCT around)
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4. Place the brain into the foil boat and add OCT to completely submerge the tissue (watch for 
bubbles)
5. Hold the boat with forcept and place it in the cold hexane in the dewar. The boat should be 
surrounded by liquid, you might need to add dry ice pieces (temperature gets warmer, you want 
to keep it as stable as possible).
6. Once OCT is becoming white, you can drop the boat to the bottom and let it there for 2minutes.
7. Then move the brain in a styrofoam container with dry ice until you freeze all the brains you 
need, then store the brains at -80C not for a long time (max 2 weeks). Even small oscillations in 
temperature can damage the tissue.
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Cutting the brain with the cryostat:
• Set cryostat temperature to -20oC
• Bring the brain to the cryostat in a styrofoam box with dry ice and leave it to equilibrate for at 
least 1 hour
• Label your 6-wells plate with animal ID, treatment, both on the lid and on the side of the plate
• Place OCT on the chuck and position the brain on it when the OCT is still liquid/non frozen
• Start cutting (follow the rat brain atlas, looking for symmetry between left and right hemisphere 
and similarity to the atlas at the top and bottom of the brain)
• Store the slices in 6-well plates with antifreeze in it. Place each slice in a consecutive well using 
all 6-well plate. For the squirrel forebrain use 5 6-wells plates, label each single well 1 to 30.
• At the end store the 6-well plate in the fridge 4oC overnight
• The day after change antifreeze solution by drawing off and adding fresh antifreeze with a 
transfer pipette (pay attention not to lose any brain slice) and store the plate at -20oC
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Appendix A 6: General Immunohistochemistry Protocol
Day One
1. 6x10 min wash PBS
2. Incubate sections with 0.52% H2O2: 175 ul 30% H2O2 in 10 ml PBS for 30 min at room 
temperature (263 ul H2O2 in 15 ml PBS - 420 ul H2O2 in 24 mL PBS)
3. Rinse sections 6 x 5 min in PBS
4. Incubate in in blocking (4% NGS normal goat serum + 0.2% Triton X-100 in PBS) for 2 h at 
4°C with gentle agitation (10 ml blocking solution: 400 μl NGS + 200 μl Triton X-100 10% + 
9400 μl PBS - 960 ul NGS + 480 ul Triton X-100 10% + 22560 ml PBS )
5. Incubate sections in Primary Antibody (Ab) diluted in PBS + 0.4% Triton X-100 24 or 48 
hours at 4°C with gentle agitation (Time depends on Ab and Dilution)
Day Two
6. Rinse sections 6 × 10 min with PBS
7. Incubate sections in biotinylated Secondary Antibody (Vector labs BA-1000), diluted 1:600 in 
PBS + 0.4% Triton X-100 for 1 h at RT (or diluted 1:1000 in blocking solution, for 2 h at 4°C)
• Make 12 ml: 480 μl Triton X-100 10% + 11.520 ml PBS + 20 μl antibody
• Make 24 ml: 960 μl Triton X-100 10% + 23000 ml PBS + 40 μl antibody
8. Rinse sections 5 × 10 min in PBS
9. During rinse, prepare ABC kit (Vectastain ABC kit PK-6100). Let stand >30 minutes before 
use. To 10 ml PBS or PBS and 0.4% Triton X-100 (400 ul Triton X-100 10% and 9.6 ml PBS), 
add 45 ul Solution A then B (24 ml: 960 ul Triton X-100 10% + 22824 ml PBS + 108 ul A + 108 
ul B)
10. Incubate sections with the A/B (Elite) solution 1 hour at room temperature
11. Rinse sections 6 x 5 min: 6 x 5 min in PBS if doing Brown DAB
3 x 5 min in PBS and 3 x5 min in Sodium Acetate if doing Ni-DAB
12. Pre-incubate sections in DAB solution (suggested: 3 ml to large wells and 1 ml to 
control)**** for 15 min at room temperature then add 30% H2O2 (1 ul per 1 ml DAB) 
directly to plate for 1-5 min (or less depending: just until properly stained) and note time 
you allowed it to incubate (50 seconds/ 1 min) CHECK at the end of the protocol for DAB 
waste disposal.
13. Rinse 3 x 5 minutes in Sodium Acetate (0.175M 5.74g Sodium Acetate per 400mL MilliQ 
H2O)
14. Rinse 3 x 5 minutes in PBS
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Nickel DAB:
20mL Sodium Acetate add 0.5gr Nickel Sulfate and let it mix. Add 1 tabled DAB let it dissolve. pH 
solution to 7.2/7.3 and filter.
Add 1ul H2O2 30% for each 1mL of DAB solution used
Brown DAB:
20mL PBS add 1 tabled DAB let it dissolve; pH solution to 7.2/7.3 and filter.
Add 1ul H2O2 30% for each 1mL of DAB solution used
If Primary Ab is mouse, Secondary Ab has to be goat anti-mouse
If Primary Ab is rabbit, Secondary Ab has to be goat anti-rabbit
Immunohistochemistry Reagents:
PBS (0.01 M/ 10 mM Phosphate Buffered Saline - pH ~7.2)
PBS Stock Solution 10X:
• 12.0 g Na2HPO4 (anhydrous) (Sodium Phosphate Dibasic SIGMA product # S9763, CAS# 7558-79­
4)
• 2.2 g NaH2PO4 · H20 (Sodium Phosphate Monobasic Monohydrate SIGMA product # S9638, CAS# 
10049-21-5)
• 85 g NaCl (Sodium Chloride SIGMA product # S7653, CAS #7647-14-5)
Add 900 mL MilliQ H2O.
Mix well until all reagents are dissolved.
Reach final volume of 1 L with MilliQ H2O.
Immuno reagents
PBS final solution 1X:
100mL PBS 10X, Stock Solution and 900 mL MilliQ H2O.
Adjust pH to 7.2 with 0.1 N HCl or 1N NaOH.
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Triton X-100 10% w/v
• In a small beaker weight 10 grams of Triton X-100 (C34H62O11 VWR product #3929-2, CAS# 
9002-93-1)
• Add around 60 mL of MilliQ H2O
• Let it on the stirring plane to dissolve (usually overnight), reach final volume 100 mL
Sodium Acetate 0.175 M
Sodium Acetate (C2H3NaO3 Na acetate anhydrous Fluka product #71179, CAS# 127-09-3)
2.87 g Sodium Acetate in 160 mL MilliQ H2O
Let dissolve and reach final volume of 200mL.
0.3% H2O2
100uL of 30%H2O2 in 10 mL MilliQ H2O
Keep it at 4C in a dark container(cover it with aluminum foil)
DAB (C12H14N4. 4HCl SIGMA product # D5905)
Tablet 10mg substrate per tablet store at -20C
1%DAB -10mg per 1mL MilliQ H2O -
Add 5tablets (50 mg) and 5 mL MilliQ H2O in the designated container (conical tube with magnetic 
stirring bar already contaminated) let mix and add 3 to 5 drops HCl 10N until the solution change colour 
to a clear brown/red.
Vectastain ABC Kit elite (Vector Laboratories product# PK-6100)
Ammonium Nickel II Sulfate hexahydrate (SIGMA product # A1827, CAS # 7785-20-8)
0.1 g Ammonium Nickel II Sulfate in 10 mL MilliQ H2O
141
Appendix A 7: Specific Immunohistochemistry Protocol for anti-Histamine Ab
Monoclonal mouse anti cFos (c-Fos Antibody (C-10): sc-271243 Santa Cruz Biotech.)
Polycolonal rabbit anti histamine (Immunostar catalog number 22939 - required antigen retrieval step 
or perfusion with no PFA)
FOS Day One
15. 6x10 min wash PBS
16. Warm the sodium citrate buffer in a water bath up to 80C
17. Incubate sections with 175 ul 30% H2O2 in 10 ml PBS for 30 min at room temperature (263 ul 
H2O2 in 15 ml PBS, 420 uL in 24 mL PBS)
18. Rinse sections 6 x 5 min in PBS
19. Incubate slices in hot sodium citrate buffer and let it sit for 30 min (it should be cooling 
down by then)
20. Rinse section 3 x 5 min in PBS
21. Incubate in in blocking (4% NGS normal goat serum + 0.2% Triton X-100 in PBS) for 2 h at 4°C 
with gentle agitation (10 ml blocking solution: 400 μl NGS + 200 μl Triton X-100 10% + 9400 
μl PBS; 24 mL blocking solution: 960 μl NGS + 480 μl Triton X-100 10% + 22560 μl PBS)
22. Incubate sections in mouse anti-cFos primary antibody diluted 1:20,000 in PBS + 0.4% 
Triton X-100. Do not add to control well.
• Make 20 ml: 800 μl Triton X-100 + 19200 μl PBS + 1 μl cFos + then 48 hours at 4°C with gentle 
agitation
• Make 24 mL: 960 μl Triton X-100 + 23040 μl PBS + 1.2 μl cFos + then 48 hours at 4°C with gentle 
agitation
FOS Day Two (48 hours later)
23. Rinse sections 6 × 10 min with PBS (begin dissolving Ni in sodium acetate, but don't add 
H2O2 yet)
24. Incubate sections in biotinylated goat anti-mouse secondary antibody (Vector labs BA- 
1000), diluted 1:600 in PBS + 0.4% Triton X-100 for 1 h at RT (or diluted 1:1000 in blocking 
solution, for 2 h at 4°C)
• Make 12 ml: 480 μl Triton X-100 + 11.520 ml PBS + 20 μl antibody
• Make 24 ml: 960 μl Triton X-100 + 23 ml PBS + 40 μl antibody
25. Rinse sections 5 × 10 min in PBS
26. During rinse, prepare ABC kit (Vectastain ABC kit PK-6100). Let stand >30 minutes before
use. To 10 ml PBS (or 400 μl Triton X-100 and 9.6 ml PBS), add 45 ul Solution A then B (24mL:
960 μl Triton X-100 + 108 μl A+ 108 μl B)
(add the DAB tablet to the Ni-Na Acetate solution and let it dissolve)
27. Incubate sections with the A/B (Elite) solution 1 hour at room temperature
28. Rinse sections 3 x 5 min in PBS
29. Rinse sections 3 x 5 min in Sodium Acetate
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30. Pre-incubate sections in Ni sulfate-DAB solution (suggested: 3 ml to large wells and 1 ml to 
control)**** for 15 min at room temperature then add H2O2 (1 ul per 1 ml Ni sulfate-DAB) 
directly to plate for 5-10 min (or less depending: just until properly stained) and note time 
you allowed it to incubate (cFos 1 min to 1 min and 30 sec)
31. Rinse 3 x 5 minutes in Sodium Acetate
32. Rinse 3 x 5 minutes in PBS
33. Incubate sections in rabbit anti-Histamine primary antibody 1:1,000 in PBS + 0.4% Triton X­
100 over night at 4°C. Do not add to control well.
Day three (24 hours later)
34. Rinse sections 6 × 10 min with PBS ( Dissolve 1 DAB tablet into 20mL PBS)
35. Incubate sections in biotinylated goat anti-rabbit secondary antibody (Vector labs BA-1000), 
diluted 1:600 in PBS + 0.4% Triton X-100 for 1 h at RT
• Make 12 ml: 480 μl Triton X-100 + 11.520 ml PBS + 20 μl antibody
36. Rinse sections 5 × 10 min in PBS
37. During rinse, prepare ABC kit (Vectastain ABC kit PK-6100). Let stand >30 minutes before 
use, 10 ml PBS ( 400 ul Triton X-100 and 9.6 ml PBS), add 45 ul Solution A then B
38. Incubate sections with the A/B (Elite) solution 1 hour at room temperature
39. Rinse sections 6 x 5 min in PBS
40. Pre-incubate sections in DAB solution (suggested: 3 ml to large wells and 1 ml to 
control)**** for 15 min at room temperature then add H2O2 (1 ul per 1 ml DAB) directly to 
plate for 5-10 min (or less depending: just until properly stained) and note time you allowed 
it to incubate (2 min)
41. Rinse 3 x 5 minutes in Sodium Acetate
42. Rinse 3 x 5 minutes in PBS
43. RECORD IN LOG
Nickel DAB:
20mL Sodium Acetate add 0.5gr Nickel Sulfate and let it mix. Add 1 tabled DAB let it dissolve. pH 
solution to 7.2/7.3 and filter.
Add 1ul H2O2 30% for each 1mL of DAB solution used
Brown DAB:
20mL PBS add 1 tabled DAB let it dissolve; pH solution to 7.2/7.3 and filter.
Add 1ul H2O2 30% for each 1mL of DAB solution used
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Appendix A 8: Double-labeling Immunofluorescence Protocol
Double staining Tanycytes and ADK (adenosine kinase) in the hypothalamus.
Protocol adapted from:
Sánchez E, Vargas MA, Singru PS, Pascual I, Romero F, Fekete C, Charli JL, Lechan RM. Tanycyte 
pyroglutamyl peptidase II contributes to regulation of the hypothalamic-pituitary-thyroid axis through 
glial-axonal associations in the median eminence. Endocrinology. 2009 May;150(5):2283-91
Mouse anti-vimentin Millipore # MAB3400 and rabbit anti-ADK Bethyl Lab #A304-280A
Humid chamber: Tupperware with a good sealed lid, inside few millimeters of water and a piece of 
nitrocellulose membrane (for Western blot) covering the bottom of the Tupperware. Place the 6-wells 
plate in the Tupperware. The 6-wells plate should be without lid, so make sure you mark the plate and 
its own lid (mark the lid and the plate with the same tape color) if you are using more than one 6-well 
plates at the time.
• Wash sections in PBS 6x10 min at RT
• Treat sections with 0.5% Triton X-100 in PBS for 20 min RT
• Treat sections with 10% Normal goat serum (original used horse serum) for 30 min in PBS
• Wash with PBS 3x10 min at RT
• The sections were then incubated in a humid chamber for 2 days at 4 C in a mixture of mouse 
anti vimentin (Millipore) diluted 1:1000 and rabbit polyclonal anti-ADK (Bethyl) at 1:4000 
dilution in PBS, 1% BSA, 0.1% triton X-100 on a shaker
• Wash with PBS 3x10 min at RT
From now on work in a DARK ROOM!!!!
• Incubate the slices in a mixture of goat anti-mouse Alexa 488 (1:500, Invitrogen, NY) and goat 
anti-rabbit Alexa 456 (1:750, Invitrogen, NY) in PBS,1%NGS in a dark room for 2hours at RT on a 
shaker.
• Wash with PBS 3x10 min at RT in the dark room.
• In the dark, mount the slice on the glass slide leave them to dry for about 30 min (not too long), 
then apply the mounting media Vectashield and cover with a coverslip, seal with nail polish the 
edges. Let the slides dry for another 30 min before storing them in a dark box at 4ºC.
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Appendix A 9: Abdominal Transmitter Protocol
■ Weight the animal (you might want to cover the jar so the AGS does not freak out)
■ Start anesthesia in the jar (induced at 4-5%; maintained at 2-3%, delivered at 1.5L/min mixed with 
medical grade O2)
■ Implant the IPTT-300 (following the protocol # 467983: The site may be shaved with a small shaver if 
necessary to locate the insertion site and the working area will be disinfected before starting on implantation. 
The skin will be lifted in a tent-shape and the trocar will be fully inserted underneath the skin, dispensing 
plunger will be pushed forward to release the transponder in the subcutaneous region, and the trocar will be 
removed. With finger roll the transponder to make sure it won't come out of the hole. The hole is plugged with 
a single drop of surgical glue applied using 25g needle and tuberculin syringe.)
■ Give the animal Buprenorphine-SR administrated SQ - it is very thick so it is necessary to use 20G 
needle , the drug is locked in room 005 (authorization needed to use it) -
■ Sx prep of the animal: Abdomen area will be shaved and washed 3 times with betadine (or generic 
equivalent). Prepare some wet gauze with tap water, use them for the wash with 
iodine/water/iodine/water/iodine/final wash 70& isopropyl alcohol rinse. Once the alcohol is dry the final prep 
is to apply full strength betadine solution by painting it on with a cotton tip swab. This is applied using a 
circling motion starting at the center of the shaved site and end at the shaved margin.
■ Move the Animal on the sx table on the heating blanket and add the eye lubricant.
■ Open the sx pack
■ Wear sx gloves and create the sterile area where you are performing the sx
■ Put the drape on the AGS (make a hole if it has not one to expose only the abdomen area and cover the rest 
of the body)
■ Make the skin incision with the scalpel blade #10 on the abdominal midline
■ Using the hemostat retract the skin and the fat
■ Make an incision along the linea alba with the scalpel blade, hold the blade up side down (the non­
sharp edge is parallel/in contact with the rat abdomen)
■ Using the hemostat open the muscle sheet along the linea alba
■ Wet the ibutton with saline and insert it into the abdomen
■ Start closing the incision (the linea alba is sutured closed using a simple interrupted pattern with 3-0 chromic 
gut (absorbable) taper, RB-1, ~17mm needle (or equivalent). Drip 0.25% bupivacaine (2 drops) onto suture site 
from 1mL sterile syringe and 26ga needle. Sub-cutaneous tissue is gently approximated with a simple 
continuous pattern using 3-0 absorbable suture (Dexon or PDS) with an RB-1, ~17mm needle (or equivalent). 
The skin is then sutured with 3-0 Prolene/Surgilene (non absorbable), FS-2 or FS-1 (or equivalent) with cutting 
needle using a simple interrupted pattern.Finally, the closed skin incision may be sealed where needed with 
tissue adhesive (Vetbond) administered from a 1mL sterile syringe, 25ga needle).
■ During skin closure the anesthesia can be gradually lowered to 0%
■ Prepare a new cage to house the animal after sx
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SX PACK:
■ Scalpel blade holder
■ Tooth forceps 2by1
■ Non tooth forceps
■ Small pair of scissor
■ Small needle driver
■ Hemostat 2 (just in case)
■ Gauze (in case there is a bleeding)
■ Drape for cover the animal
List Equipment:
■ SX Gloves size 6 ½
■ Transmitter gas-sterilized




■ Scalpel blade #10
■ Chromic gut 3-0/PDS monosorb 3-0/Prolene 3-0
■ Vetbond
■ Needle 26G and 20G




■ Chlorexine to clean
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Appendix B: Syllabi
Appendix B 1: Biology of Torpor Syllabus
Course information:
INDS XXX Biology of Torpor





The instructor will assign current research papers relevant to the phenomenon of torpor.
Course description:
Torpor is an energy saving strategy widely used within species. This class is a 1 credit class that will 
expand the student knowledge of hibernation and torpor. The course will provide the student with well- 
known and novel information about torpor within different phylum (i.e. Arthropoda, Chordata), 
different class (i.e. Mammalia, Aves) and in different habitat (i.e. the Arctic, Madagascar).
A focus of the individual study will be also teaching how to perform a literature search, to be exposed to 
different journals and to present the information learnt during the class.
Course Goals:
The specific goals of the course are:
• to learn about torpor in different species
• to be able to perform a literature search
• become familiar with peer-reviewed journals
Student Learning Outcomes:
At the end of the course:
1. The student will perform literature searches by using specific keywords and search engines 
as PubMed and Google Scholar providing a list with paper title, keywords and the search 
engine used, twice during the course.
2. The student will describe what is an impact factor
3. The student will recognize different article structures
4. The student will recognize when an article follows the ARRIVE guidelines
5. The student will relate the article with the journal mission ( demonstrate if the journal and 
the article are a good fit)
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6. The student will critique the fit between the article and the journal, using the table 
provided.
7. The student will be able to outline some of the article qualities for a high impact factor 
journal
8. The student will describe the difference between Torpor and Hibernation
9. The student will describe and compare Torpor in difference species
10. The student will compare torpor in different climate and habitat.
11. The student will be able to combine the knowledge in an oral presentation
12. The student will be able to communicate his/her results to peers.
Course Calendar: 
6 hours per week will be scheduled in line with the student's class schedule, the 6 hours will be broken 
down in 2.5 hours reading of the assigned paper, 2.5 hour for journal analysis and/or literature review 
and 1 hour per week will be used for paper discussion and review the journal format.
Learning objectives Due







Definition of torpor and hibernation and 
discussion
Paper-Journal Fit Form






• Paper-Journal Fit Form




Paper discussion • Paper-Journal Fit Form
• Literature search (2 
articles and keywords)











Paper discussion • Paper-Journal Fit Form
• Literature search (2 
articles and keywords)




Paper discussion • Paper-Journal Fit Form
Week 7 Oral presentation
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Instructional methods:
This is an individual study course primarily based on independent reading of the material followed by an 
active discussion with the instructor summarizing the paper findings and the quality of the study.
Evaluation:
The overall grade will be based on the total score in the following categories:
Time management (Completing tasks, following deadline, organizing the presentation) 10% 
Comprehension skills (summarizing and giving definitions) 15%
Critical thinking (the use of literature to interpret the results) 25%
Communication (content of presentation) 30%
Communication (mechanics of the presentation) 20%
98% - 100% A+
93% - 97% A
90% - 92% A-
88% -89% B+
83% - 87% B
80% - 82% B-
78% - 79% C+
73% - 77% C
70% - 72% C-



















1. The student provides a list 
with paper title, keywords 




2. The student follows the 








4. The student is able to 




5. The student is able to 
explain the ARRIVE 
guidelines
Critical Thinking 6. The student is able to 
relate the article structure 
to the quality of the journal
Critical Thinking 7. The student identifies the 
limitation of the study
Critical Thinking 8. The student recognizes 
different article structures 
(review, research, report) 
and give examples during 
the discussion
Critical Thinking 9. The student relates the 
article with the journal 
mission. During discussion 
the student is able to 
demonstrate if the article 
is/is not a good fit for the 
journal
Critical Thinking 10. The student critiques the fit 
between the article and the 
journal filling up the 
evaluation
Communication 11. The student describes the 
difference between Torpor 
and Hibernation
Communication 12. The student describes and 
compares Torpor in 
difference species
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Communication 13. The student compares 
Torpor in different climate 
and habitat.
Communication 14. The student uses 
appropriate graphics to 
present the information









Rubric to evaluate the mechanic of the presentation taken from:
Points 1 2 3 4 Total
Organization
There is no sequence 
of information and/or 
so much is missing 
that the presentation 
makes little sense
Information is inconsis­
tently organized (i.e. 
the visual information 
may be in order but the 
student jumps around).
Student presents infor­
mation in logical se­
quence More or less 
information would have 
been helpful
Student presents ade­




no graphics or graph­
ics are unrelated to the 
subject or distract from 
the message
Presentation includes 
graphics that rarely 
support text and pres­
entation. Graphics are 
too busy
Student’s graphics re­
late to text and presen­
tation.
Student’s graphics ex­
plain and reinforce 
screen text and pres­
entation.
Mechanics
Presentation has four 
or more spelling errors 
and/or grammatical 
errors.
Presentation has three 
misspellings and/or 
grammatical errors.
Presentation has no 
more than two mis­
spellings and/or gram­
matical errors.




Student reads all of 
report with no eye con­
tact.
Student occasionally 
uses eye contact, but 
still reads most of re­
port.
Student maintains eye 
contact most of the 
time but frequently re­
turns to notes.
Student maintains eye 
contact with audience, 





terms, and speaks too 
quietly for students in 
the back of class to 
hear.
Student's voice is low 
Student incorrectly pro­
nounces terms. Audi­
ence members have 
difficulty hearing pres­
entation
Student’s voice is 
clear Student pro­
nounces most words 
correctly Most audi­
ence members can 
hear presentation
Student uses a clear 
voice and correct, pre­
cise pronunciation of 
terms so that all audi­





Be punctual and communicate in advance any changes in schedule so we can locate a substitute 
assistant.
Support services:
Other reading materials will be available when necessary as well as longer discussion time if concepts 
have not been understood.
Disabilities services:
The instructor will work with the Office of Disabilities Services (208 WHITAKER BLDG, 474-5655) to 


















Paper-Journal Fit Evaluation Form
Paper PMID: Journal:







and add somehow 
new information
Research confirm 
previous finding and 
add novel information






The paper does 
not really fit in 
any 
categories/topics 
listed in the 
mission
Match at least one 
of the 
categories/topics 
listed in the mission
Match at least two of 
the categories/topics 
listed in the mission
Match more than 
two the 
categories/topics 




The paper does 
not follow the 
ARRIVE guidelines
Comply with the 
ARRIVE guidelines 




Comply with the 
ARRIVE guidelines 




Comply with the 
ARRIVE guidelines 




Methods Only one lab 
technique is used
More than one lab 
technique are used 
but are similar (i.e. 
immunohistochemi 
stry and histology)
More than one lab 
technique are used and 
are not similar (i.e. 
immunohistochemistry 
and PCR)
More than one lab 
technique are used 
and complement 
each other (i.e. 
immunohistochemis 
try, Western Blot, 
PCR and behavioral 
test)
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Attending a conference is a fundamental step for your professional development; it combines both the 
professional and social aspects of your work, during this experience you will develop a professional 
network that will be essential along your career.
Preparation for a conference consists of three main sections: Before (what to do and how to prepare for 
it) During (how to handle the busy schedule) After (how to complete the travel, how to consolidate new 
connections).
Before the Conference:
• Identify personal goals: The student will answer the questions: Why do you want to attend the 
conference? What do you want to gain from this experience?
• Planning: The student will need to plan ahead. The student will notify as soon as possible the 
class instructors about the intention to attend the conference. Note the main deadline: as 
submission deadline, registration deadline and travel grant submission. The student will apply 
for travel grant and plan the trip with the travel office. When available the student will apply for 
the student award or poster competition.
• Schedule: Once the conference program is released the student will make a schedule with the 
different talks and event to attend. When attending talks of major interest in the student 
project, the student will read relevant papers to prepare. The student will make a list of people 
that she/he wants to meet.
• Presentation: Prepare poster and practice the presentation several times before leaving.
During the Conference:
• Take a picture with your poster, it is important to document your presentation, usually a picture 
is requested in the travel report
• Build your network: Don't hesitate to introduce yourself: “Hi I am Carla, grad student at UAF, are 
you enjoying the conference?/ what do you think about this talk?/ is this your first time at this 
conference?” , meet people from different institutions and industry. Connect over meals and 
after conference events. If you are part of the hosting society attend the society reception.
• Don't overbook yourself, schedule break and downtime. Take some time to look over your notes 
and to think how they may apply to your research project.
After the Conference:
• If you are interested in some of the institutions, plan a visit in the local labs or facilities.
• Fill the travel report and submit the receipts.
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• Stay in touch with the new contacts; send a personal email after the conference or a follow up 
questions.
• Share the new acquired information at the next meeting with your peers.
Learning outcome:
The student will learn how to effectively attend a conference. The student will be able to use his/hers 
time to attend talks and poster sessions as well as networking.
Learning goals:
• The student will identify the criteria of a good talk after attending oral sessions.
• The student will learn how to formulate good questions. The student will listen to other people's 
questions - what makes a good or a bad question? What types of question stimulate 
discussions? What language people are using that makes a clear, concise question?
• The student will identify the good poster. First the student will identify personal preference in a 
poster layout. Then the student will evaluate the overall poster quality using the following 
questions: Does the poster tell a story? Can you read the figure legend and the text from a 
distance? Is there a “hero image”? Does it stimulate your curiosity?
• The student will learn how to introduce herself/himself: who you are, your institution, what you 
study, and why it is important. If possible, tailor the importance statement to each person so 
they immediately know why they should be interested in meeting you.
• The student will be able to explain her/his research in 1 minute/elevator speech
• The student will make at least one new connection, to start developing her/his networking skills.
• The student will learn about career options attending career development workshop or talk.
Course requirement:
Download the conference program and notes from the instructor.
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Appendix B 3: Neurochemistry Research Syllabus
Course information:
INDS F497 Neurochemistry research
Individual study 4 credits
Instructor:
Course reading materials:
Immunohistochemistry technical notes and primary immunohistochemistry literature:
• Morgan JI, Curran T. Stimulus-transcription coupling in neurons: role of cellular immediate-early genes. 
Trends Neurosci. 1989 Nov;12(11):459-62.
• Hoffman GE, Smith MS, Verbalis JG. c-Fos and related immediate early gene products as markers of 
activity in neuroendocrine systems. Front Neuroendocrinol. 1993 Jul;14(3):173-213.
Papers relevant to the research topic.
Course description:
Neurochemistry research will teach basic laboratory practice, microscopy and immunohistochemistry, a 
specific laboratory technique widely used in Neuroscience. A focus of the individual study will be 
teaching brain pathways, brain anatomy and the physiological functions associated with each brain 
region as well as good laboratory technique.
Course Goals:
The specific goals of the course are:
• to be able to perform immunohistochemistry and microscopy
• to understand and apply good laboratory practice
• to learn the hibernation phenomenon
• to understand brain pathways related to the sleep-wake cycle, thermogenesis and energy 
balance.
• to learn hypothesis driven research
• become familiar with current peer-reviewed literature related to the specific research topic
Student Learning Outcome:
At the end of the course:
1- The student will perform immunohistochemistry independently.
2- The student will apply good laboratory technique.
3- The student will be able to describe the hibernation phenomenon.
4- The student will identify the brain regions in the arctic ground squirrel using a brain rat atlas.
5- The students will be able to describe the physiological functions of each investigated brain 
regions.
6- The student will be able to sketch the investigated neuronal pathways.
7- The student will apply literature-based knowledge to develop a research hypothesis and test it.
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8- The student will collect and analyze data.
9- The student will compare the results with the initial hypothesis to proof or disproof it
10- The student will be able to connect the results with the current scientific models of sleep-wake 
cycle and thermoregulation.
11- The student will be able to communicate his/her results to peers.
Course Calendar:
12 hours per week will be scheduled in line with the student's class schedule. 9 hours will be assigned 
for laboratory experiments, data collection and analysis. 2 hours will be used for literature reviews and 
discussion and hypothesis development. 1 hour per week will be used for data discussion and updates to 
lab meeting.
Instructional methods:
This is an individual study course primarily based on hands on laboratory experience and literature 
review.
Evaluation:
1. Test of competence
The instructor will assign a brain region based on the rat atlas and ask to perform a full stain 
with assigned antibody (as cFos or GAD) and mount slides.
Referring to the Rat Brain Atlas, the student will choose the assigned slice form the wells where 
the brain is stored. He/She will perform immunohistochemistry without supervision. The 
student will deliver a mounted glass slides as a final product for the test together with the 
notebook pages of the procedure.
2. The evaluation of lab performance will be based on attention to details (as bubble on the 
mounted slides, if any slice have been lost during the procedure, if slices have been dried for too 
long etc...), completion of assigned tasks on time, notebook keeping and basic lab techniques as 
solutions making, use of the pipette, pH meter and chemical handles (location and storage of 
chemicals/reagents and waste disposal)
3. Cell count skill will be evaluated on count reproducibility between two different people on the 
same slides.
4. Hypothesis development. The student will start reading paper with the instructor and discuss 
them; we will formulate a hypothesis based on the paper. Afterwards the student will received a 
set of results which may prove or not the initial hypothesis. This will train the student to 
independently think of hypothesis while reading current literature
5. Intellectual engagement will be evaluated on the ability to contextualize the results with current 
literature. The student will perform literature review related to the background knowledge to be 
used for data interpretation.
6. Communication skills will be evaluated by poster organization/structure as well as poster 
presentation at local events as UAF Research Day and University of Alaska Biomedical 
Conference 2018.
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Points 1 2 3 4 Total
Organization
There is no sequence 
of information and/or 
so much is missing 
that the presentation 
makes little sense.
Information is inconsis­
tently organized (i.e. 
the visual information 
may be in order but the 
student jumps around).
Student presents infor­
mation in logical se­
quence More or less 
information would have 
been helpful
Student presents ade­




no graphics or graph­
ics are unrelated to the 
subject or distract from 
the message
Presentation includes 
graphics that rarely 
support text and pres­
entation. Graphics are 
too busy’.
Student’s graphics re­
late to text and presen­
tation.
Student’s graphics ex­
plain and reinforce 
screen text and pres­
entation.
Mechanics
Presentation has four 
or more spelling errors 
and/or grammatical 
errors
Presentation has three 
misspellings and/or 
grammatical errors.
Presentation has no 
more than two mis­
spellings and/or gram­
matical errors.




Student reads all of 
report with no eye con­
tact
Student occasionally 
uses eye contact, but 
still reads most of re­
port.
Student maintains eye 
contact most of the 
time but frequently re­
turns to notes.
Student mainlains eye 
contact with audience, 





terms, and speaks too 
quietly for students in 
the back of class to 
hear
Student’s voice is low. 
Student incorrectly pro­
nounces terms. Audi­
ence members have 
difficulty hearing pres­
entation.
Student's voice is 
clear Student pro­
nounces most words 
correctly Most audi­
ence members can 
hear presentation
Student uses a clear 
voice and correct, pre­
cise pronunciation of 
terms so that all audi­




The overall grade will be based on:
Lab technique (perform the experiment in an efficient way as combining incubation time with other 
tasks as making solution) 51%
Time management (Completing tasks, following deadline, organizing and planning time spent in the lab 
with class work) 13%
Critical Thinking (the use of literature to interpret the results) 13%
Communication (poste presentation) 13%
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1 The student will perform 
immunohistochemistry 
independently
2 The student will apply good 
laboratory technique
3 The student will be able to 
describe the hibernation 
phenomenon.
4 The student will identify the 
brain regions in the arctic ground 
squirrel using a brain rat atlas.
5 The students will be able to 
describe the physiological 
functions of each investigated 
brain regions
6 The student will be able
to sketch the investigated 
neuronal pathways.
7 The student will apply 
literature-based knowledge to 
develop a research hypothesis 
and test it.
8 The student will collect and 
analyze data.
9 The student will compare the 
results with the initial hypothesis 
to proof or disproof it
10 The student will be able to 
connect the results with the 
current scientific models of 
sleep-wake cycle and 
thermoregulation.
11 The student will be able to 





Be punctual and communicate in advance any changes in schedule so we can locate a substitute 
assistant.
Support services:
Other reading materials will be available when necessary as well as longer discussion time if concepts 
have not been understood.
Disabilities services:
The instructor will work with the Office of Disabilities Services (208 WHITAKER BLDG, 474-5655) to 
provide reasonable accommodation to students with disabilities.
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Appendix B 4: Neuroendocrinology Syllabus
Course information: Neuroendocrinology
Individual study 2 credits
Instructor:
Course reading materials:
Textbook: An Introduction to Neuroendocrinology Micheal Wilkinson and Richard E. Brown second 
edition, Cambridge
Papers relevant to the topic
Course description:
Neuroendocrinology investigates the interaction between the endocrine system and the brain. In this 
introductory class the endocrine system and the central nervous system will be discussed as part of the 
same integration process that regulates physiological response.
Course Goals:
This course will provide an introduction to the interaction between hormones and brain, to help the 
student understand neuroendocrine integration. The specific goals of the course are:
• to be able to explain the basic concept of hormone physiology
• to be able to describe the interaction between hormones and CNS
• to apply his/her concepts of hormone physiology to better understand the CNS
• to develop a syllabus for a specific course topic
Student Learning Outcome:
At the end of the class the student will write a Neuroendocrinology class syllabus and develop a class 
structured on the essential concepts, the important aspects and the interesting topics in neuroscience.
Course Calendar:
Reading assignments for each week to discuss: Activity in class:
Week 1 Chapter 1 Classification of chemical messengers
Chapter 2 The endocrine glands and their 
hormones
• Identify the basics 
concepts of the chapters
• Develop the learning goals 
and outcomes for the 
chapter
• Decide the topic to assign 
a paper for
Week 2 Chapter 3 The pituitary glands and their hormones 
Chapter 4 The hypothalamic hormones
Week 3 Chapter 5 Neurotransmitters
Chapter 6 Neurotransmitter and neuropeptide 
control of hypothalamic, pituitary and other 
hormones
Week 4 Chapter 7 Regulation of hormone synthesis, 
storage, release, transport and deactivation 




Week 5 Chapter 9 Steroid and thyroid hormone receptors 
Chapter 10 Receptors for peptide hormones, 
neuropeptides and neurotransmitters
Week 6 Chapter 11 Neuropeptides I: classification, 
synthesis and co-localization with classical 
neurotransmitters
Chapter 12 Neuropeptides II: function
Week 7 Chapter 13 Cytokines and the interaction between 
the neuroendocrine and immune systems 
Chapter 14 Methods of the study of behavioral 
neuroendocrinology
Week 8 Syllabus Outlines
Week 9 Research Paper Discussion
Week 10 Research Paper Discussion
Week 11 Research Paper Discussion
Week 12 Identify which activities would be 
useful to reach the learning 
objectives of the class
Week 13 Identify which activities would be 
useful to reach the learning 
objectives of the class
Week 14 Final the student would have the 
syllabus completed with the 
reading lists of papers
This is an individual study course primarily based on discussions, at the end of each class the essential 
concepts will be highlighted for each chapter.
Evaluation:
The student will be evaluated based on the quality of the discussions and on the final syllabus.
Course policies:
Weekly meetings are required, reading of the chapters before the meetings are essential to develop the 
discussion.
Support services:
Other reading materials will be available when necessary as well as longer discussion time if concepts 
have not been understood.
Disabilities services:
The instructor will work with the Office of Disabilities Services (208 WHITAKER BLDG, 474-5655) to 
provide reasonable accommodation to students with disabilities.
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Appendix B 5: Teachable Unit Optogenetics
Topic: OPTOGENETICS
Duration: 3 lectures (3 hours)
Goal and outcomes:
1. The student will familiarize with the concept of interdisciplinary using optogenetics as an 
example and he/she will be able to recognize the importance of cross-talking between 
disciplines.
a) The student will be able to illustrate how the different disciplines in 
optogenetics are important and how they are linked together.
b) The student will be able to apply the concept of interdisciplinary collaboration 
to other research techniques and in real life (defining the instructor's examples 
and giving examples themselves).
2. The student will be able to understand the principles and explain the utility of optogenetics. the 
student will also be able to apply the technique.
a) The student will be able to define the different elements required for 
optogentics (channel rhodopsin, adenovirus, optic fiber,..).
b) The student will be able to describe how the light activates the neurons.
c) The student will be able to explain the basic principles and defend the validity 
of optogenetics.
3. The student will be able to critically discuss scientific papers.
a) The student will be able to find papers on the topic using web sources as 
“pubmed”.
b) The student will be able to analyze a scientific paper using a template to help 
them training in identify the key points.
c) The student will be able to formulate a critical review on the paper after 
discussing it with classmates and instructor.
Pre-class assignment: student will read a paper assigned by the instructor about optogenetics technique 
(pure technique paper) and complete the analysis (following a template) about the paper-paper 1-. 
Lecture Day 1:
• Class discussion about paper 1 (15 min)
• Lecture about how different disciplines are used in optogenetics and general overview of the 
technique (20 min).
• Group Activity: everyone write on a piece of paper an interdisciplinary technique that can think 
of, the instructor put all of them together and every group gets one. Group discussion and the 
conclusions of each group will be written and turned in (15 min).
• Last part of the class will be dedicated to a brief web research, using key words to find paper 
about the topic (10 min).
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Pre class assignment: student will write a critical review on paper 1 and complete the analysis (following 
a template) about paper 2. The student will have a list of three papers on optogenetics found online. 
Lecture Day 2:
• Lecture on optogenetics, how channel rhodopsin is delivered in the neurons, how the neurons 
are activated and the role of the optic fiber. How turning on the light make the neurons release 
neurotransmitters. How the same structure is used to block neurons response (40 min).
• Discussion on paper 2 (10 min).
• Group activity: the groups choose a common paper between the lists the student brought to 
class (5 min).
• The instructor will give directions about the group presentations (5 min).
Pre class assignment: student will write a critical review on paper 2 and complete the analysis (following 
a template) about paper 3. Each group will be ready to present.
Lecture day 3:
• Quiz on optogenetics (15 min)
• Small Group discussion on paper 3 (10 min)
• Group presentations and discussions, each student will have to grade each presentations (it 
won't count as a grade but they will get point to do so and turn in the grade sheet) (35 min).
Critical review on paper 3 to turn in next class.
Presentations
There will be tow kind of presentation for this unit:
• short 10 min presentations for a non-scientific audience about optogenetics.
• 30 seconds elevator talk to an expert to convince him/her about the validity of the technique.
Post-assessment of this topic will occur with a short quiz at the end of the teachable unit.
On the final project the students may apply this knowledge on the experimental design for their 
research topic. On the final exam the students will have to know which the principles of optogenetics 
and its utility are.
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Appendix C: Mentoring Resources




For undergraduate teaching purpose, all materials and information were compiled from 
several online resources. All citations included.
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“Immunohistochemistry (IHC) combines anatomical, immunological and biochemical techniques to 
identify tissue components (e.g. proteins) by the interaction of target antigens with specific antibodies 
tagged with a visible label. IHC makes it possible to visualize the distribution and localization of specific 
cellular components within cells (Rogers and Hoffman, 2012).
Introduction
History
IHC takes its name from the roots "immuno", in reference to antibodies used in the procedure, and 
"histo," meaning tissue. “The principle of IHC has been known since the 1930s, but it was not until 1942 
that the first IHC study was reported. Coons et al. (1942) used FITC-labeled antibodies to 
identify Pneumococcal antigens in infected tissue. Since then, improvements have been made in protein 
conjugation, tissue fixation methods, detection labels and microscopy, making immunohistochemistry a 
routine and essential tool in diagnostic and research laboratories. “
(From https://www.thermofisher.com)
Applications
“IHC is used for disease diagnosis, drug development and biological research. Using specific tumor 
markers, physicians use IHC to diagnose a cancer as benign or malignant, determine the stage and grade 
of a tumor, and identify the cell type and origin of a metastasis to find the site of the primary tumor. IHC 
is also used in drug development to test drug efficacy by detecting either the activity or the up- or down­
regulation of disease targets. Samples are prepared on individual slides, or multiple samples can be 
arranged on a single slide for comparative analysis. IHC slides are processed and stained manually. 
Samples can be viewed by either light or fluorescence microscopy, and advances in the last 15 years 
have improved the ability to capture images. Visualizing an antibody-antigen interaction can be 
accomplished in a number of ways. In the most common instance, an antibody is conjugated to an 
enzyme, such as peroxidase, that can catalyse a colour-producing reaction. Alternatively, the antibody 
can also be tagged to a fluorophore, such as fluorescein or rhodamine (see immunofluorescence).




The immune system is a system of biological structures and processes within an organism that protects 
against disease. To function properly, an immune system must detect a wide variety of agents, known as 
pathogens, from viruses to parasitic worms, and distinguish them from the organism's own healthy 
tissue.
“Antibodies are immune system-related proteins called immunoglobulins. Each antibody consists of 
four polypeptides- two heavy chains and two light chains joined to form a "Y" shaped molecule. The 
amino acid sequence in the tips of the "Y" varies greatly among different antibodies. This variable 
region, composed of 110-130 amino acids, give the antibody its specificity for binding antigen. The 
variable region includes the ends of the light and heavy chains. Treating the antibody with a protease 
can cleave this region, producing fragment antigen binding (Fab) that includes the variable ends of an 
antibody. The constant region determines the mechanism used to destroy antigen. Antibodies are 
divided into five major classes, IgM, IgG, Iga, IgD, and IgE, based on their constant region structure and 
immune function. There are 5 types of heavy chain constant regions in antibodies. The 5 types - IgG, 
IgM, IgA, IgD, IgE - (isotypes) are classified according to the type of heavy chain constant region, and are 




IgG is the main antibody in blood. It is the only isotype that can 
pass through the placenta, and IgG transferred from the 
mother's body protects a newborn until a week after birth. IgG 
widely distributed to the blood and tissue, and protects the 
body.
IgM
IgM is made up of 5 antibodies. IgM has a key role in the initial 
immune system. It is distributed to the blood.
IgA
Secreted IgA is made up of 2 antibodies. It is distributed
to serum, nasal discharge, saliva, breast milk and bowel fluid.
Breast milk protects the gastrointestinal tract of newborns from 
bacterial and viral infection (maternal immunity).
IgD
IgD is present on the surface of B cells and plays a role in the 
induction of antibody production.
IgE
IgE is believed to be related to immunity reactions to parasites, 









Antibodies bind to a specific antigen using their variable region. This process is called the specificity of 
an antibody toward that antigen. An antibody has a pair of variable regions, one on the left and one on 
the right, and they bind to the same antigen. The binding may involve electrostatic interactions, 
hydrophobic interactions, hydrogen bonds and van der Waals forces. Since these interactive forces are 
relatively weak, the “fit” between antigen and its complementary site on the antibody must occur over 
an area large enough to allow the summation of all the possible available interactions. This requirement 
is the basis for the exquisite specificity observed in immunologic interactions. This fit is often compared 
to a lock and a key (Benjamini et al., 2000).
(Retrieved From http://www.kyowa-kirin.com/antibody/basics/specificity.html)
Antibody Production
Animals have an immune system that produces antibody corresponding to each foreign 
substance (antigen) that enters the body. Antigen-antibody Interactions are extremely high specific, 
each antibody bind only to its target antigen to remove it.
Researcher can produce an antibody against the molecule that is the target of study, as
a label to recognize the target molecule.
Polyclonal Antibody
“Antibodies used for research and diagnostic purposes are often obtained by injecting a lab animal such 
as a rabbit or a goat with a specific antigen. Within a few weeks, the animal's immune system will 
produce high levels of antibodies specific for the antigen. These antibodies can be harvested in an 
antiserum, which is whole serum collected from an animal following exposure to an antigen. Because 
most antigens are complex structures with multiple epitopes, they result in the production of multiple 
antibodies in the lab animal. This so-called polyclonal antibody response is also typical of the response 
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to infection by the human immune system. Antiserum drawn from an animal will thus contain 
antibodies from multiple clones of B cells, with each B cell responding to a specific epitope on the 
antigen.
Lab animals are usually injected at least twice with antigen when being used to produce antiserum. The 
second injection will activate memory cells that make class IgG antibodies against the antigen. The 
memory cells also undergo affinity maturation, resulting in a pool of antibodies with higher average 
affinity. Affinity maturation occurs because of mutations in the immunoglobulin gene variable regions, 
resulting in B cells with slightly altered antigen-binding sites. On re-exposure to the antigen, those B cells 
capable of producing antibody with higher affinity antigen-binding sites will be stimulated to proliferate 
and produce more antibody than their lower-affinity peers. An adjuvant, which is a chemical that 
provokes a generalized activation of the immune system that stimulates greater antibody production, is 
often mixed with the antigen prior to injection.
Antiserum obtained from animals will not only contain antibodies against the antigen artificially 
introduced in the laboratory, but it will also contain antibodies to any other antigens to which the 
animal has been exposed during its lifetime. For this reason, antisera must first be “purified” to remove 





“Some types of assays require better antibody specificity and affinity than can be obtained using a 
polyclonal antiserum. To attain this high specificity, all of the antibodies must bind with high affinity to a 
single epitope. This high specificity can be provided by monoclonal antibodies (mAbs). Unlike polyclonal 
antibodies, which are produced in live animals, monoclonal antibodies are produced in vitro using 
tissue-culture techniques. mAbs are produced by immunizing an animal, often a mouse, multiple times 
with a specific antigen. B cells from the spleen of the immunized animal are then removed. Since normal 
B cells are unable to proliferate forever, they are fused with immortal, cancerous B cells called myeloma 
cells, to yield hybridoma cells. All of the cells are then placed in a selective medium that allows only the 
hybridomas to grow (HAT medium); unfused myeloma cells cannot grow, and any unfused B cells die off. 
The hybridomas, which are capable of growing continuously in culture while producing antibodies, are 
then screened for the desired mAb. Those producing the desired mAb are grown in tissue culture; the 
culture medium is harvested periodically and mAbs are purified from the medium. This is a very 
expensive and time-consuming process. It may take weeks of culturing and many liters of media to 
provide enough mAbs for an experiment or to treat a single patient. mAbs are expensive.” (From 
https://courses.lumenlearning.com/microbiology/chapter/polyclonal-and-monoclonal-antibody-production/ )
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Table 1. Characteristics of Polyclonal and Monoclonal Antibodies
Monoclonal Antibodies Polyclonal Antibodies
Expensive production Inexpensive production
Long production time Rapid production
Large quantities of specific 
antibodies
Large quantities of nonspecific 
antibodies
Recognize a single epitope on an 
antigen
Recognize multiple epitopes on 
an antigen
Production is continuous and 
uniform once the hybridoma is made






"An antibody's specificity results from the antigen-binding site formed within the variable regions— 
regions of the antibody that have unique patterns of amino acids that can only bind to target antigens 
with a molecular sequence that provides complementary charges and noncovalent bonds. There are 
limitations to antibody specificity, however. Some antigens are so chemically similar that cross­
reactivity occurs; in other words, antibodies raised against one antigen bind to a chemically similar but 
different antigen. Consider an antigen that consists of a single protein with multiple epitopes. This single 
protein may stimulate the production of many different antibodies, some of which may bind to 
chemically identical epitopes on other proteins.
Cross-reactivity is more likely to occur between antibodies and antigens that have low affinity or avidity. 
Affinity, which can be determined experimentally, is a measure of the binding strength between an 
antibody's binding site and an epitope, whereas avidity is the total strength of all the interactions in an 
antibody-antigen complex (which may have more than one bonding site). Avidity is influenced by affinity 
as well as the structural arrangements of the epitope and the variable regions of the antibody. If an 
antibody has a high affinity/avidity for a specific antigen, it is less likely to cross-react with an antigen for 






Preparation of the sample is critical to maintain cell morphology, tissue architecture and the antigenicity 
of target epitopes. This requires proper tissue collection, fixation and sectioning. A common solution is 
paraformaldehyde.
Tissue Collection and Perfusion
Tissue must be rapidly preserved to prevent protein degradation and tissue architecture damages.
Often, the tissue is perfused. Perfusion is performed on anesthetized animals by using a peristaltic 
pump, tissue is rinsed with sterile saline to eliminate any blood residual and to prevent the detection of 
hematologic antigens, which may interfere with the detection of target protein. Next, the target organ 
or tissue is collected for IHC. (From https://www.scribd.com/document/112873948/IHC)
Tissue Fixation
“The broad objective of tissue fixation is to preserve cells and tissue components in a “life-like state” 
and to do this in such a way as to allow for the preparation of thin, stained sections. For practical 
purposes fixation aims to prevent or arrest the degenerative processes which commence as soon as a 
tissue is deprived of its blood supply. Loss and diffusion of soluble substances must be avoided as far as 
possible by precipitation or coagulation of these components or by cross-linking them to other insoluble 
structural components. Tissues must retain reactivity to stains and other reagents including antibodies 
and nucleic acid probes.” (From https://www.leicabiosystems.com/pathologyleaders/fixation-and-fixatives-1- 
the-process-of-fixation-and-the-nature-of-fixatives/)
“Fixation chemically crosslinks proteins or reduces protein solubility, which can mask target antigens 
during prolonged or improper fixation. Therefore, the right fixation method must be optimized based on 
the application and the target antigen to be stained. The most common fixative is formaldehyde, a semi- 
reversible, covalent crosslinking reagent that can be used for perfusion or immersion fixation for any 
length of time, depending on the level of fixation required”. (Retrieved from 
https://www.thermofisher.com)
“The non-coagulant fixing agents chemically react with proteins and other cell and tissue components, 
becoming bound to them by addition and forming inter-molecular and intra-molecular cross-links, 
covalent chemical bonds. Because these agents are reactive compounds they bind to a variety of 
chemical groups in tissues, often affecting the charge at the site of attachment.
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These crosslinking fixatives-especially formaldehyde-tend to preserve the secondary 




The decision to section tissue is dependent upon the application used; Formalin-fixed tissue is sectioned 
into slices as thin as 4 to 5μm with a pre-cooled cryostat (-20°C) and mounted to adhesive glass slides or 
stored in well-plates for free floating immunohistochemistry
Immunohistochemistry
Immunohistochemistry (IHC) is the process of using monoclonal or polyclonal antibodies to detect 
proteins (antigens) in cells within a tissue section as brain but other tissue as liver, heart.... IHC localizes 
specific proteins in tissue with labeled antibodies based on antigen-antibody interactions. This method 
gives information in a spatial manner (e.g. specific proteins are detected in specific brain structures). A 
marker including fluorescent dyes and enzymes visualizes the immune reactive products.
Direct: Primary Antibody Only
“Direct method is one step staining method, and involves a labeled antibody (i.e. FITC conjugated 
antiserum) reacting directly with the antigen in tissue sections. This technique utilizes only one 
antibody and the procedure is short and quick. However, it is insensitive due to little signal amplification 
and rarely used since the introduction of indirect method.” (From http://www.abcam.com/secondary- 
antibodies/direct-vs-indirect-immunofluorescence)
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Indirect: Primary and Secondary Antibodies
“Indirect method involves an unlabeled primary antibody (first layer) which reacts with tissue antigen, 
and a labeled secondary antibody (second layer) reacts with primary antibody (Note: The 
secondary antibody must be against the IgG of the animal species in which the primary antibody has 
been raised). This method is more sensitive due to signal amplification through several 
secondary antibody reactions with different antigenic sites on the primary antibody. In addition, one 
labeled second layer antibody can be used with many first layer antibodies (raised from the same animal 
species) to different antigens. The second layer antibody can be labeled with a fluorescent dye called 
indirect immunofluorescence method. The second layer antibody may be labeled with an enzyme such 




• Incubate sections with H2O2 (hydrogen peroxide). Endogenous peroxide characterized the tissue. 
To avoid peroxide activity a pre-treatment with H2O2 produce an irreversible inactivation. This 
step will decrease non-specific background.
• Incubate in in blocking solution from the animal used for the secondary antibody. If secondary 
antibody is made in goat, normal goat serum (NGS) is used. Serum carries antibodies that will 
bind to the non-specific epitopes in the tissue, thus blocking the antibody used from binding to 
these non-specific epitopes. Important step when using polyclonal antibodies.
• Incubate sections in Primary Antibody (Ab). Dilution reported in the package is a starting point; 
the optimal dilution for the sample is identified by titration.
• Incubate sections in biotinylated Secondary Antibody. Dilution reported in the package is a 
starting point; the optimal dilution for the sample is identified by titration.
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Amplification step
Amplification step using the ABC kit (From https://www.thermofisher.com):
Biotin, also known as vitamin H, is a small molecule (MW 244.3) that is present in tiny amounts in all 
living cells and is critical for a number of biological processes. The valeric acid side chain of the biotin 
molecule can be derivatized in order to incorporate various reactive groups that are used to attach 
biotin to other molecules. In the context of IHC, biotin is conjugated to antibodies or to the enzyme 
reporters used to detect target antigens (e.g. Biotinylated Goat Anti-Rabbit IgG Antibody) 
The extraordinary affinity of avidin for biotin allows biotin-containing molecules in a complex mixture to 
be specifically bound to avidin. Avidin is a glycoprotein found in the egg white and tissues of birds, 
reptiles and amphibia. It contains four identical subunits having a combined mass of 67 to 68kDa. Each 
subunit consists of 128 amino acids and binds one molecule of biotin; thus, a total of four biotin 
molecules can bind to a single avidin molecule. The extent of glycosylation on avidin is very high; 
carbohydrates account for about 10% of the total mass of the tetramer. Avidin has a basic isoelectric 
point (pI) of 10 to 10.5 and is stable over a wide range of pH and temperatures. Extensive chemical 
modification has little effect on the activity of avidin, making it especially useful for protein purification. 
However, because of its carbohydrate content and basic pI, avidin exhibits relatively high nonspecific 
binding properties.
Avidin-biotin binding is the strongest known non-covalent interaction between a protein and ligand. The 
bond formation between biotin and avidin is very rapid, and once formed, is unaffected by extremes in 
pH, temperature, organic solvents and other denaturing agents. These features of avidin make detecting 
or purifying biotin-labeled proteins or other molecules particularly useful for a number of biomedical 
applications.
Streptavidin is isolated from Streptomyces avidinii, and is similar in size and affinity for biotin. In 
contrast to avidin, though, streptavidin is not glycosylated, which makes the protein less-prone to 
nonspecific binding in IHC applications. There are considerable differences in the composition of avidin 
and streptavidin, but they are remarkably similar in other respects. Streptavidin is also a tetrameric 
protein, with each subunit binding one molecule of biotin with affinity similar to that of avidin. 
Streptavidin is much less soluble in water than avidin. Guanidinium chloride at pH 1.5 will dissociate 
avidin and streptavidin into subunits, but streptavidin is more resistant to dissociation.
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Reporter intensity is a function of the localized enzyme activity, and improved sensitivity can be 
achieved by increasing the number of enzyme molecules bound to the target antigen. The multiple 
biotin binding sites in each tetravalent avidin molecule are ideal for achieving this amplification.
1. The primary antibody is incubated with the tissue sample to allow binding to the target antigen.
2. A biotinylated secondary antibody, with specificity against the primary antibody, is incubated with 
the tissue sample to allow binding to the primary antibody.
3. A biotinylated enzyme (HRP or AP) is pre-incubated with free avidin to form large avidin-biotin- 
enzyme complexes. Typically, the avidin and biotinylated enzyme are mixed together in a specified 
ratio (1:1) to prevent avidin saturation and incubated for about 15 minutes at room temperature to 
form the complex.
4. An aliquot of this solution is then added to the tissue sample, and any remaining biotin-binding sites 
on the avidin bind to the biotinylated antibody that is already bound to the tissue.
The result is a greater concentration of enzyme (three enzyme molecules to one avidin molecule) at the 






Triton-X 100% is a detergent used to improve membrane penetration of antibody. (Do not use 
when membrane-associated antigens are investigated)
DAB (3, 3'-diaminobenzidine), a derivative of benzene, is an organic compound that is used in 
the staining of nucleic acids and proteins, most commonly for immunohistochemical 
procedures. Although it is water soluble in its unoxidized form, it forms a water-insoluble brown 
precipitate when oxidized. In immunohistochemical procedures, the location of proteins can be 
detected using DAB as a substrate. The secondary antibody is conjugated with a 
peroxidase enzyme (HRP), and in the presence of hydrogen peroxide (H2O2), DAB is readily 
catalyzed to its oxidized form, forming a brown precipitate.
181
(From https://www.sheffield.ac.uk/polopoly_fs/1.458351!/file/IHC_bitesize.pdf)
Troubleshooting (From https://www.abcam.com/protocols/troubleshooting-and-using-controls-in-ihc-and-icc) 
No staining
The primary antibody and the secondary antibody are not compatible
Use a secondary antibody that was raised against the species in which the primary was raised (e.g. 
primary is raised in rabbit, use anti-rabbit secondary). Be sure that the isotypes of the primary and 
secondary are compatible (e.g. IgY vs. IgG).
Not enough primary antibody is bound to the protein of interest
Concentrate the antibody more, incubate longer (e.g. overnight) at 4°C.
The antibody may not be suitable for IHC procedures
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Check the antibody datasheet to see if it has been validated in IHC, and what type of IHC (formalin/PFA 
fixation, fresh frozen, etc.).
Test the antibody in a native (non-denatured) WB to make sure it is not damaged.
The primary/secondary antibody/amplification kit may have lost its activity due to improper storage, 
improper dilution or extensive freezing/thawing
Run positive controls to ensure that the primary/secondary antibody is working properly (see section 4 
for more information about controls).
The protein is not present in the tissue of interest
Run a positive control recommended by the supplier of the antibody (see section 4 for more information 
about controls).
The protein of interest is not abundantly present in the tissue
Use an amplification step to maximize the signal. For example, use a biotin conjugated secondary 
antibody and a conjugated streptavidin.
The secondary antibody was not stored in the dark (if your detection system is immunofluorescence).
Always prevent the secondary antibody from exposure to light.
Fixation procedures (using formalin and paraformaldehyde fixatives) may be modifying the epitope 
the antibody recognizes
Use different antigen retrieval methods to unmask the epitope (heat mediated with pH 6 or pH 9 buffer, 
enzymatic, etc.).
Fix the sections for less time.
The protein is located in the nucleus and the antibody (nuclear protein) cannot penetrate the nucleus 
Add a strong permeabilizing agent like Triton X to the blocking buffer and antibody dilution buffer. See 
our protocol about permeabilization techniques.
The PBS buffer is contaminated with bacteria that damage the phosphate groups on the protein of 
interest
Add 0.01% azide in the PBS antibody storage buffer or use fresh sterile PBS.
High background
Blocking of non-specific binding might be absent or insufficient
Increase the blocking incubation period and consider changing blocking agent. Abcam recommends 10% 
normal serum of the species of the secondary antibody for 1 hr, or 1-5% BSA for 30 min for cells in 
culture.
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Another option is to try a secondary antibody that has been pre-adsorbed against the lg of the species of 
your samples.
The primary antibody concentration may be too high
Titrate the antibody to the optimal concentration, dilute the antibody further and incubate at 4°C (a 
slow but targeted binding is best).
Incubation temperature may be too high
Incubate sections or cells at 4°C.
The secondary antibody may be binding non-specifically
Run a secondary control without primary antibody.
If you see staining with your secondary only, change your secondary or use a secondary antibody that 
has been pre-adsorbed against the lg of the species of your samples.
Tissue not washed enough, fixative still present
Wash extensively in PBS between all steps.
Endogenous peroxidases are active
Use enzyme inhibitors i.e. Levamisol (2mM) for alkaline phosphatase or H2O2 (0.3% v/v) for peroxidase. 
Fixation procedures (using formalin or paraformaldehyde fixatives) are causing autofluorescence (if 
your detection system is immunofluorescence)
Formalin/PFA usually autofluorescence in the green spectrum, so try a fluorophore in the red range.
Use a fluorophore in the infrared range if you have an infrared detection system.
Too much amplification (amplification technique)
Reduce amplification incubation time and dilute the secondary antibody or amplification kit.
Too much substrate was applied (enzymatic detection)
Dilute substrate more and reduce substrate incubation time.
The chromogen reacts with the PBS present in the cells/tissue (enzymatic detection)
Use Tris buffer to wash sections prior to incubating with the substrate, then wash sections/cells in Tris 
buffer.
Permeabilization has damaged the membrane and removed the membrane protein (membrane 
protein)
Use a less stringent detergent (e.g.) Tween 20 instead of Triton X). Or simply remove permeabilizing 
agent from your buffers. See our protocol about permeabilization techniques.
Non-specific staining
Primary/secondary antibody concentration may be too high
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Try decreasing the antibody concentration and/or the incubation period. Compare signal intensity 
against cells or tissue that do not express the target.
Endogenous peroxidases are active
Use enzyme inhibitors i.e. Levamisol (2 mM) for alkaline phosphatase or H2O2 (0.3% v/v) for peroxidase.
The primary antibody is raised against the same species as the tissue stained (e.g. mouse primary 
antibody tested on mouse tissue). When the secondary antibody is applied it binds to all the tissue as 
it is raised against that species
Use a primary antibody made against a different species than your tissue. Use a biotinylated primary 
antibody and a conjugated streptavidin for the detection system.
The sections/cells have dried out
Keep sections/cells at high humidity and do not let them dry out.
Using controls
Positive controls
Why positive controls are necessary:
To validate the staining in your sample, use a positive control. This is a section from a cell line or tissue 
known to express the protein you are detecting. A positive result from the positive control, even if the 
samples are negative, will indicate the procedure is optimized and working. It will verify that any 
negative results are valid.
How to know what tissue type or cell line is a suitable positive control:
1. First check the antibody datasheet. This will often provide a suggested positive control. Always 
ensure the tissue or cell line you use is from a tested species.
2. If the antibody datasheet does not list a positive control, we recommend the following in these 
circumstances:
a. Check to see if there are any Abreviews for the antibody. Any tissues, cells or lysates 
that have been used successfully by these customers can be considered a suitable 
positive control.
b. Try looking at the Swiss-Prot or Omnigene database links on the datasheet. These 
databases will often have a list of tissues that the protein is expressed in. These can also 
be considered suitable positive controls.
c. Check the GeneCards entry for the protein. This will usually provide you with relative 
levels of expression in various tissues.
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d. Check the Human Protein Atlas for the protein. This has a database of protein detection 
in different tissue types, cancers, and cell lines. Find this at www.proteinatlas.org.
e. If you still have difficulty finding a suitable control, we recommend doing a quick 
literature search on PubMed to see which tissues and cells express the protein of 
interest.
Negative controls
Why negative controls are necessary:
Use a section from a cell line or tissue sample known not to express the protein you are detecting. This 
is to check for non-specific binding and false positive results. Recommended negative control tissues are 
knock down (KD) or knock out (KO) tissue samples.
No primary controls
This is when the primary antibody is not added to the sample. This indicates if any non-specific binding 
or false positives may be due to non-specific binding of the secondary antibody.
Antibody dilution buffer containing no antibody is incubated on the same sample in the same way as 
usual.
Isotype controls
An isotype control is an antibody of the same isotype (IgG2a, IgY, etc.), clonality, conjugate, and host 
species as the primary antibody that is raised against a molecule that is non-existent in the sample you 
are using. Usually this is raised against a chemical or a non-mammalian protein.
Use the same concentration (μg∕ml) for the isotype control antibody and the primary antibody. This will 
determine the level of background in your sample.
Much like the no-primary control step, you would use this on your sample instead of the specific primary 
antibody. You would then use your secondary antibody as usual.
(From http://www.abcam.com/protocols/troubleshooting-and-using-controls-in-ihc-and-icc)
Indirect Immunoenzyme
Arctic ground squirrel, hypothalamic slice:
TRH neurons brown DAB, cFos neurons Ni-DAB 
Carla Frare, 2015
Indirect Immunofluorescence
Arctic ground squirrel, hypothalamic slice: 
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Appendix C 2: Undergraduate Research Mentoring Contract
Undergraduate Research Mentoring Contract
This agreement is between the Mentor,...... , and the Mentee,........... , and will last for the approximate
time period of four months and then informally thereafter.
Both Mentor and Mentee agree to meet daily in the lab setting and once per week to discuss progress 
and research papers and maintain communication between meetings via communication methods 
deemed appropriate by both parties.
The Mentor agrees to:
> Maintain communication and be available to provide assistance and support as needed;
> Assist Mentee in identifying goals and projects that would be beneficial to her;
> Advise Mentee as to services at the institution that would benefit her;
> Be honest with the Mentee and give praise as well as constructive criticism; and
> Send articles and reading materials that would benefit the Mentee.
The Mentee agrees to:
> Maintain communication;
> Ask for assistance as the need arises;
> Complete tasks by the established deadlines; and
> Read all the articles and materials sent by the Mentor.
Discussions between the Mentor and the Mentee will be discreet unless otherwise discussed and agreed 
to by both parties. Both the Mentor and the Mentee agree to follow the guidelines of this agreement for 
the period specified and to make a good faith effort to resolve any issues that may arise.
Mentor Signature and Date Mentee Signature and Date
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Expected learning outcomes:
1. The student will master the brainstem anatomy and will be able to identify the nuclei of 
interests in the ground squirrel brain.
2. The student will gain a wide understanding of hibernation through literature review.
3. The student will learn how to perform literature search.
4. The student will learn the brainstem physiological function.
5. The student will learn how to formulate hypotheses and how to link the brainstem functions to 
the phenomenon of hibernation.
6. The student will master immunohistochemistry, a widely used laboratory technique.
7. The student will be able to confidently use the microscope, learning the basic components and 
their functions.
8. The student will perform data analysis, first acquiring images, then doing cell counting and at 
the end performing statistical analysis.
Final products:
• Poster to present at the sleep conference.
• Data will be included in a publication which defines brain nuclei activated by CHA in 
hypothalamus and brainstem.
Student's Expectation from the research experience:
Approximately number of hours available per week _______________________________________
Day and hours when the student will be in the lab
If the student must deviate from the agreed schedule (e.g. to study for an exam), then she/he will 
communicate this to the mentor at least three days before the change occurs.
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Appendix C 3: Student's Performance Evaluation
Student's Performance Evaluation
Circle one: 1=I understand the skill and work independently, 2= I understand the skill but not 
effectively independent, 3= I understand the skill with help, 4= I don't understand the skill yet
1. Knowledge Application
• Ability to apply knowledge to the 
research field
1 2 3 4 n/a
• Ability to search independently 1 2 3 4 n/a
• Knowledge of primary scientific 
literature in the research field
1 2 3 4 n/a
2. Problem Solving Skills
• Ability to identify a problem and 
suggest solution
1 2 3 4 n/a
• Ability to use resources 
(technology, literature) to make 
decisions and solve problems
1 2 3 4 n/a
• Ability to apply knowledge to 
solve problems
1 2 3 4 n/a
• Ability to see underlying 
connections between concepts 
from different subjects areas
1 2 3 4 n/a
3. Lab Skills
• Use of laboratory equipment
1 2 3 4 n/a
• Follows laboratory safety
• procedures
1 2 3 4 n/a
• Lab record keeping and data
• gathering
1 2 3 4 n/a
• Ability to design and conduct 
experiment
1 2 3 4 n/a
• Ability to analyze results 1 2 3 4 n/a
• Ability to interpret data by 
relating to original hypothesis 
and current literature
1 2 3 4 n/a
4. Teamwork Skills
• Ability to give and receive 
constructive criticism
1 2 3 4 n/a
• Ability to take charge of tasks 
without being asked
1 2 3 4 n/a
• Ability to complete assigned tasks 
timely




1 2 3 4 n/a
• Writing Skills 1 2 3 4 n/a
6. General Competencies:
• Take initiative
1 2 3 4 n/a
• Time management 1 2 3 4 n/a
• Troubleshooting 1 2 3 4 n/a
• Reliability and dependability 1 2 3 4 n/a
• Capacity of improvement 1 2 3 4 n/a
• Resilience and adaptability 1 2 3 4 n/a
• Understanding of professional 
and ethical responsibilities
1 2 3 4 n/a
Other Comments
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This assessment is designed to collect feedback with the purpose to benefit and improve the mentor- 
mentee relationship. This assessment will not affect any future recommendation letters. Honest and 
constructive observations and comments are highly appreciated.
Reasons for ending the mentor-mentee relationship:
Mentee Accomplishments (conference presentations, awards, technical skills, soft skills...):
What really worked during your mentee experience?
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What was not successful or where did you find difficulties during your mentee experience?
Do you think this experience helped you improving the following skills?
Provide one or more examples that 
helped you improving the skill














(Make a poster, 
presentation, 
communicate changes 






suggest novel idea, Self­
correct as needed.)
Problem Solving






(Meet deadline, good at 




(Scientific as journals, 
people who could 
answer my questions...)
Which skills will be more beneficial for your future projects/jobs?
Evaluate your mentor:




Was accessible and available N/A
Kept open communication with me N/A
Showed a reasonable interest/concern towards me N/A
's behavior and attitude were generally professional N/A
Gave feedback and constructive criticism N/A
Encourage me to participate in professional activities 
outside the University (conferences, science 
activities..)
N/A
Encourage me to submit proposals, projects.. N/A
Set clear goals and objectives N/A
Completed the goals planned together N/A
The relationship met your expectation N/A
Overall, I would work with my mentor again N/A
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Please provide suggestions to improve your mentor's mentoring style:
What was one of your favorite memories of your mentor-mentee relationship?
Sign and Date
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